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ABSTRACT 
As an alternative to blanket dry cow therapy (BDCT), selective dry cow therapy 
(SDCT) is considered a more judicious approach to antimicrobial use for the purpose of 
mastitis control during the non-lactating period.  The purpose of this research was to 
evaluate the utility of a 3M Petrifilm-based on-farm milk culture system (OFCS) for use 
in a SDCT program.  A randomized clinical trial was conducted using 16 low bulk tank 
somatic cell count (<250,000 cells/mL) dairy herds from Prince Edward Island (n = 10) 
and Quebec (n = 6), Canada.  When used to detect intramammary infection (IMI) in 
cows at drying off, the OFCS performed well with a sensitivity of 85% and specificity of 
73%.  By comparing producer-derived Petrifilm results to those obtained using an 
accurate automated reader, it was determined that producers were able to correctly 
interpret Petrifilm results with an observed agreement of 91% and kappa value of 0.82.   
The study groups comprising the clinical trial were a positive control group 
consisting of cows receiving blanket application of dry cow therapy (DCT) with the 
addition of an internal teat sealant (ITS), and the OFCS group consisting of cows 
selectively treated at drying off based on OFCS results with ITS alone (Petrifilm 
negative) or DCT + ITS (Petrifilm positive).  No significant differences in postcalving 
IMI risk and risk of clinical mastitis in the first 120 days of the subsequent lactation were 
detected between the study groups.  Furthermore, no significant differences were 
observed between study groups regarding test day milk yield and somatic cell count in 
the first 180 days of the subsequent lactation.  Petrifilm-OFCS-based SDCT enabled a 
reduction in DCT of 21% as compared to BDCT.  
vi 
 
 The effect of ITS on the interdependence of quarters towards the acquisition of 
new IMI (NIMI) with coagulase negative staphylococci (CNS) over the dry period was 
also investigated.  It was demonstrated that in cows that were infused with ITS, the 
presence of CNS in another quarter at drying off was a risk factor for CNS NIMI, but this 
association was absent in cows without ITS infusion.  This unexpected finding may have 
resulted from inadvertent introduction of CNS during ITS infusion.  In quarters of cows 
without a CNS IMI at drying off (i.e. without a source of contagious CNS), ITS was 
protective against CNS NIMI suggesting that CNS infection over the non-lactating period 
can be partly attributed to CNS species located within the environment.  
 According to economic analyses, OFCS-based SDCT resulted in a marginally 
higher total cost per cow than BDCT.  However, OFCS-based SDCT provided the 
combined benefits of lowering DCT treatment risk without increasing the risk of 
postcalving IMI, and was superior economically to a SDCT program based on somatic 
cell count and clinical mastitis history.  Overall, the Petrifilm OFCS was an accurate 
diagnostic tool that was effective in reducing DCT use without compromising the health, 
welfare, and future milk production of the cow. 
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CHAPTER 1. GENERAL INTRODUCTION 
 
1.1 Bovine mastitis 
Mastitis is defined as inflammation of the mammary gland.  In dairy cows, this 
inflammation is almost always due to infection with bacteria, but mycotic pathogens, 
viruses, and trauma can also play causative roles (Radostits et al., 1994).  When infection 
of the mammary gland results in visible changes in the milk, with or without signs of 
inflammation (heat, pain, redness, and swelling) in the quarter, a diagnosis of clinical 
mastitis is made.  In acute clinical mastitis, systemic signs such as fever, anorexia, 
tachycardia, tachypnea and dehydration are also exhibited.  Subclinical mastitis is 
characterized only by an increase in inflammatory cells within the milk and is therefore 
undetectable by the naked eye (Blowey and Edmondson, 2010). 
Classification of mastitis is commonly based on the source of infection.  Mastitis 
is considered environmental in origin when the source of the causative pathogen is the 
environment in which the cow lives.  Mastitis pathogens with environmental reservoirs 
include: non-Streptococcus agalactiae streptococci, coliforms, Trueperella pyogenes, 
yeasts, molds, and algae (Blowey and Edmondson, 2010).  Contagious mastitis occurs as 
a result of cow-to-cow transmission of pathogens that reside within the udder.  
Contagious pathogens include: Staphylococcus aureus (Staph. aureus), Streptococcus 
agalactiae, Mycoplasma spp., and Corynebacterium spp (Blowey and Edmondson, 
2010).  In addition to the above, coagulase negative staphylococci (CNS) are a group of 
mastitis-causing bacteria comprising both environmental and contagious species 
(Piessens et al., 2012).  Coagulase negative staphylococci and Corynebacterium spp. are 
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considered minor mastitis pathogens because infection with these bacteria generally 
results in only a minor inflammatory response (Bradley et al., 2012).  It is important to 
note that while the organization of mastitis pathogens into contagious and environmental 
categories is a classical approach, recent studies have demonstrated that certain species of 
mastitis-causing bacteria have strain-specific behaviours such that a strain of a contagious 
pathogen can exhibit environmental properties (i.e. the ability to survive in the 
environment) or a strain of environmental pathogen can possess contagious properties 
(i.e. the ability to persist in the mammary gland; Bradley et al., 2012).  Mastitis is a very 
important disease in the dairy industry because it is common, costly, and production-
limiting.  In Canada, the mean incidence rate for clinical bovine mastitis was reported to 
be 23 cases per 100 cow-years (Olde Riekerink et al., 2008).  As a consequence of 
treatment, discarded milk, veterinary fees, reduced milk production, and culling, a case of 
clinical mastitis can incur financial losses averaging CAD$1,050 (Huijps et al., 2008; 
CBMRN, 2009).  Furthermore, estimates of milk yield losses for clinical mastitis average 
around 300 to 400 kg per case and losses associated with subclinical mastitis can be even 
greater (Hortet and Seegers, 1998a; Hortet and Seegers, 1998b). 
 
1.2 The dry period 
 In dairy production, the non-lactating or dry period is a time of rest between 
successive lactations and is generally 6 to 8 weeks in length.  With respect to udder 
health, the purpose of the dry period is to provide an opportunity for mammary epithelial 
cells to regress, proliferate, and differentiate with the ultimate goal of maximizing milk 
production in the subsequent lactation (Capuco et al., 1997).  The practice of drying off 
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cows prior to calving originated in the early 1900s (Arnold and Becker, 1936) and is still 
widely practiced today, but recently there has been much debate regarding the optimal 
length of the dry period (van Knegsel et al., 2013).  Beyond milk production effects, dry 
period length has an influence on other important factors in the subsequent lactation such 
as fertility and the incidence of metabolic disease.  While some studies have 
demonstrated that shortening or abolishing the dry period resulted in increases to 
production income, improved fertility, and reductions in the frequency of postpartum 
diseases, others have failed to show any benefit of deviating from the traditional 50 to 60 
days (Rastani et al., 2005; Andersen et al., 2005; Kuhn et al., 2006).  In a recent meta-
analysis of 24 randomized controlled trials, van Knegsel et al. (2013) concluded that 
shortening of the dry period actually reduced milk production and did not affect fertility 
nor the incidence of important postpartum diseases such as mastitis, metritis, or displaced 
abomasums. 
 
1.3 Intramammary infection during the dry period 
For almost 65 years, the dry period has been recognized as the stage of the 
lactation cycle with the highest incidence of new intramammary infection (NIMI).  In a 
classic paper by Neave et al. published in 1950, it was reported that the incidence rate for 
NIMI was six times higher during the first 21 days of the dry period than at any time 
during the preceding lactation (Neave et al., 1950).  Subsequent studies have confirmed 
an increase in susceptibility to NIMI after drying off and have identified a second high 
risk period occurring in the late dry period (Oliver and Mitchell, 1983; Smith et al., 1985; 
Bradley and Green, 2000). 
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A better understanding of the dynamics of NIMI over the dry period can be had 
with some general knowledge of mammary gland physiology (for an in-depth review see: 
Smith and Todhunter, 1982; Bradley and Green, 2004).  Three phases of the dry period 
have been described: active involution, steady-state involution, and colostrogenesis 
(Smith and Todhunter, 1982).  During the first phase of the dry period (involution), there 
is an increase in susceptibility to NIMI as a result of the cessation of milking and a slow 
transition to steady-state involution (Sordillo and Nickerson, 1988; Bradley and Green, 
2004).  In the absence of the milking routine, germicidal teat-dipping stops and bacteria 
are no longer expelled from the teat canal.  Furthermore, the accumulation of milk within 
the udder and resulting increase in intramammary pressure causes the teat canals to 
remain open and be at risk for bacterial invasion (Bradley and Green, 2004). 
Once fully involuted, protection against NIMI is partially conferred by the 
presence of a keratin plug which blocks the teat orifice and teat canal (Comalli et al., 
1984).  Additionally, because of high levels of lactoferrin (an antimicrobial protein), 
elevated concentrations of leukocytes, and the absence of nutritive milk, the mammary 
parenchyma is not conducive to bacterial proliferation (Jensen and Eberhart, 1981; 
Sordillo et al., 1997; Bradley and Green, 2004).  Because mastitis pathogens enter the 
gland via the teat canal, the rate at which the keratin plug is formed is considered to be a 
key factor in determining the risk of NIMI at the quarter-level.  Keratin plug formation 
can be delayed or absent altogether, thus leaving the teat canal unprotected against 
pathogen migration (Williamson et al., 1995; Dingwell et al., 2004).  In quarters without 
a functional keratin plug, the risk of NIMI increases by a factor of 1.7, and it is estimated 
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that 5 to 23% of teats experience a failure or extended delay in plug formation 
(Williamson et al., 1995; Dingwell et al., 2004). 
During the last phase of the dry period, the mammary gland is once again at 
increased risk for NIMI.  With impending parturition, colostrum production is initiated 
and the accumulation of mammary secretions leads to the dilution of protective factors 
within the gland (Bradley and Green, 2004).  Furthermore, as calving approaches, the 
keratin plug breaks down leaving the teat canal patent and in danger of bacterial invasion 
(Oldham et al., 1991). 
 
1.3.1 Impact of dry period intramammary infection on the subsequent lactation 
Perhaps of utmost importance when considering the dynamics of intramammary 
infection (IMI) over the dry period are the effects of dry period acquired infections on 
the subsequent lactation.  While clinical mastitis is rare in non-lactating cows, IMI 
present at calving are a significant cause of clinical mastitis in early lactation (Bradley 
and Green, 2000; Bradley and Green, 2001; Green et al., 2002).  Using DNA 
fingerprinting, Bradley and Green (2000) estimated that 52% of all cases of clinical 
coliform mastitis occurring in the first 100 days of lactation can be traced-back to NIMI 
acquired during the dry period.  Regarding the effects on milk production in the 
subsequent lactation, it is estimated that IMI present at calving, either because of failure 
to eliminate existing infections or acquisition of new infections, can reduce lactational 
milk yields by 5% (Hogeveen, 2003; Berry et al., 2004). 
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1.4 Mastitis control during the dry period 
Considering the negative consequences associated with IMI at calving, mastitis 
control measures during the dry period are particularly important for a healthy and 
productive subsequent lactation. The aim of mastitis control during the dry period is to 
minimize the prevalence of IMI at the beginning of the next lactation, and in order to 
attain that goal, both prevention of NIMI and effective clearing of existing IMI must 
occur. 
 
1.4.1 Dry cow antibiotic therapy 
Dry cow antibiotic therapies, commonly known as dry cow therapy (DCT), are 
long-acting intramammary antimicrobials that are administered to cows at the end of 
lactation for the purpose of treatment and prevention of IMI.  Treatment of IMI during 
the dry period has benefits over treatment in lactation for reasons such as the following: 
1) a higher dose of antimicrobial can be used, 2) in the absence of milking, antimicrobials 
are maintained within the mammary gland parenchyma for longer periods, 3) DCT are 
formulated to be slow-release and long-acting, and 4) the risk for contamination of 
saleable milk is reduced (Blowey and Edmondson, 2010).  Consequently, when DCT is 
used to treat existing IMI present at drying off, high cures rates can be achieved.  In a 
meta-analysis of 22 peer-reviewed studies on the effectiveness of DCT, the cure risk for 
IMI by any pathogen was estimated at 78%; the spontaneous cure risk (i.e. the risk in 
untreated quarters) according to the same study was only 46% (Halasa et al., 2009a).   
Regarding protection against NIMI, the effectiveness of DCT is uncertain.  
Despite infusion with DCT at drying off, a large proportion of previously uninfected 
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quarters will become infected over the dry period (Godden et al., 2003; Arruda et al., 
2013).  While DCT is considered protective against Streptococcus spp., there is a lack of 
evidence supporting a prophylactic effect against coliforms and questionable efficacy 
against Staphylococcus spp. (Halasa et al., 2009b).  With respect to the etiology of dry 
period NIMI, in the absence of the milking routine and related risk factors for the cow-to-
cow transfer of mastitis pathogens, non-lactating cows are at greater risk of infection with 
environmental pathogens, such as coliforms and non-Streptococcus agalactiae 
streptococci, than they are with contagious pathogens (Oliver and Mitchell, 1983; Smith 
et al., 1985; Green et al., 2002; Godden et al., 2003; Dingwell et al., 2003).  Therefore, an 
important drawback of DCT is that they are ineffective against coliform bacteria, 
environmental pathogens which pose an important new infection risk during the dry 
period.  Even when effective against the pathogen of concern, as a result of declining 
concentration of active compound over time, DCT do not protect against NIMI in the 
periparturient period when infection rates are known to be high (Oliver et al., 1990). 
 
1.4.2 Internal teat sealants 
Internal teat sealants (ITS) are a non-antimicrobial alternative to DCT for the 
prevention of NIMI during the dry period.  An initial formulation consisting of bismuth 
subnitrate in a paraffin base was developed and evaluated in Ireland in the early 1970s 
but it wasn‘t until thirty years later that a commercial product became more widely 
available (Meaney, 1977).  The internal teat sealant currently available in North America 
(Orbeseal, Zoetis Canada Inc., Kirkland, QC) is an inert viscous paste, 65% bismuth 
subnitrate by weight, that forms a physical barrier within the teat cistern and canal thus 
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preventing entry of bacteria into the mammary gland (Godden et al., 2003).  Internal teat 
sealants are effective against all bacteria, including Gram-negative coliforms, and have 
been show to persist within the teat canal for up to 100 days (Woolford et al., 1998).  
According to the published literature, infusion of ITS in conjunction with DCT 
significantly reduces the risk of dry period NIMI when compared to DCT alone 
(Woolford et al., 1998; Huxley et al., 2002; Berry and Hillerton, 2002a; Sanford et al., 
2006a; Rabiee and Lean, 2013).  Furthermore, in quarters without existent IMI at drying 
off, ITS are just as effective as DCT at preventing NIMI in non-lactating cows (Woolford 
et al., 1998; Sanford et al., 2006a; Rabiee and Lean, 2013; Kromker et al., 2013).  
 
1.5 Blanket dry cow therapy 
 In the late 1960s, with the knowledge that cows are highly susceptible to NIMI 
during the non-lactating period, mastitis researchers made the recommendation to infuse 
all quarters of all cows with DCT after the last milking prior to drying off (Neave et al., 
1969).  This practice, know as blanket or total dry cow therapy (BDCT), became a 
mainstay of mastitis control following its inclusion in the Five Point Mastitis Control 
Plan described by Neave et al. (1969), and it has persisted to the current day as a control 
point in the National Mastitis Council‘s Recommended Mastitis Control Program 
(National Mastitis Council, 2006).  Previous work has shown that when the Five Point 
Mastitis Control plan is in place, contagious pathogens are better controlled and 
reductions in bulk tank somatic cell count (BTSCC) are observed (Berry et al., 1997; 
Bradley and Green, 2004).  Since the promotion of BDCT in Canada, Streptococcus 
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agalactiae is nearly eradicated and the average provincial geometric-mean BTSCC in 
2005 was 225,000 cells/mL (Olde Riekerink et al., 2006; Olde Riekerink et al., 2010). 
 
1.6 Issues surrounding antimicrobial use in dairy production 
Concerns regarding antimicrobial drug use in food animal production systems as a 
contributor to the development of antimicrobial resistance (AMR) are increasing across 
the world (White and McDermott, 2001; Call et al., 2008; Oliver and Murinda, 2012; 
World Health Organization, 1997).  Consequently, a significant challenge facing the 
dairy industry is the mounting pressure to reduce the amount of antimicrobials used in 
production.  The most common reason for antimicrobial use in dairy cows is for the 
treatment and prevention of mastitis (Erskine et al., 2003; Pol and Ruegg, 2007b; 
Thomson et al., 2008; USDA, 2008).  According to recent investigations into 
antimicrobial drug use on Canadian dairy farms, antimicrobials were administered via an 
intramammary route at an average rate of 5 animal defined-daily doses / 1,000 cow-days 
which represents over a third of all routes (Saini et al., 2012a).  With respect to 
antimicrobial use in the form of DCT, it is estimated that 72% of herds in the United 
States and 88% of herds in Canada practice BDCT (USDA, 2008; Dufour et al., 2012).  
This is in contrast to many Nordic countries where antimicrobial use is highly regulated 
and BDCT is rarely used (Ekman and Østerås, 2003). 
In lactating cows, current scientific evidence has failed to support a clear trend of 
increased resistance among mastitis pathogens to the antimicrobials commonly used in 
mastitis therapy (Erskine et al., 2002; Makovec and Ruegg, 2003; Pol and Ruegg, 2007a).  
With regard to antimicrobial use in non-lactating cows, studies focused on the effect of 
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DCT on AMR are lacking in the published literature (Rajala-Schultz et al., 2009).  In a 
study of AMR among CNS species isolated before and after treatment with DCT, Rajala-
Schultz et al. (2009) identified an association between DCT and resistance, but only in 
older cows with history of high somatic cell count (SCC) at drying off and clinical 
mastitis in the succeeding lactation.  Even though the relationship between antimicrobial 
drug use in dairy production and AMR remains unclear (Call et al., 2008; Saini et al., 
2012b), both human and veterinary antimicrobial drug use is considered a driving force 
for the development of resistance (Levy and Marshall, 2004; Call et al., 2008), thus 
motivating research into alternative practices to manage herd health. 
An additional consideration when antimicrobials are administered to dairy cows is 
the risk of inadvertent contamination of milk (Berry and Hillerton, 2002b; Robert et al., 
2006a).  According to the US National Milk Drug Residue Data Base for the fiscal year 
2011, 0.021% (2.1 per 10,000 samples) of milk tanker samples were positive for 
antimicrobial residues (Food and Drug Administration, 2012).  Although the 
contamination of milk with antimicrobial compounds is uncommon, studies have 
estimated that 75 to 93% of violations are due to intramammary treatments of which one 
third are non-lactating preparations (Booth, 1982; Booth and Harding, 1986; McEwen et 
al., 1991). 
 
1.7 Selective dry cow therapy 
In view of today‘s well-managed farms with low prevalence of contagious 
mastitis pathogens and capable of maintaining a low BTSCC, reconsideration of the 
practice of BDCT is warranted.  Firstly, not all cows have an IMI at drying off.  
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Considering that the prevalence of IMI at the end of lactation is estimated at 28 to 41% of 
cows, BDCT does result in the over-usage of antimicrobials for the purpose of 
eliminating existing infections (Browning et al., 1994; Sanford et al., 2006b; Torres et al., 
2008; Torres et al., 2009).  In light of heightened awareness and concern over the 
development of AMR in both human and veterinary medicine, it will become 
increasingly difficult to defend practices that support the non-therapeutic use of 
antimicrobials.  
As previously discussed, DCT is not protective in the late dry period as a result of 
decreasing levels of active compound over time; simultaneously, the late dry period is 
characterized by a high rate of NIMI.  Thus, there is an important lapse of protection that 
exists when DCT is the single form of treatment at drying off.  This gap in protection can 
be overcome by the addition of an ITS to the end-of-lactation treatment protocol.  
Furthermore, because studies have demonstrated that in quarters without an IMI at drying 
off, ITS are just as effective as DCT for the prevention of NIMI, ITS can be used as a 
sole treatment in the absence of existing infection.  Choosing cows for DCT treatment 
based on known or suspected infection status at the end of lactation is known as selective 
dry cow therapy (SDCT).  Selective dry cow therapy has the potential to reduce the 
amount of antimicrobials used in dairy production and is considered a more targeted 
approach to the control of IMI during the dry period (Berry and Hillerton, 2002b; Robert 
et al., 2006b; Rajala-Schultz et al., 2011).  Addition of an ITS to a SDCT treatment 
protocol will ensure that all quarters will have some form of protection against NIMI 
during the dry period. 
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1.7.1 Selection procedures in selective dry cow therapy 
The success of a SDCT program depends on the accurate identification of a cow‘s 
IMI status at drying off so that appropriate treatment decisions can be made, and this is a 
consistent theme in SDCT research.  A common protocol for SDCT is based on monthly 
SCC and clinical mastitis history such that cows with a low SCC (generally < 200,000 
cells/mL) in late lactation and no clinical mastitis are considered to have low probability 
of IMI at drying off and are not infused with DCT (Torres et al., 2008; McDougall, 2010; 
Rajala-Schultz et al., 2011).  Benefits of this approach include no additional costs for 
herds already enrolled in a monthly milk testing program, and the convenience of readily 
accessible data, either in paper or electronic format, from which selective treatment 
decisions can be made.  Important disadvantages do exist however, as monthly SCC and 
clinical mastitis criteria lack accuracy and may be a poor reflection of a cow‘s current 
IMI status considering the potential delay between the last milk test and the end of 
lactation. 
With respect to measures of test accuracy as it relates to the diagnosis of IMI, 
sensitivity (Se) is the proportion of cows with an IMI that are identified as test positive; 
conversely, test specificity (Sp) is the proportion of cows without an IMI that are 
identified as test negative (Dohoo et al., 2009).  While both Se and Sp are important to 
consider when choosing a test for SDCT, the potential risk associated with not treating an 
infected cow will be minimized by a test with high Se.  In the published literature, reports 
for the Se and Sp of monthly SCC and clinical mastitis criteria for the detection of IMI at 
drying off range from 58.4% to 69.4% and 62.7% to 71.5%, respectively (Torres et al., 
2008; McDougall, 2010; Rajala-Schultz et al., 2011). 
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 A popular cow-side test, the California Mastitis Test (CMT), has also been 
investigated as a diagnostic tool for SDCT (Sanford et al., 2006b; Bhutto et al., 2012).  
The California mastitis test is an inexpensive and simple test for the detection of 
subclinical IMI.  California mastitis test scores range from 0 (negative) to 3 (strong 
positive) based on the viscosity of the reaction between CMT reagent and a milk sample.  
As the number of somatic cells in a sample increase, the viscosity of the reaction, and 
thus the test score, also increases (Sanford et al., 2006b).  Using a CMT score cut point of 
> 0 and quarter milk samples collected on the day of drying off, the Se and Sp of the 
CMT to identify cows with IMI were estimated at 70% and 48%, respectively (Sanford et 
al., 2006b). 
In terms of false negative diagnoses, SDCT programs that rely on the CMT or on 
monthly SCC and CM history to dictate treatments will fail to detect and subsequently 
treat up to 30 and 40% of infected cows, respectively.  Perhaps of less concern from a 
health standpoint but resulting in the continued overuse of antimicrobials, these criteria 
will also result in the unnecessary treatment of numerous uninfected cows. 
 
1.8 On-farm milk culture systems 
Rapid on-farm milk culture systems have recently become available for use in 
dairy production.  Investigations into the Minnesota Easy Culture System (University of 
Minnesota, Saint Paul) and the 3M Petrifilm on-farm culture system (Maritime Quality 
Milk, University of Prince Edward Island, Charlottetown, PE) have shown that farm-
based mastitis diagnostics is useful for the selective antibiotic treatment of mastitis in 
lactating cows (McCarron et al., 2009b; MacDonald et al., 2011; Lago et al., 2011a; Lago 
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et al., 2011b).  These culture systems enable producers to culture milk directly on-farm 
and obtain results within 24 hours.  In addition to the benefits to producers when treating 
lactating cows, on-farm culture has the potential to allow dairy producers to make SDCT 
treatment decisions as well.   
The Minnesota Easy Culture System consists of a bi-plate system for the 
differentiation between Gram positive and Gram negative organisms, or a tri-plate system 
which contains an additional agar that is selective for streptococci.  To the authors‘ 
knowledge, investigations into the application of the Minnesota Easy Culture System for 
use in SDCT has not appeared in the published literature.   
Petrifilms are a ready-made culture medium containing standard method nutrients 
and an indicator dye that allows for the identification and enumeration of individual 
bacterial colonies. Three types of Petrifilms have been show to be useful in mastitis 
detection and control: 1) the Aerobic Count Petrifilm (AC Petrifilm), 2) the Coliform 
Count Petrifilm (CC Petrifilm), and 3) the Staph Express Petrifilm (Leslie et al., 2005; 
Silva et al., 2005; McCarron et al., 2009a; McCarron et al., 2009b; Wallace et al., 2011).  
With respect to the distinguishing features of each product, the AC supports growth of all 
aerobic bacteria, the CC will only grow coliform bacteria, and the Staph express allows 
for the differentiation of Staph. aureus from other Staphylococcus spp.  For the purpose 
of SDCT, where the interest is in the identification of overall infection status rather than 
in the species-specific classification of mastitis, the AC Petrifilm is the most suitable.  In 
a preliminary laboratory study to assess the ability of the on-farm culture system to detect 
IMI at drying off, the AC Petrifilm correctly identified infected cows with 100% Se at 
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colony-count cut points of 5, 10 and 20; using the same colony counts, the Sp was 70, 82, 
and 84%, respectively (McLaughlin et al., 2010). 
 
1.9 Level of dry cow therapy treatment decision 
As the diagnosis of IMI can be made at both the quarter and the cow level, so can 
the decision to treat with dry cow therapy.  Treatment decisions made at the quarter level 
would result in greater reductions in antimicrobial use when compared to selective 
therapy at the cow level.  However, due to evidence that quarters of a cow do not act 
independently with respect to the risk of NIMI, research supports that DCT treatment 
decisions be made at the cow level (Berry et al., 2003; Robert et al., 2006a).  Considering 
that ITS create a barrier to infection, it is plausible that quarter interdependence towards 
dry period NIMI would be reduced in the presence of an ITS.  Since the advent of ITS, 
only one study has reported the potential impact of ITS on quarter interdependence over 
the dry period.  In cows treated with ITS at drying off, the observed distribution of 
quarters with an IMI at calving was not different than what was expected based on the 
binomial distribution (Berry et al., 2003).  The outcome in that study, prevalence of IMI 
at calving, was a combination of both cure of existing IMI and prevention of NIMI, 
therefore no evaluation of the effect of ITS on the interdependence of quarters towards 
acquisition of NIMI was performed.  Results of an analysis to determine the effect of ITS 
on the within-cow clustering of dry period NIMI could be used to make 
recommendations regarding the level of treatment in SDCT treatment protocols that also 
employ ITS. 
 
16 
 
1.10 Economics of selective dry cow therapy programs 
In North America, BDCT is the most popular method of mastitis control during 
the non-lactating period.  Economic outcomes are a major influence on farm management 
decisions, therefore if SDCT is going to gain favour with dairy producers, it must be, at 
minimum, a revenue neutral alternative to BDCT.  According to a cow-level analysis of 
the economics of mastitis control over the dry period, treatment with DCT was the only 
economically viable option when considering cows with existing IMI (Berry et al., 2004).  
Regarding cows without IMI at the end of lactation, DCT and ITS were financially 
equivalent choices for the prevention of NIMI (Berry et al., 2004).  At the herd level, 
there is uncertainty regarding which dry period protocol (BDCT or SDCT) is the most 
cost-effective.  Using stochastic modeling of the dynamics of IMI over the dry period, 
Huijps and Hogeveen (2007) estimated the economic consequences of BDCT, SDCT and 
no DCT, and determined that SDCT resulted in the lowest annual cost.  In contrast, 
Halasa et al. (2010), who in addition to BDCT and SDCT also combined these protocols 
with an ITS, identified BDCT without ITS to be the most economical option.  In both 
studies, differences between protocols were small and the importance of herd-specific 
factors, particularly the incidence of NIMI over the dry period, was recognized.  Results 
were presented with the caveat that conclusions regarding the most economical approach 
should be made based on farm-specific calculations.  While previous research has 
estimated the economic consequences of SDCT based on SCC criteria (Hujips and 
Hogeveen, 2007; Halasa et al., 2010), the financial implications of SDCT based on on-
farm culture have yet to be reported. 
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1.11 Summary 
 The dry period is a very important stage of the lactation cycle with respect to 
udder health.  It is during this time that the mammary gland regenerates secretory tissues 
in preparation for the next lactation and therefore provides an ideal opportunity to treat 
existing IMI.  Concurrently, non-lactating cows are at increased risk for the development 
of NIMI as previous research has demonstrated that rates of NIMI are higher in the dry 
period than at any point during lactation.  The most common approach to dry period 
mastitis control in North America is to infuse all quarters of all cows with DCT after the 
last milking and this practice is known as BDCT.  As a result of concerns regarding the 
association between antimicrobial drug use in food animal production systems and the 
development of AMR, dairy producers are facing pressure to reduce antimicrobial use on 
their farms.  While DCT is protective against sensitive pathogens in the early dry period, 
DCT are not effective in the late dry period, when NIMI rates are known to be elevated.  
As an alternative to DCT, ITS do not contain antimicrobials but prevent dry period NIMI 
by creating a physical barrier within the teat cistern and canal.  Internal teat sealants are 
broad-spectrum and have been shown to persist right up until calving.  In quarters 
without IMI at drying off, ITS are just as effective as DCT in prevention of dry period 
NIMI, suggesting that ITS can be used as a sole treatment at drying off when existent IMI 
is not a concern.  The selective DCT treatment of cows at drying off based on infection 
status is known as SDCT, and has the potential to reduce the amount of antimicrobials 
used on dairy farms.  In order to be successful, SDCT required a method to determine a 
cow‘s end-of-lactation infection status so that appropriate treatment decisions can be 
made.  Previous SDCT protocols have relied on monthly SCC combined with clinical 
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mastitis history, or the CMT to diagnose IMI at drying off.  Studies show that these 
methods lack accuracy, thus when used to target DCT treatment at drying off, numerous 
infected cows are left untreated and many cows are treated unnecessarily.  Recently, a 
Petrifilm-based OFCS has been validated for use in the selective antimicrobial treatment 
of mastitis in lactating cows.  These techniques allow producers to culture milk samples 
directly on the farm and make treatment decisions within 24 hours.  The same on-farm 
culture system, when used to culture milk samples collected prior to drying off, could be 
used to make targeted DCT treatment decisions as well. 
 
1.12 Objectives and clinical trial description  
 The overall objective of this thesis was to evaluate a Petrifilm-based on-farm 
culture system for use in a SDCT program.  The study was designed as a randomized 
clinical trial with two treatment groups: 1) BDCT plus infusion of ITS (the positive 
control group); 2) SDCT based on results obtained using an Petrifilm OFCS (the study 
group).  For cows in the study group, a composite milk sample was collected on the day 
prior to drying off and was cultured using the on-farm culture system.  On the day of 
drying off, Petrifilm results were interpreted by the producer and cows with a positive 
Petrifilm result received DCT and ITS, while cows with a negative Petrifilm result did 
not receive DCT but were infused solely with an ITS. 
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Specific objectives were: 
 Chapter 2: To determine the test characteristics of the Petrifilm on-farm culture 
system when used to detect intramammary infection at the end of lactation;   
 Chapter 3: To compare the risk of intramammary infection at calving and the risk 
of a first case of clinical mastitis during the first 120 days of the subsequent 
lactation between the two treatment groups (quarter-level analysis); 
 Chapter 4: To compare the somatic cell count and milk production in the first 180 
days of the subsequent lactation between the two treatment groups (cow-level 
analysis);   
 Chapter 5: To evaluate the interdependence of quarters towards new 
intramammary infection with CNS over the dry period and the effect of treatment 
with internal teat sealants; 
  Chapter 6: To determine the economic outcome of Petrifilm-based SDCT and to 
make comparisons to BDCT, and to SDCT based on somatic cell count and 
clinical mastitis history criteria  
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2.1 ABSTRACT 
 
The purpose of this study was to evaluate a 3M Petrifilm-based on-farm culture 
system for the detection of intramammary infection (IMI) in low somatic cell count 
(SCC) cows (<200,000 cells/ml) at drying off.  The main objectives were to determine 
the test characteristics and the predictive values of the Petrifilm on-farm culture system.  
The ability of dairy producers to correctly classify cows as infected or uninfected based 
on Petrifilm culture and a set colony count threshold was also assessed.  A total of 360 
cows originating from 16 low bulk tank SCC (<250,000 cells/mL) dairy herds were 
enrolled at drying off.  Enrolled cows had an expected dry period of 30 to 90 days, a SCC 
<200,000 cells/mL on the last 3 tests prior to drying off, no clinical mastitis in the same 
time period, and no antibiotic treatment in the last 14 days.  Quarter milk samples were 
collected on the day prior to drying off, and a composite milk sample was created by 
combining 5 mL of milk from each quarter sample.  Composite milk samples were 
cultured on-farm using the Petrifilm culture system, which provided results within 24 
hours.  Quarter milk samples were cultured in a reference laboratory, and the results were 
aggregated to the cow level.  On the day of drying off, the Petrifilm was read by the 
producer and cows were classified as positive if ≥5 colonies (equivalent to 50 colony 
forming units/mL) were present.  When read by the producer, 47.8% of the cows cultured 
negative on Petrifilm and were infused with only an internal teat sealant at drying off.  
The test characteristics of the Petrifilm on-farm culture system were calculated by 
comparing the producer-derived Petrifilm results to those obtained by standard laboratory 
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culture.  The sensitivity and specificity of the Petrifilm on-farm culture system were 
85.2% (78.5 – 90.5) and 73.2% (66.4 – 79.3), respectively.  The negative predictive value 
of the Petrifilm test system was high (86.6%) when estimated using the prevalence of IMI 
in this data set, and the positive predictive value was moderate (70.9%).  An automated 
3M Petrifilm reader was used to obtain accurate colony counts.  The agreement between 
Petrifilm results obtained by the producer and those obtained by the automated Petrifilm 
reader was high, with a kappa value of 0.82 (0.75 – 0.89).      
 
2.2 INTRODUCTION 
 
Mastitis is an important production limiting disease of dairy cattle and is endemic 
in the dairy industry (Halasa et al., 2007).  Efforts to treat and prevent mastitis represent 
the primary motivation behind antibiotic usage on dairy farms worldwide (Erskine et al., 
2003; Thomson et al., 2008; USDA, 2008; Saini et al., 2012).   The introduction of the 
Five Point Mastitis Control Plan in the late 1960s (Neave et al., 1969), and it‘s further 
development into a ten point plan (National Mastitis Council, 2006), has resulted in a 
significant reduction in the prevalence of contagious mastitis pathogens and a 
consequential reduction in bulk tank somatic cell counts (Berry et al., 1997; Bradley and 
Green, 2004).  In compliance with the ten point plan, most dairy producers in North 
America treat all quarters of all cows with a dry cow intramammary antibiotic (DCT) at 
the end of lactation (USDA, 2008; Dufour et al., 2012).  This practice is commonly 
known as blanket dry cow therapy (BDCT) and its purpose is twofold:  (1) to clear up 
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any existing intramammary infections (IMI) and (2) to prevent new infections from being 
acquired during the dry period.   
Owing to increasing public awareness of the practices common to food animal 
agriculture, consumers have expressed concern with respect to antibiotic use on dairy 
farms (White and McDermott, 2001).  Consequently, a significant challenge facing the 
dairy industry is the mounting pressure to reduce the amount of antibiotics used in 
production.  In 2010, with the aim of controlling antibiotic resistance, the Ministry of 
Economic Affairs, Agriculture and Innovation in the Netherlands called for a mandatory 
50% reduction in antibiotic use on all farms by 2013, based on 2009 levels (SDA, 2012).  
In 2012, the Food and Drug Administration (FDA) of the United States presented a 
guidance document titled: The Judicious Use of Medically Important Antimicrobial 
Drugs in Food-Producing Animals.  According to the FDA, the use of antimicrobials for 
the purpose of prophylaxis requires veterinary oversight, as well as justification of the 
medical rationale for such use (FDA, 2012).  In view of today‘s well managed farms, 
capable of maintaining a low bulk tank somatic cell count (BTSCC), reconsideration of 
the practice of BDCT is warranted. 
As an alternative to BDCT, selective dry cow therapy (SDCT) has the potential to 
reduce the amount of antibiotics used in dairy production.  First introduced in 1978, the 
goal of SDCT is to reserve DCT for cows which would benefit from treatment (Rindsig 
et al., 1978; Rindsig et al., 1979).  Therefore, cows not suspected of having an IMI at 
drying off would enter the dry period without having received intramammary antibiotics.  
The addition of an internal teat sealant (ITS) can improve the success of a SDCT 
33 
 
program.  An ITS is a non-antibiotic infusion that has been shown to be effective at 
preventing new IMI throughout the entire dry period (Woolford et al., 1998; Berry and 
Hillerton, 2002a; Huxley et al., 2002; Sanford et al., 2006a).  Selective dry cow therapy 
plus internal teat sealant (SDCT + ITS) is a dry cow approach that would provide the 
therapeutic benefits of DCT for cows with an IMI at the end of lactation, in addition to 
the prophylactic effects of ITS.         
In order to be successful, a SDCT+ITS program requires an easy, cost-effective, 
and rapid method to identify cows with an IMI at the time of drying off (Sanford et al., 
2006b).  On-farm systems for the bacteriological culture of milk have been validated for 
the detection of mastitis pathogens in clinical milk samples (McCarron et al., 2009; Lago 
et al., 2011; MacDonald et al., 2011; Wallace et al., 2011).  An important benefit of on-
farm culture is the provision of prompt results, allowing producers to make informed and 
targeted treatment decisions for cases of clinical mastitis.  Recent investigations into 3M 
Petrifilms (3M Canada, London, Ontario) have shown that they are a useful tool for the 
selective antibiotic treatment of mastitis in lactating cows (McCarron et al., 2009; 
MacDonald et al., 2011).  These techniques allow the producer to culture milk directly 
on-farm and obtain results within 24 hours.  In addition to the benefits to the producer 
when treating lactating cows, Petrifilm-based on-farm culture has the potential to allow 
the dairy producer to detect IMI at drying off as well.  
The objective of the present study was to determine the test characteristics and 
predictive values of a Petrifilm on-farm culture system when used in low BTSCC herds 
to make treatment decisions on low somatic cell count (SCC) cows at drying off, and to 
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evaluate the ability of dairy producers to correctly classify cows as infected and 
uninfected based on a set colony count threshold. 
 
2.3 MATERIALS AND METHODS 
 
2.3.1 Herd and animal selection 
In order to be considered for inclusion in the trial, herds were required to have an 
annual average of monthly BTSCC of less than 250,000 cells/mL in the year prior to the 
study and be enrolled in a dairy herd improvement program.  A convenience sample of 16 
Canadian dairy herds were selected based on their proximity to the Atlantic Veterinary 
College, Charlottetown, PE (n = 10) and the Faculté de médecine vétérinaire, Université 
de Montréal, Saint-Hyacinthe, QC (n = 6).   
Inclusion criteria at the cow level consisted of monthly SCC below 200,000 
cells/mL on the last three milk tests prior to drying off, no evidence of clinical mastitis 
during the same time period, no antibiotic treatment within the last 14 days, ≥ three 
functional quarters, and an expected dry period of no less than 30 days and no more than 
90 days.  On the day prior to drying off, eligible cows were subjected to a California 
Mastitis Test (CMT) by the investigator or a trained technician.  Cows with a score of 
two or greater on any quarter were excluded from the trial.  As part of a larger clinical 
trial evaluating the utility of the Petrifilm on-farm culture system when used in a SDCT 
program, cows were randomly allocated to either the Petrifilm on-farm culture system 
group, with selective antibiotic treatment at drying off based on Petrifilm culture results, 
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or the positive control group which received blanket dry cow therapy.  The focus of the 
present paper is on the data pertaining to the Petrifilm on-farm culture group only (Figure 
2.1). 
 
2.3.2 Sampling procedures 
Producers scheduled a dry off day every other week to allow for sample 
collection.  On the day prior to drying off (Day -1), quarter level milk samples were 
collected by the study investigator or a trained technician.  Following pre-milking udder 
preparation as per farm protocol, teat ends were scrubbed with alcohol swabs until clean 
and initial foremilk streams were discarded into a strip cup.  Approximately 30 mL of 
milk was collected aseptically according to the procedures recommended in the 
Laboratory Handbook on Bovine Mastitis (National Mastitis Council, 1999).  Following 
quarter level sampling, a composite milk sample was created by combining 5 mL from 
each quarter sample in a new sample vial.  Quarter milk samples were frozen to -20°C 
before submission to the laboratory for standard bacteriological culture.  Composite milk 
samples were utilized fresh with the Petrifilm on-farm culture system. 
 
2.3.3 Gold standard  
Trained laboratory technicians (n = 2) were blinded to the results obtained by the 
Petrifilm on-farm culture system.  Within one month from collection, milk samples were 
thawed and cultured in a laboratory using standardized methods outlined in the 
Laboratory Handbook on Bovine Mastitis (National Mastitis Council, 1999).  Briefly, 
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disposable plastic loops were used to streak 0.01 mL of milk on bi-plates containing half 
Columbia agar + 5% sheep blood and half MacConkey agar.  Plates were incubated at 35 
ºC and examined for bacterial growth after 24 and 48 hours.  Colonies were tentatively 
identified as staphylococci, streptococci, coliforms, or other pathogens based on colony 
growth characteristics, morphology, pattern of hemolysis, catalase reaction, and Gram 
staining.  Staphylococcal isolates were tested for coagulase production with the tube 
coagulase test.  API tests (API 20 E and API 20 Strep; bioMérieux (Marcy L‘Etoile, 
France) and the latex agglutination test for streptococcal Lancefield groups were used for 
the final identification of bacterial organisms as required.  For each positive sample, the 
number of colony forming units (cfu) per 0.01 mL of milk was enumerated up to a 
maximum of 10 colonies.  A quarter was considered infected if ≥ 100 cfu/mL of milk of 
any pathogenic organism of interest, except coagulase negative staphylococci (CNS), 
were cultured.  For CNS, a definition of ≥ 200 cfu/mL was used.  These definitions are in 
accordance with the recent publication of characterization of IMI based on single sample 
bacteriological testing (Dohoo et al., 2011).  Samples with three or more differing isolates 
were classified as contaminated.  However, when Staphylococcus aureus (Staph. aureus) 
was identified in a contaminated sample, it was enumerated and the associated quarter 
was classified as infected (Reyher et al., 2011). 
The quarter level culture results were interpreted in parallel to generate cow level 
results.   If one or more quarter samples were contaminated, a cow was considered 
infected if at least one of the remaining quarters was infected.  If one or more quarter 
samples were contaminated and no IMI was diagnosed in the remaining samples, the 
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cow‘s overall infection status was considered unknown, and the observation was removed 
from the analyses.   
 
2.3.4 On-farm bacteriological culture  
The on-farm culture system was set-up by the investigator or technician on the 
day prior to drying off.  A 3 mL aliquot of composite milk was added to 27 mL of sterile 
water to make a 1:10 dilution.  One millilitre of diluted milk was plated on an AC 
Petrifilm (3M Canada, London, Ontario) and incubated on-farm at 35°C for 24 hours in a 
TurboFan Hova-Bator (GQF Manufacturing, Savannah, Georgia, USA).  Consistent with 
a dilution factor of 1:10, a single cfu present on the Petrifilm was equivalent to 10 cfu per 
mL of milk. 
On the scheduled day of drying off (Day 0), the Petrifilm was read by the 
producer and, in accordance with study protocol, cows were classified as infected if 5 or 
more colonies were present (equivalent to ≥ 50 cfu/mL).  In order to determine the 
performance of the Petrifilm on-farm culture system at different colony count thresholds, 
producers were asked to record the Petrifilm culture result under the following categories: 
0, 1-4, 5-9, and ≥ 10 colonies.  Cows positive on Petrifilm were treated with DCT + ITS; 
cows negative on Petrifilm were treated solely with ITS.  The Petrifilms were frozen to -
20°C at the farm, collected during the subsequent visit, and maintained at -20°C in the 
laboratory.  To evaluate the ability of producers to correctly classify cows into DCT and 
no DCT groups, the Petrifilms were thawed and subsequently scanned using an 
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automated 3M Petrifilm reader (3M Canada, London, Ontario) which provided an 
accurate colony count (Gambrel-Lenarz and Lindberg, 2004). 
 
2.3.5 Statistical analysis 
Statistical analysis was performed using Stata/IC 11.0 (StataCorp, College 
Station, TX).  Values of P ≤ 0.05 were considered statistically significant.  The test 
characteristics of the Petrifilm on-farm culture system were calculated using 2x2 tables 
(diagt command in Stata).  Sensitivity (Se) was defined as the proportion of cows with an 
IMI, as determined by standard bacteriological culture, that were classified as positive on 
Petrifilm.  Conversely, specificity (Sp) was defined as the proportion of cows without an 
IMI that were classified as negative on Petrifilm.  The predictive values of a test are 
dependent upon the Se and Sp of the test and the prevalence of disease in the study 
population (Dohoo et al., 2009).  In order to examine the performance of the Petrifilm on-
farm culture system in different populations, with varying degrees of subclinical mastitis, 
the positive (PPV) and negative (NPV) predictive values were calculated for prevalence 
estimates ranging from 1 to 100%.  The PPV was the proportion of Petrifilm positive 
cows that truly had an IMI, and the NPV was the proportion of Petrifilm negative cows 
that did not have an IMI.  Estimates of Se, Sp and predictive values were calculated at a 
colony-count threshold of ≥ 5 colonies (the threshold at which treatment decisions were 
made) and ≥ 10 colonies.  The higher cut point was evaluated to determine if increasing 
the colony count threshold would decrease the number cows treated unnecessarily (i.e. 
increase Sp) without sacrificing the accuracy of a negative test (i.e. preserve Se). 
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Generalized estimating equations (GEE) were used to evaluate the effect of 
clustering of cows within herds on the estimates of Se, Sp, and the confidence intervals 
(Dohoo et al., 2009).  Using the Petrifilm test result as the outcome of interest and herd as 
a random effect, separate models were examined for gold standard positive and gold 
standard negative cows.  The resulting estimates for Se and Sp, and associated 95% 
confidence intervals, were compared to those obtained from the unconditional analyses.  
The results obtained by the automated 3M Petrifilm reader were used to evaluate 
the ability of producers to correctly classify cows into DCT and no DCT groups based on 
on-farm culture results.  The level of agreement between the producer-derived results and 
the automated reader was assessed using McNemar‘s test for paired data to check for 
bias, followed by calculation of the kappa statistic.   
 
2.4 RESULTS 
 
2.4.1 Samples 
Enrolment of cows from participating herds took place from July 2009 to 
September 2010.  During this time, a total of 1584 cows entered the dry period.  Seven 
hundred and twenty-nine cows (46.0%) ultimately met the inclusion criteria, of which 
360 were randomly assigned to the Petrifilm on-farm culture system group and 369 to the 
positive control group (Figure 2.1).   Of the cows in the on-farm culture system group, 16 
(4.4%) cows were omitted from the analyses due to contamination of ≥ 1 quarter 
sample(s) and no IMI diagnosed in the remaining quarters.  Eleven of these cows (68.8%) 
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were diagnosed as infected by the dairy producer based on Petrifilm results and were 
infused with DCT at drying off.  One additional cow was removed due to incomplete 
records.  Overall, data from 343 cows (1368 quarters) from the on-farm culture system 
group were included in the analyses.  The number of cows per herd cultured on-farm 
using the Petrifilm culture system ranged from 6 to 68 (median = 13).    
 
2.4.2 Gold standard 
According to standard bacteriological culture, the cow level prevalence of IMI at 
drying off in cows meeting the inclusion criteria, i.e. low monthly SCC on the last three 
milk tests prior to drying off, was 43.4% (n = 149).  For the purpose of analysis, the 
environmental streptococci were grouped together, and included all Streptococcus spp. 
other than Streptococcus agalactiae.  Gram negative bacteria, other than Escherichia coli 
and Klebsiella spp., were also amalgamated into a grouping, and encompassed 
Enterobacter spp., Proteus spp., Citrobacter spp., Pseudomonas spp., Serratia spp., 
Salmonella spp., Pasteurella multocida, and other non-differentiated gram negative 
bacteria.  The most common pathogens isolated at the end of lactation were CNS, 
followed by environmental streptococci, Corynebacterium spp., and Staph. aureus (Table 
2.1).  Of the cows with significant growth of any pathogen on standard bacteriological 
culture, 107 (71.8%) had 1 infected quarter, 31 (20.8%) had 2 infected quarters, and 11 
(7.4%) had 3 or 4 infected quarters.   
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2.4.3 On-farm bacteriological culture  
The producer-derived prevalence of IMI at the end of lactation by Petrifilm on-
farm culture results was 52.2%.  Therefore, at a treatment threshold of ≥ 5 colonies, 
47.8% of the cows meeting the inclusion criteria were assigned to the no DCT group and 
received an internal teat sealant as a sole treatment at drying off.  Of the 149 cows with 
an IMI at drying off according to standard culture, the Petrifilm on-farm culture system, 
as interpreted by the producer, correctly identified 127 (85.2%) cows as positive and 
misclassified 22 (14.8%) cows as negative.  The breakdown of causative pathogens 
isolated from the 22 misclassified cows was as follows:  11 CNS, 6 environmental 
streptococci, 3 Corynebacterium spp., and 2 Staph. aureus.  A false positive Petrifilm 
result occurred in 52 (15.2%) cows that, according to standard bacteriology, did not have 
a significant intramammary infection in any quarter at drying off. 
 
2.4.4 Test characteristics and predictive values of the Petrifilm on-farm culture 
system 
 The unconditional estimates of Se and Sp of the Petrifilm on-farm culture system 
at a colony count threshold value of ≥ 5 was 85.2 (95% confidence interval (95% CI): 
78.5 – 90.5) and 73.2 (95% CI: 66.4 – 79.3), respectively.  At a colony count threshold of 
≥ 10 colonies, the estimates of Se and Sp were 71.8 (95% CI: 63.9 – 78.9) and 86.1 (95% 
CI: 80.4 – 90.6), respectively.  The GEE estimates and 95% confidence intervals for Se 
and Sp were very close to the unconditional estimates (Appendix A), therefore only the 
unconditional estimates are reported.  The test characteristics of the Petrifilm culture 
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system varied between herds, but the variation was not according to frequency of use.  
The Se ranged from 0% (n = 1 herd) to 100% (n = 7 herds), with a median of 86.6%; the 
Sp ranged from 0% (n = 1) to 100% (n = 3), with a median of 75.3%.  A Se of 0% was 
obtained in a herd where a single cow was identified with an IMI according to standard 
culture, but was misclassified as uninfected on Petrifilm.  A Sp of 0% was obtained in a 
herd where all cows (n = 6) were classified as infected on Petrifilm, but only three cows 
had an IMI according to standard culture.   
The NPV of the Petrifilm on-farm culture system, with a treatment threshold of ≥ 
5 colonies, was high (86.6%) when estimated using the prevalence of IMI in this data set.  
The NPV increased with decreasing prevalence and was lower at a threshold of ≥ 10 
colonies (Figure 2.2).  High NPV of 80% to 90% were maintained in populations where 
the proportion of cows with an IMI at drying off ranged from 55% to 35%.  The PPV was 
moderate (70.9%) in the study population when a cut point of ≥ 5 colonies was used and 
increased slightly when the threshold was increased to ≥ 10 colonies (Figure 2.2). 
 
2.4.5 Agreement between the producers and the automated Petrifilm reader 
A total of 265 Petrifilms were available for evaluation by the automated reader.  
The agreement between the producer and automated reader for the Petrifilm on-farm 
culture system with a treatment threshold of ≥ 5 colonies is presented in Table 2.2.  The 
level of agreement was high, with an observed agreement of 91.0% and a kappa value of 
0.82 (0.75 – 0.89).  Because the Se was highest at a threshold of ≥ 5 colonies, the level of 
agreement calculation was not repeated for the ≥ 10 colonies cut point.   
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The test characteristics of the Petrifilm on-farm culture system, as compared to 
standard bacteriology, were calculated for the subset of Petrifilms submitted for 
evaluation by the automated reader using the producer-derived results and the automated 
reader results.  For the producer-derived results, the Se was 88.0% (80.7 to 93.3) and the 
Sp was 74.3% (66.5 to 81.1); for the automated reader results, the Se was 89.7% (82.8 to 
94.6) and the Sp was 67.6% (59.4 to 75.0).   
 
2.5 DISCUSSION 
 
2.5.1 Test characteristics of the Petrifilm on-farm culture system 
The goal of a SDCT+ITS program is to reserve intramammary antibiotics for 
cows that are suspected of having an IMI at drying off.  A significant limitation of 
SDCT+ITS is that, in most cases, a cow‘s true infection status is not known.  Therefore, 
essential to the success of a SDCT+ITS program is a method to identify a cow‘s IMI 
status at drying off, and the method should have high Se to maximize the treatment of 
infected cows (Sanford et al., 2006b). When used to detect IMI in low SCC cows at 
drying off, the Petrifilm on-farm culture system, with a colony count threshold of ≥ 5 
colonies, had reasonably high Se (85.2%).  A test with high Se will have few false 
negative results.  As a result, dairy producers could use the on-farm culture system to 
make selective dry cow treatment decisions with the confidence that few infected cows 
would be missed.  The Sp (73.2%) of the Petrifilm on-farm culture system using a 
treatment threshold of ≥ 5 colonies was moderate.  The quantity of milk plated on the 
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Petrifilm (0.1 mL) is larger than that used in standard culture (0.01 mL), and this 
discrepancy is partially accounted for by the lower cfu threshold used with the Petrifilm.  
Increased recovery of pathogens on Petrifilm due to a larger inoculation volume would 
result in an increase in the number of apparent false positive diagnoses, and would 
therefore decrease the Sp of the test.  The Sp of the Petrifilm on-farm culture system is 
reported with the caution that false positive Petrifilm results could in fact be true 
positives that were missed by standard bacteriological culture. 
   
2.5.2 Treatment threshold  
The colony count threshold used in this study was derived from McCarron et al. 
(2009), where a treatment cut point of ≥ 5 colonies maximized the Se of the Petrifilm for 
the detection of pathogens in mastitic milk samples.  In the present study, increasing the 
colony count threshold to ≥ 10 colonies improved the Sp of the test, but unfavourably 
decreased the Se to 71.8%.  As a result, if the higher threshold was used, fewer cows 
would be treated unnecessarily, but at the unacceptable expense of increased 
misdiagnosis of truly infected cows.  From a clinical perspective, the cost of a false 
negative diagnosis (i.e. failing to treat an infected cow) is much greater than the cost of a 
false positive diagnosis (i.e. treating an uninfected cow), therefore for the purpose of 
SDCT, a treatment cut point of ≥ 5 colonies is recommended.     
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2.5.3 Petrifilm on-farm culture versus other diagnostic methods 
Historically, SDCT programs have relied on prior information, such as monthly 
SCC and clinical mastitis (CM) history, to determine a cow‘s infection status at the end 
of lactation.  In a previous study by Torres et al. (2008), evaluating the performance of 
cow level monthly SCC and CM history for the identification of infected and uninfected 
cows at drying off, it was determined that the accuracy of the test method was optimized 
by using three months SCC records with a threshold of 200,000 cells/mL for cows 
without CM during lactation, and a threshold of 100,000 cells/mL for cows with a case of 
CM in the first 90 days of lactation.  Using single quarter sample bacteriological culture 
aggregated to the cow level as the gold standard, the Se and Sp of the criteria described 
above were 69.4% and 63.3%, respectively (Torres et al., 2008).  In a similar study 
carried out in Atlantic Canada, a maximum Se of 64.9% was obtained using data from 
three months prior to drying off and a cow level SCC cut-off of 150,000 cells/mL 
(McCarron, 2012).  Given the results of these prior studies, monthly SCC data, with or 
without CM history, are not sensitive enough and should not be recommended to be used 
alone as a guide for SDCT.  Conversely, in the present study, when Petrifilm on-farm 
culture was applied to a SDCT program in addition to SCC and CM criteria, the Se of the 
overall IMI screening method was greatly improved.  In effect, the criteria used to select 
cows for enrolment in this study included low monthly SCC and the absence of CM in 
the last 120 days prior to drying off.  However, despite following these commonly 
accepted SDCT protocols, the prevalence of IMI in the group of cows that met the 
inclusion criteria was 43.4% according to standard bacteriological culture.  The 
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diagnostic information currently used by dairy producers is therefore inadequate for the 
detection IMI at the time of drying off.  As a result, the implementation of a SDCT 
program that relies on these criteria can put the health of a cow at risk, not only for the 
length of the dry period but into the next lactation as well.  With the addition of Petrifilm-
based on farm culture to the SDCT+ITS program protocol, 85.2% of the cows with an 
IMI at drying off, as determined by standard bacteriology, were detected and 
subsequently received the therapeutic benefit of DCT.   
A popular cow-side test, the California Mastitis Test, has also been evaluated for 
use in a SDCT program (Sanford et al., 2006b).  Like the Petrifilm on-farm culture 
system, the advantages of the CMT are its on-farm application and speed with which 
results are produced. Using a CMT score cut point of > 0 on quarter milk samples, and 
generating cow level results by parallel interpretation of quarter level outcomes, the Se 
and Sp of the CMT to identify cows with IMI on the day of drying off were estimated at 
70% and 48%, respectively (Sanford et al., 2006b).  Using the CMT alone to select cows 
for DCT would result in an unacceptably high proportion of infected cows being missed, 
and an even higher proportion of uninfected cows receiving antibiotics.  Furthermore, 
although the CMT is relatively simple to use, it can be difficult to get accurate and 
consistent results due to the subjectivity of the scoring.  In the present study, cows were 
excluded from the trial if they had a CMT score of two or greater in any quarter on the 
day prior to drying off.  The addition of the CMT to the enrolment criteria resulted in 
only 7 additional cows being excluded from the trial, and therefore provided little 
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information beyond what was obtained using selection criteria based on SCC and CM 
history.   
 
2.5.4 Predictive values of the Petrifilm on-farm culture system 
Knowledge of the test characteristics of the Petrifilm on-farm culture system 
enabled the calculation of the predictive values of a positive or negative Petrifilm across 
populations with varying levels of IMI at drying off.  As illustrated in Figure 2.2, when 
the proportion of cows with an IMI at drying off increased, the NPV decreased.  For 
example, at a low prevalence of 30% and a high prevalence of 70%, the NPV of the 
Petrifilm on-farm culture system was 92.0% and 68.0%, respectively.  Translating the 
NPV to the probability that a Petrifilm negative cow truly has an IMI (positive predictive 
value of a negative test; 1 – NPV; Dohoo et al., 2009), the proportion of infected cows 
that would not receive DCT would be very small (8%) for low prevalence herds, but 
unacceptable (32%) for high prevalence herds.  Consequently, when considering 
implementing a SDCT program, assessment of a herd‘s current level of udder health (pre-
test probability) is an important first consideration.  
The positive predictive value of the Petrifilm on-farm culture system was 
moderate at a treatment threshold of ≥ 5 colonies, and as a result a number of uninfected 
cows received DCT at drying off.  In North America, blanket dry cow therapy is 
customary, as it is estimated that 72% of herds in the United States and 88% of herds in 
Canada utilize this form of mastitis control over the dry period (USDA, 2008; Dufour, 
2012).  While selective dry cow therapy has received interest by the dairy industry as a 
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means to reduce antibiotic use on dairy farms, in order for it to be attractive to North 
American dairy farmers, SDCT must be a low risk alternative to the established practice 
of BDCT.  Thus, although increasing the treatment threshold to ≥ 10 colonies would have 
resulted in a greater decrease in the unnecessary antibiotic treatment of uninfected cows, 
and may be more favourable in the eyes of the general public, the subsequent increase in 
the risk of missing infected cows would undoubtedly affect the willingness of dairy 
producers to adopt the alternative strategy.   
 
2.5.5 Agreement between producer-derived Petrifilm results and automated 
Petrifilm reader 
The level of agreement between the producer-derived Petrifilm results and the 
automated reader was high indicating that the producers were able to accurately classify 
the cows into infected and uninfected categories.  Correspondingly, the test 
characteristics of the Petrifilm on-farm culture system based on producer-derived results 
were very close to the true test characteristics determined using the automated reader 
results.  Interpretation of the AC Petrifilm is made easy by the presence of an indicator 
dye that stains the colonies a bright pink colour.  Furthermore, enumeration of colonies to 
five or greater made it simple to classify cows into treatment categories.  As a result, 
producers performed well with only minimal training at the outset of the trial.  The level 
of agreement reported in this study is higher than reported in a previous study by 
MacDonald et al. (2011).  In that field trial, when clinical milk samples were cultured on-
farm using the culture system, the agreement between the producer-derived results and 
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the automated reader was 67.9% with a kappa value of 0.33 (MacDonald et al., 2011).  It 
is possible that due to low incidence rates of CM (range = 1 to 24 cases; mean = 6.3 
cases), the producers failed to obtain enough practice to become proficient in 
identification and enumeration of colonies on the Petrifilm (MacDonald et al., 2011).  In 
the present study, all producers read at least six Petrifilms during the course of the study, 
and the majority (n = 12 herds) read twelve or more.  It is very likely that the increased 
exposure to Petrifilms provided additional practice, enabling producers to obtain more 
accurate Petrifilm results.  Additionally, in the earlier study, clots present in clinical milk 
samples could be mistaken for bacterial growth on Petrifilms, resulting in lower accuracy.  
The milk samples used in this study were from clinically normal quarters, therefore no 
clots should have interfered with Petrifilm interpretation. 
 
2.5.6 Gold standard definition of intramammary infection 
It is difficult to compare the performance of the Petrifilm on-farm culture system 
to previously published detection methods, as studies differ with respect to the definition 
of IMI used as gold standard.  The detection limit of the gold standard test used in this 
study was quite rigorous, in accordance with the recent publication of new definitions of 
IMI based on single sample bacteriological testing (Dohoo et al., 2011).  It is recognized 
that standard bacteriological culture is not a perfect test (Dohoo et al., 2011), therefore a 
strict classification system to define IMI at the quarter level was used with the aim of 
identifying as many existing infections as possible.  Using a threshold of 200 cfu of CNS 
from a 1.0 mL milk sample resulted in a higher proportion of cows diagnosed with 
50 
 
significant growth than had a definition of ≥ 1000 cfu/mL based on NMC guidelines been 
used (National Mastitis Council, 1987).  For the CNS isolates identified in the quarter 
milk samples, 47.7% (n = 82) displayed a growth of ≥ 1000 cfu/mL of milk.  
Correspondingly at the cow level, 54.4% (n = 68) of the cows with an IMI due to CNS 
had cultures with a growth of ≥ 1000 cfu/mL of milk.  Evaluating the performance of the 
Petrifilm on-farm culture system using the NMC guidelines for significant growth of 
CNS resulted in a very small improvement in Se (86.3% vs. 85.2%) and a drop in Sp 
(62.7%  vs. 75.2%).  As a result of a larger inoculation volume and a lower cfu/mL 
threshold used with the on-farm culture system, the Petrifilm detected cases of CNS IMI 
that were missed by standard bacteriological culture using NMC guidelines, resulting in a 
drop in Sp.  Mastitis as a result of IMI with CNS is typically mild and subclinical 
(Pyörälä and Taponen, 2009).  Previous research has focused on CNS infection during 
lactation, and is conflicting with respect to the effects of CNS on milk production, as well 
as on the susceptibility of a quarter to infection with a major mastitis pathogen (Reyher et 
al., 2012).  Research into the outcome of CNS infection at drying off is scarce in the 
literature.  In a study by Berry and Hillerton (2002b) investigating SDCT, the risk of a 
new Streptococcus uberis infection at calving, in quarters that did not receive DCT, was 
4.2 greater when CNS was isolated at drying off then if no pathogen had been cultured.  
For the same group of cows, the risk of a new coliform infection was 4.7 times greater 
(Berry and Hillerton, 2002b).  Furthermore, while the diagnosis of CNS in a milk sample 
usually terminates at the group level, individual species of CNS differ in their effects on 
udder health, and the determination of the relevance of different CNS species requires an 
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accurate and practical method to make species-specific diagnoses (Supré et al., 2011).  
Until identification of different CNS isolates is possible, and until further research into 
the consequences of CNS infection at drying off is available, the most prudent course of 
action would be to treat all affected cows with DCT.   
 
2.5.7 Effect of contamination on Petrifilm results 
A limitation of the on-farm culture system is the inability of the Petrifilm to 
distinguish contamination from infection.  The AC Petrifilm does not allow for species 
identification, making it impossible to determine if the presence of colonies represents 
significant growth of pathogens.  A cow incorrectly classified as positive by on-farm 
culture would receive DCT when no antibiotic treatment was indicated, thus the risk 
associated with a false positive test result is considered minimal.  Following well-
documented procedures outlined in the Laboratory Handbook on Bovine Mastitis 
(National Mastitis Council, 1999), low sample contamination rates were achieved in this 
study.  Attention to strict aseptic technique when collecting samples for use with the 
Petrifilm on-farm culture system would help to reduce unnecessary antibiotic use.  
Additionally, periodic submission of milk samples to a diagnostic bacteriology 
laboratory, particularly if a herd is experiencing a higher than expected proportion of 
Petrifilm positive cows, should be recommended as a means to assess quarter sampling 
technique and the quality of the resultant milk samples used with the on-farm culture 
system.         
 
52 
 
2.5.8 Effect of sample type and sample storage 
In the present study, application of the Petrifilm on-farm culture system was at the 
level of the cow.  The culture system was implemented in this manner to reflect current 
SDCT practice, where treatment decisions are most frequently made the at the cow level.  
Gold standard diagnoses at the cow level were originally measured at the quarter level.  
Petrifilm diagnoses were based on composite samples, which are measurements at the 
cow level.  The Se of composite samples is lower than that of quarter samples due to the 
dilution effect (Reyher and Dohoo, 2011), therefore the Petrifilm on-farm culture system 
had an inherent limitation when compared to standard bacteriological culture.  Despite 
this constraint, the Petrifilm on-farm culture system correctly identified 85.2% of infected 
cows.   
 In order to transport samples to the bacteriology laboratory, and to comply with 
weekly sample processing capacity, it was necessary to freeze and maintain all milk 
samples at -20°C.  Freezing of the milk samples may have had an impact on the isolation 
of pathogens by gold standard bacteriological culture.  While Murdough et al. (1996) 
reported that freezing of milk samples for 6 weeks did not affect the viability of Staph. 
aureus, CNS, Streptococcus dysgalactiae, Streptococcus uberis, Corynebacterium bovis, 
or E.coli, Schukken et al. (1989) observed that freezing up to 16 weeks resulted in a 
decrease in positive cultures for E. coli and Truperella pyogenes, an increase in the 
recovery of CNS, and no effect on streptococci and Staph. aureus.  As a result of freezing 
the milk samples prior to gold standard bacteriological culture, the estimates of Se and Sp 
of the Petrifilm on-farm culture system may be somewhat over or under-estimated.   
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2.5.9 Future directions 
Following the procedures outlined in the current study, 46.0% of the cows dried-
off during the enrolment period met the inclusion criteria, and 47.8% of those cows 
cultured negative on-farm and did not receive dry cow antibiotics.  Therefore, when the 
Petrifilm on-farm culture system was applied at the cow level, a total reduction in DCT of 
22% was realized. Application of the Petrifilm on-farm culture system at the level of the 
individual mammary quarter would allow for DCT treatment decisions to be made at the 
quarter level, thus reducing even further the amount of antibiotics used in dairy 
production.     
In the present study, 82.7% of quarters did not have an IMI at drying off 
according to standard bacteriology.  By comparison, at the cow level, just under half of 
the cows were identified as uninfected by Petrifilm on-farm culture.  Had the Petrifilm 
on-farm culture system been applied at the quarter level, an even greater reduction in the 
use of DCT would have been realized, potentially leading to greater cost savings and a 
more judicious use of antimicrobials. Moreover, quarter level culturing would result in an 
improvement in the sensitivity when compared to composite culturing (Reyher and 
Dohoo, 2011), thus reducing the false negative rate of the Petrifilm on-farm culture 
system. 
 
54 
 
2.6 CONCLUSION 
 
Petrifilm-based bacteriological culture allows producers to culture milk directly 
on-farm and obtain results within 24 hours.  The Petrifilm on-farm culture system, when 
used to diagnose IMI in low SCC cows at drying off, had a reasonably high Se and a high 
NPV, and application of the Petrifilm on-farm culture system in a selective dry cow 
therapy program enabled a reduction in the use of long-acting intramammary antibiotics 
at drying off.   
The success of a SDCT program can be determined by the prevalence of 
intramammary infection at freshening and in early lactation, as well as the cure rates 
achieved over the dry period.  The information presented in this paper comprises data 
from a clinical trial comparing Petrifilm-based SDCT+ITS to BDCT+ITS.  Further 
analysis of the data from the clinical trial will cover aspects of the measured success of 
SDCT, as well as the economics of Petrifilm-based SDCT.   
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Table 2.1  Distribution of pathogens isolated in quarter milk samples collected on the day 
prior to drying off from cows with a low somatic cell count (< 200 000 cells/mL) on the 
last three milk tests prior to the end of lactation.  Results are presented as the number of 
quarters and cows (as a percentage of total quarters or cows) infected with a particular 
organism1. 
Pathogen
 
Number of quarters 
(% of total quarters) 
Number of cows 
(% of total cows) 
No significant growth 1134 (82.7) 194 (56.6) 
Coagulase negative staphylococci  172 (12.5) 125 (36.4) 
Environmental streptococci
2 
16 (1.2) 14 (4.1) 
Corynebacterium spp. 13 (0.9) 11 (3.2) 
Staphylococcus aureus 7 (0.5) 7 (2.0)  
Escherichia coli 2 (0.1) 2 (0.6)  
Trueperella  pyogenes 1 (0.1) 1 (0.3) 
Other gram negative
3 
1 (0.1) 1 (0.3) 
Fungi 1 (0.1) 1 (0.3) 
Contaminated 40 (2.9) - 
No sample 4 (0.3) - 
1 
Number of quarters (or cows) may add up to more than the total number of quarters (or 
cows) included in the analysis as quarters (or cows) could be infected with more than one 
pathogen. 
2 
Environmental streptococci include all streptococci other than Streptococcus agalactiae. 
3
 Other Gram negatives include: Serratia spp., Citrobacter spp., Proteus spp., Salmonella 
spp., Pseudomonas spp., Pasteurella multocida. 
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Table 2.2  Agreement between producers and an automated Petrifilm reader for the 
Petrifilm on-farm culture system, when used to diagnose intramammary infection in low 
somatic cell count cows (< 200 000 cells/mL) at the end of lactation, with an infection 
threshold of  ≥ 5 colonies.  Cells displaying the disagreement between producers and the 
automated reader, resulting in the misclassification of a cow into treatment categories, are 
shaded.   
   Producer  
   Negative Positive  
 
 
Colony 
count 
0 1 to 4 5 to 9 ≥10 Total 
Automated 
reader 
Negative 
0 24 4 0 0 28 
1 to 4 20 58 5 1 84 
Positive 
5 to 9 4 8 11 0 23 
≥10 1 5 19 105 130 
  Total 49 75 35 106 265 
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Figure 2.1  Tree diagram illustrating the enrolment of cows in the field trial for the 
evaluation of a Petrifilm on-farm culture system for the detection of intramammary 
infection at the end of lactation. (SCC: somatic cell count) 
 
 
Entered the dry 
period between 
July 2009 and 
September 2010
n = 1584 cows
Included 
n = 729 cows
Petrifilm on-farm 
culture system group
n = 360 cows
Number of cows 
included in final 
analysis
n = 343
Removed due to 
contamination
n = 16 cows
Removed due to 
incomplete records
n = 1 cow
Positive control 
group
n = 369 cows
Excluded
n = 855 cows
Reason for exclusion
- High SCC = 504
- Dry period <30 or >90 days = 249
- SCC and dry period = 81
- Other exclusion = 21
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Figure 2.2 Positive predictive values (PPV) and negative predictive values (NPV) for the 
Petrifilm on-farm culture system, at colony count threshold values of 5 and 10 colonies, 
when used to diagnose intramammary infection (IMI) in low somatic cell count cows (< 
200 000 cells/mL) at drying off, for prevalences of IMI ranging from 0 to 100
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3.1 ABSTRACT 
 
The objective of the study was to evaluate the utility of a Petrifilm-based on-farm 
culture system when used to make selective antimicrobial treatment decisions on low 
somatic cell count cows (< 200,000 cells/mL) at drying off.  A total of 729 cows from 16 
commercial dairy herds with a low bulk tank somatic cell count (< 250,000 cells/mL) 
were randomly assigned to receive either blanket dry cow therapy or Petrifilm-based 
selective dry cow therapy.  Cows belonging to the blanket dry cow therapy group were 
infused with a commercial dry cow antimicrobial product (DCT) and an internal teat 
sealant (ITS) at drying off.  Using composite milk samples collected on the day prior to 
drying off, cows in the selective dry cow therapy group were treated at drying off based 
on the results obtained by the Petrifilm on-farm culture system with DCT + ITS 
(Petrifilm culture positive), or ITS alone (Petrifilm culture negative).  Quarters of all 
cows were sampled for standard laboratory bacteriology on the day prior to drying off, at 
3 to 4 days in milk (DIM), at 5 to 18 DIM, and from first cases of clinical mastitis 
occurring within 120 DIM. 
Multilevel logistic regression was used to assess the effect of study group (blanket 
or selective dry cow therapy), and resulting dry cow treatment (DCT + ITS, or ITS 
alone), on the risk of intramammary infection (IMI) at calving and the risk of a first case 
of clinical mastitis between calving and 120 DIM.  According to univariable analysis, 
there was no difference between study groups with respect to quarter level cure risk and 
new IMI risk over the dry period.  Likewise, the risk of IMI at calving and the risk of 
clinical mastitis in the first 120 DIM was not different between quarters belonging to 
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cows in the blanket dry cow therapy group and quarters belonging to cows in the 
selective dry cow therapy group.  The results of this study indicate that selective dry cow 
therapy based on results obtained by the Petrifilm on-farm culture system achieved the 
same level of success with respect to treatment and prevention of IMI over the dry period 
as blanket dry cow therapy, and did not affect the risk of clinical mastitis in the first 120 
days of the subsequent lactation.   
 
3.2 INTRODUCTION 
 
3.2.1 Dry Cow Therapy Practices in North America 
In North America, the preferred mastitis control strategy during the dry period is 
the infusion of a long-acting intramammary antimicrobial product (DCT) in all quarters 
of all cows.  This practice, known as blanket dry cow therapy (BDCT), has been 
prescribed by the National Mastitis Council (NMC) as part of their Recommended 
Mastitis Control Program (National Mastitis Council, 2006).  In the United States and 
Canada, uptake of BDCT is estimated at 72% and 88% of all dairy herds, respectively 
(USDA, 2008; Dufour et al., 2012).  The function of DCT in mastitis control is twofold: 
1) the cure of IMI present at drying off and 2) the prevention of new IMI in the early dry 
period.  Historically, BDCT has played an important role in the overall reduction in the 
prevalence of contagious mastitis pathogens, and a consequential reduction in bulk tank 
somatic cell counts (BTSCC) (Hillerton et al., 1995; Bradley, 2002; Ruegg, 2012).  Since 
the promotion of BDCT in Canada in the late 1960s, Streptococcus agalactiae is nearly 
eradicated and the average provincial geometric-mean BTSCC in 2005 was 225,000 
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cells/mL (Olde Riekerink et al., 2006; Olde Riekerink et al., 2010).  In light of these 
changes in the epidemiology of mastitis, it is argued that the practice of BDCT by all 
herds is no longer required (Robert et al., 2006b; Huijps and Hogeveen, 2007; Rajala-
Schultz et al., 2011). In support of this argument, there is growing concern regarding the 
impact of antimicrobial use in dairy production systems on the emergence of 
antimicrobial resistant bacteria (Call et al., 2008; Oliver et al., 2011).  In dairy 
production, antimicrobials are most frequently used for the purpose of treatment and 
prevention of mastitis (Saini et al., 2012; USDA, 2008), but the relationship between 
antimicrobial drug use and the development of resistance in bacteria is unclear (Call et 
al., 2008; Saini et al., 2012).  Furthermore, studies examining the association between the 
use of DCT and antimicrobial resistance are sparse (Rajala-Schultz et al., 2009).  
Nonetheless, antimicrobial drug use is considered a driving force for the development of 
resistance (Call et al., 2008), thus motivating research into alternative practices which 
have the potential to limit their application. 
 
3.2.2 Internal Teat Sealants and Selective Dry Cow Therapy 
Antimicrobials still play a vital role in dry period mastitis control.  Dry cow 
intramammary antibiotics achieve high cure rates for susceptible pathogens (Gruet et al., 
2001; Bradley and Green, 2004; Halasa et al., 2009a), and DCT remains effective in the 
prevention of new IMI by sensitive pathogens in the early dry period (Williamson et al., 
1995; Berry and Hillerton, 2002b; Halasa et al., 2009b).  Nevertheless, new IMI still 
occurs despite DCT when the causative pathogens are non-susceptible, or in the late dry 
period when antibiotic levels have fallen below the minimum inhibitory concentration 
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(Oliver et al., 1990; Bradley and Green, 2000).  Obstacles to the prevention of new IMI 
during the dry period can be overcome by the addition of an internal teat sealant (ITS) to 
the dry cow protocol.  Internal teat sealants are a non-antimicrobial alternative to DCT 
for the prevention of IMI during the non-lactating period, and the effectiveness of ITS is 
well-supported in the literature (Berry and Hillerton, 2002a; Huxley et al., 2002; Sanford 
et al., 2006a).  In studies that have compared ITS to DCT in quarters uninfected at drying 
off, ITS performed just as well as DCT with respect to the prevention of new IMI 
(Woolford et al., 1998; Sanford et al., 2006a), suggesting that ITS can be used alone in 
the absence of IMI at the end of lactation.  Antibiotic treatment of cows at the end of 
lactation based on IMI status is a dry period mastitis control strategy known as selective 
dry cow therapy (SDCT).  The addition of an ITS to a SDCT protocol ensures that all 
quarters have some protection against new IMI, thus reducing the necessity for the 
prophylactic use of antimicrobials over the non-lactating period. 
 
3.2.3 Selection Procedures for Dry Cow Therapy  
While previous research supports the use of ITS alone in uninfected quarters, 
failing to treat an infected quarter with DCT results in financial losses (Berry et al., 
2004).  Therefore, an accurate selection method is required to correctly identify quarters 
free of IMI at drying off (Huxley et al., 2002; Robert et al., 2008; Torres et al., 2008).  
Selection procedures based on standard bacteriological culture (Robinson et al., 1988; 
Browning et al., 1990; Browning et al., 1994), somatic cell count (SCC) and clinical 
mastitis history (Rindsig et al., 1978; Torres et al., 2008; Rajala-Schultz et al., 2011), the 
California Mastitis Test (Rindsig et al., 1978; Sanford et al., 2006b; Bhutto et al., 2012), 
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and NAGase (Hassan et al., 1999) have been described in the literature with varying 
degrees of accuracy.  The most commonly used selection method is based on monthly 
SCC which has a reported sensitivity of 70% and specificity of 63% (Torres et al., 2008).  
The Petrifilm-based on-farm culture system is an easy to interpret, accurate, and quick 
diagnostic tool that enables dairy producers to culture milk directly on the farm and 
obtain results within 24 hours (McCarron et al., 2009; Cameron et al., 2013).  The 
Petrifilm-based on-farm culture system performed well when used to diagnose IMI in low 
SCC cows at drying off, with a sensitivity of 85.2% and specificity of 73.2% (Cameron et 
al., 2013).  The aim of the research outlined in this paper was to evaluate the use of a 
Petrifilm-based on-farm culture system in a selective dry cow therapy program.  The 
main objectives were to compare IMI risk at calving between quarters of cows receiving 
blanket dry cow therapy with the addition of an ITS and quarters of cows selectively 
treated based on the results of the Petrifilm on-farm culture system with DCT + ITS, or 
ITS alone.  A comparison between the two study groups was also made regarding the risk 
of a first case of clinical mastitis between calving and 120 days in milk (DIM) of the 
subsequent lactation. 
 
3.3 MATERIALS AND METHODS 
 
3.3.1 A Priori Sample Size Calculation 
Sample size calculations were based on a published prevalence of IMI at calving 
of approximately 20% when both DCT and ITS were used at drying off (Godden et al., 
2003; Sanford et al., 2006a).  With a significance level of 95% (two-sided) and a power 
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of 80%, it was determined that approximately 2,280 quarters (570 cows with 285 being in 
each group) would be required to detect a minimum change in risk of IMI at calving from 
20% to 25% (margin of non-inferiority of 5%).  This calculation assumes that quarters 
within a cow are independent, although research has shown interdependence of quarters 
with respect to IMI (Barkema et al., 1997; Berry and Meaney, 2006).  To account for 
clustering of quarters within cows, an adjustment to the sample size was made using a 
published intraclass correlation coefficient (ρ) of 0.20 (Barkema et al., 1997; Berry and 
Meaney, 2006) resulting in a sample size of 3,632 quarters (908 cows, with 454 per 
group). 
 
3.3.2 Herd Selection 
In order to be considered for inclusion, herds were required to have an annual 
average of monthly BTSCC below 250,000 cells/mL over the last 12 months and be 
enrolled in a dairy herd improvement program.  A convenience sample of 16 Canadian 
dairy herds from Prince Edward Island (n = 10) and Quebec (n = 6) were enrolled in the 
randomized clinical trial.  Eligible herds were selected based on willingness to adhere to 
the study protocol and proximity to the veterinary college in each province. 
 
3.3.3 Cow Selection 
Cow level inclusion criteria consisted of monthly SCC below 200,000 cells/mL 
on the last three milk tests prior to drying off, no clinical mastitis in the same time period, 
an expected dry period of 30 to 90 days, no antibiotic treatment in the last 14 days, and at 
least 3 functional quarters.  On the day prior to drying off, eligible cows were subjected 
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to a California Mastitis Test by the trained study personnel, and cows with a score of two 
or greater in any quarter were excluded from the trial. 
Based on an analysis of the Canadian Bovine Mastitis Research Network cohort 
study, it was expected that 30% of cows would fail to meet the inclusion criteria for SCC 
less than 200,000 cells/mL (unpublished data).  Additional exclusions based on other 
criteria were estimated at 10% of cows.  Therefore, a pre-exclusion sample of 
approximately 1,500 cows would be required to achieve the required sample size of 908 
cows. 
 
3.3.4 Pre-Dry Sampling and Random Allocation to Treatment Groups 
Producers scheduled a dry off day every other week to allow for cow enrolment 
and sample collection.  On the day prior to drying off (Day -1), single quarter level milk 
samples were collected by the study personnel.  Following pre-milking udder preparation 
as per farm protocol, teat ends were scrubbed clean with alcohol swabs and initial 
foremilk streams were discarded into a strip cup.  Approximately 30 mL of milk was 
collected aseptically according to the procedures recommended in the Laboratory 
Handbook on Bovine Mastitis (National Mastitis Council, 1999).  Following sample 
collection (DO = dry off sample), cows were randomly assigned to either the blanket dry 
cow therapy (BDCT) or the Petrifilm-based selective dry cow therapy (SDCT) study 
group according to a randomization table unique to each herd, with a block size of six 
thus randomizing six cows at a time, three to BDCT and three to SDCT. 
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3.3.5 On-Farm Bacteriological Culture and Treatment at Drying Off 
The study personnel set-up the Petrifilm-based on-farm culture system for cows 
assigned to SDCT.  A composite sample was created by combining 5 mL of milk from 
each quarter sample into a new sample vial.  A 3 mL aliquot of composite milk was 
added to 27 mL of sterile water to make a 1:10 dilution (McCarron et al., 2009).  One 
milliliter of diluted milk was plated on an Aerobic Count (AC) Petrifilm (3M Canada, 
London, Ontario) and incubated on-farm at 35°C for 24 hours in a TurboFan Hova-Bator 
(GQF Manufacturing, Savannah, Georgia, USA).  The Aerobic Count Petrifilm is a 
ready-made culture medium used for the detection of all aerobic bacteria and contains an 
indicator dye which facilitates colony enumeration. On the scheduled day of drying off 
(Day 0), the Petrifilm was read by the producer and, in accordance with study protocol, 
cows were classified as positive if 5 or more colonies were present (equivalent to ≥ 50 
cfu/mL of milk).  Cows negative on Petrifilm were treated solely with an ITS composed 
of 65% bismuth subnitrate (Orbeseal, Pfizer Animal Health, Kirkland, Quebec, Canada) 
at drying off.  Cows positive on Petrifilm were treated with a long-acting intramammary 
formulation of 500 mg ceftiofur hydrochloride (Spectramast DC, Pfizer Animal Health, 
Kirkland, Quebec, Canada) followed by an ITS.  Producers recorded the number of 
colonies present on the Petrifilm, as well as the treatment applied, to verify compliance 
with the study protocol.  Cows in the BDCT group were infused with ceftiofur followed 
by an ITS in all four quarters, and again producers recorded the treatments given.  All 
cows were dried-off abruptly and dry cow treatments were administered by the producer 
or farm personnel immediately after the last milking.  Teats were prepared aseptically 
prior to treatment, and were disinfected post treatment with a commercial teat dip. 
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3.3.6 Post-Calving Sampling and Record Keeping 
Post-calving quarter milk samples were aseptically collected by the producer 
between 3 and 4 DIM (PC1 = post-calving sample 1) and by the study personnel between 
day 5 and 18 DIM (PC2 = post-calving sample 2) using the methods outlined for pre-dry 
off sampling.  At the time of sample collection, the producer and the study personnel 
recorded the occurrence of any post-partum disease (such as milk fever, mastitis, or 
retained placenta) and any given antibiotic treatment.  The antibiotic treatment of a cow 
prior to the collection of the first post-calving sample resulted in the removal of the entire 
observation from the analyses.  All post-enrolment exclusions were enumerated and 
reported separately from pre-enrolment exclusions to allow for comparison between 
groups. 
 
3.3.7 Clinical Mastitis Sampling 
Clinical mastitis cases occurring in participating cows in the first 120 days of the 
next lactation were recorded and sampled by the producer prior to treatment.  Only the 
first clinical mastitis episode per quarter was considered in the analysis.  Clinical mastitis 
was defined as visible changes in milk, with or without heat, swelling or redness in the 
quarter, and with or without signs of systemic disease.  Milk samples were collected 
aseptically and frozen on farm until collection by the study personnel during their visit 
every other week. 
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3.3.8 Laboratory Bacteriological Culture 
Subsequent to collection, all milk samples were frozen at -20°C before shipment 
to the Maritime Quality Milk research laboratory at the University of Prince Edward 
Island.  Laboratory technicians were blinded to the results obtained by the Petrifilm on-
farm culture system.  Laboratory bacteriological culture was performed according to 
procedures outlined in the NMC‘s Laboratory Handbook on Bovine Mastitis (National 
Mastitis Council, 1999).  A quarter was considered infected if ≥ 100 cfu/mL of milk of 
any pathogenic organism of interest, except for coagulase negative staphylococci (CNS), 
were cultured.  For CNS, a definition of ≥ 200 cfu/mL was used.  These definitions are in 
accordance with the recent publication of characterization of IMI based on single sample 
bacteriological testing (Dohoo et al., 2011b).  Samples with three or more differing 
isolates were classified as contaminated, and isolation of Bacillus spp. was considered 
non-significant growth.  However, when Staphylococcus aureus (Staph. aureus) was 
identified in a contaminated sample, it was enumerated and the associated quarter was 
classified as infected (Reyher et al., 2011). 
For the purpose of analysis, Gram-negative bacteria, other than Escherichia coli 
(E. coli) and Klebsiella spp., were amalgamated into a grouping and encompassed 
Enterobacter spp., Proteus spp., Citrobacter spp., Pseudomonas spp., Serratia spp., 
Salmonella spp., Pasteurella multocida, and other non-differentiated Gram-negative 
bacteria.  Coagulase negative staphylococci were not differentiated beyond the group 
level, but if two phenotypically different species of CNS displayed growth on culture, 
each isolate was enumerated and reported. 
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3.3.9 Definitions 
Post-Calving Intramammary Infection. Two definitions for post-calving IMI were 
applied, considering either PC1 alone, or both PC1 and PC2 interpreted in parallel.  For 
the first definition, a quarter was considered to have an IMI if one or two pathogens were 
isolated in PC1.  If PC1 was missing or contaminated, the observation was dropped from 
the analysis.  For the second definition, a quarter was considered infected if either PC1 or 
PC2 displayed growth of one or two pathogens.  In cases where one of the post-calving 
samples was missing or was classified as contaminated, the quarter infection status was 
determined solely by the results of the remaining sample.  If both post-calving samples 
were contaminated or missing, the associated quarter was removed from the analysis. 
Dry Period Cure.  Dry period cure was determined at both the pathogen and quarter 
levels.  A pathogen isolated in DO was considered cured over the dry period if it was 
absent in both PC1 and PC2.  A quarter was considered cured when a pathogen isolated 
in DO was not recovered in either PC1 or PC2.  If a quarter was infected with two 
pathogens at drying off, the absence of both pathogens in PC1 and PC2 was required for 
that quarter to be labeled cured.  In cases where one, or both, of the post-calving samples 
were missing or contaminated, the associated quarter was dropped from the analysis. 
New Intramammary Infection.  Two definitions of new intramammary infection were 
investigated.  According to both definitions, a quarter was defined as having a new IMI if 
a pathogen was cultured at calving that was not present in DO. Therefore, both uninfected 
and infected quarters were considered at risk for new IMI during the dry period.  For the 
first definition, only PC1 was considered.  The second definition was based on parallel 
interpretation of PC1 and PC2, thus if a pathogen was present in either post-calving 
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samples, but was not present in DO, that quarter was considered newly infected over the 
dry period. 
 
3.3.10 Statistical Analysis 
Statistical analysis was performed using Stata/IC 11.0 (StataCorp, College 
Station, TX).  The experimental unit for statistical analysis was the individual mammary 
quarter.  Univariable analysis of the effect of study group was carried out using Fisher‘s 
exact test for the following outcomes: risk of IMI at drying off, risk of IMI at calving, 
risk for cure over the dry period, and risk of new IMI during the dry period. 
Multilevel logistic regression models were applied to evaluate the effect of study 
group, and treatment within the study group, on 1) the risk of IMI at calving, and 2) the 
risk of a first case of clinical mastitis between calving and 120 DIM.   Random effects for 
cows and herds were incorporated in the models to account for clustering of quarters 
within cows, and cows within herds.  The main predictor of interest ‗treatment group‘ 
was specified at the cow level, and was created by combining the variables study group 
(BDCT or SDCT) and subsequent treatment at drying off (DCT + ITS, or ITS alone), 
thus comprising three levels: BDCT, Petrifilm positive, and Petrifilm negative.  
Additional explanatory variables considered for inclusion in the models included region, 
herd size, housing type (tie-stall or free-stall), season at calving, parity at calving (2, 3, or 
4+), last recorded 24 hour milk yield (in Kg) prior to drying off, length of the dry period, 
quarter infection status at drying off as determined by standard bacteriologic culture, and 
quarter position (front or hind).  The variable for season at calving was created using 
three month intervals, such that winter was designated as December to February, spring 
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as March to May, summer as June to August, and fall as September to November.  All 
variables were explored using descriptive statistics and graphical analyses where 
appropriate.  Continuous predictors were evaluated for linearity with the logit of the 
outcomes using a locally weighted scatter plot smoothed (lowess) curve. 
The primary predictor of interest ‗treatment group‘ was forced into all models 
regardless of statistical significance.  Intramammary infection status at drying off 
according to gold standard bacteriological culture was also retained in all models in order 
to control for the confounding effect of this variable on the association of treatment group 
with both the risk of IMI at calving and the risk of clinical mastitis in the subsequent 
lactation.  Unconditional associations between the other explanatory variables and the 
outcomes were examined using simple univariable logistic regression, and variables with 
P values < 0.30 were offered for inclusion in the multivariable models.  A backwards 
stepwise procedure was used to determine the final models, and all two-way interactions 
involving the main predictor ‗treatment group‘ were evaluated.  Of particular interest, an 
interaction between ‗treatment group‘ and quarter infection status at drying off as 
determined by standard bacteriologic culture was created to examine the effects of a false 
negative and a false positive Petrifilm result.  Significance was declared at a P value < 
0.05, but variables were retained in the models with a P value < 0.10, or if they were 
involved in a significant two-way interaction.  Once the final models were reached, the fit 
was evaluated by examination of residual plots (Dohoo et al., 2009). 
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3.4 RESULTS 
 
3.4.1 Cow Enrolment and Descriptive Statistics 
During the cow enrolment period of July 2009 to September 2010, a total of 1,584 
cows from the 16 participating herds entered the dry period.  The number of cows dried-
off per farm ranged from 42 to 263, with a median of 81 cows.  Details of cow enrolment 
and a flow chart of study units can be found in Figure 3.1.  The most common reason for 
exclusion from the trial was high SCC (504/855; 58.9% of exclusions), followed by an 
anticipated long or short dry period (249/855; 29.1% of exclusions).  The addition of the 
CMT to the enrolment criteria resulted in only 7 additional cows being excluded from the 
trial and therefore provided little information beyond what was obtained using selection 
criteria based on SCC and clinical mastitis history.  The proportion of cows per farm 
eligible for inclusion ranged from 28.3% (15/53) to 69.4% (145/209), and ultimately a 
total of 729 (46.0%) cows were enrolled in the trial.  Of these cows, 369 (1,476 quarters) 
were assigned to the BDCT group and 360 (1,440 quarters) were assigned to the SDCT 
group (Figure 3.1).  Post-enrolment exclusions and attrition resulted in the loss of 126 
cows for the following reasons: no post-calving sample was collected (n = 9), death (n = 
10), sold prior to calving (n = 11), abortion (n = 2), not pregnant (n = 2), an actual dry 
period greater than 90 days or shorter than 30 days (n = 51), other antibiotic treatment 
prior to post-calving sample collection (n = 40), and contamination of all post-calving 
milk samples (n = 1).  Sixteen cows that received antibiotic treatment prior to sample 
collection were treated for mastitis (BDCT = 7 cows; SDCT = 9 cows).  An additional 
114 quarters were dropped due to contamination, and 11 quarters were non-lactating.  
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There were no significant differences between study groups with respect to post-
enrolment exclusion or attrition.  Thus, 1,157 BDCT group quarters (n = 305 cows) and 
1,130 SDCT quarters (n = 298 cows) were available for analysis (Figure 3.1).  The cow 
level prevalence of IMI at drying off in the SDCT group according to Petrifilm on-farm 
culture was 54.4% (162/298).  Therefore, at a Petrifilm treatment threshold of ≥ 50 
cfu/mL, 45.6% (136/298) of the cows were classified as uninfected and did not receive a 
long-acting intramammary antibiotic at drying off.  Descriptive statistics for the cows 
included in the final analysis can be found in Table 3.1. 
 
3.4.2 Risk of Intramammary Infection at Drying Off and Post-Calving 
The standard bacteriological culture results from quarter level milk samples 
collected at the end of lactation and at calving are shown in Tables 3.2 and 3.3.  Despite 
random allocation into study groups, the proportion of quarters with an IMI at drying off 
was higher in the SDCT group than in the BDCT group, but this difference was only 
borderline significant (BDCT: 12.4% (10.5, 14.3) vs. SDCT: 15.1% (13.0, 17.2); P = 
0.054).  In the SDCT group, a false negative Petrifilm result occurred in 20 cows and as a 
result, 23 quarters were misclassified as negative and did not receive DCT at drying off.  
Out of the group of cows (n = 162) that cultured positive on Petrifilm, 67.3% had at least 
one quarter with an IMI at drying off according to standard culture. 
Following calving, the prevalence of IMI was not different between study groups, 
whether post-calving IMI status was determined by the first post-calving sample (BDCT: 
11.1% (9.0, 13.2) vs. SDCT: 10.6% (8.6, 12.7); P = 0.77) or by parallel interpretation of 
both post-calving samples (BDCT: 15.3% (13.2, 17.4) vs. SDCT: 15.8% (13.7, 18.0); P = 
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0.72).  As the second definition resulted in higher statistical power and represented a 
more liberal definition of post-calving IMI, it was examined as the outcome in the 
multivariable model.  Coagulase negative staphylococci were the most commonly 
isolated pathogens at all sampling periods.  The next most common pathogens isolated at 
drying off were Corynebacterium spp. and environmental streptococci, followed by 
Staph. aureus.  After calving, environmental streptococci and Staph. aureus were the next 
most prevalent pathogens. 
 
3.4.3 Cure Risk Over the Dry Period 
Quarter level cure risk over the dry period was high and was not different between 
study groups (BDCT: 84.5% (76.0, 90.9); SDCT: 89.0% (81.9, 94.0); P = 0.33).  There 
was no significant difference in species-specific cure risks between quarters that received 
BDCT and quarters that received SDCT.  The cure risk for Staph. aureus in the BDCT 
group was 100% (5/5), but in the SDCT group the cure risk was 75% (3/4).  In the SDCT 
group, the quarter infected with Staph. aureus that failed to cure belonged to a cow that 
was misdiagnosed by the Petrifilm on-farm culture system and therefore that quarter did 
not receive DCT at drying off.  The same was true for a SDCT group quarter that 
remained infected with Streptococcus dysgalactiae and one quarter that remained 
infected with CNS from drying off to calving.  However, the overall apparent self-cure 
risk for quarters misdiagnosed by the Petrifilm on-farm culture system was 87.0% 
(20/23).  Pathogens isolated from the quarters with spontaneous cure were CNS (n = 12), 
nondifferentiated streptococci (n = 5), and Corynebacterium spp. (n = 3). 
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3.4.4 New Intramammary Infection Risk Over the Dry Period  
When new intramammary infection risk was examined using only the first post-
calving sample, the results were similar to those obtained using both post-calving 
samples (Appendix B).  Because analyses using both post-calving samples resulted in 
greater power, and a more liberal definition of new IMI, only those results are presented.  
The pathogen-specific and quarter-level new IMI risks are presented in Table 3.4.  
Overall, there was no significant difference between quarters that received BDCT and 
quarters under SDCT based on Petrifilm results.  There were more quarters with new IMI 
caused by fungi and yeast in the BDCT group than in the SDCT group (0.9% vs. 0.2%; P 
= 0.04).  The majority of new infections were caused by CNS, followed by environmental 
streptococci and Staph. aureus. 
 
3.4.5 Unconditional Analyses and Final Multilevel Model for the Risk of 
Intramammary Infection at Calving 
Unconditional associations between independent variables and the probability of 
IMI at calving are presented in Table 3.5.  Significantly associated with the risk of IMI 
post-calving were IMI status at drying off according to standard culture, season at drying 
off, parity at calving, and quarter position.  Twenty-four hour milk yield on the last test 
prior to drying off was borderline significant (Odds ratio (OR) 1.02 (1.00, 1.04)). 
The results of the final multivariable logistic model are presented in Table 3.6.  In 
the final model, treatment group was not significantly associated with the probability of 
IMI at calving (P = 0.95).  Similarly, the following independent variables were not 
associated with the risk of IMI at calving and were dropped from the final model: region, 
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herd size, housing type, 24 hour milk yield on the last test, parity at calving, and length of 
the dry period.  Neither intramammary infection status at drying off according to standard 
bacteriological culture (P = 0.29), nor the interaction term between infection status and 
treatment group (P = 0.36) were significant.  Quarter position was a significant predictor 
in the model, with hind quarters having a higher odds of IMI (OR 1.36 (1.05, 1.75)).  
Season at calving was also significant, with quarters belonging to cows calving in the 
summer and the fall having a higher likelihood of IMI (OR 1.95 (1.21, 3.15); OR 1.75 
(1.10, 2.78), respectively) than quarters of cows calving in the winter (referent category).  
Evaluation of residual plots did not indicate a problem with the fit of the final model.  
 
3.4.6 Risk of Clinical Mastitis in the First 120 Days of Lactation 
Clinical mastitis data were available for 11 herds, for a total of 620 enrolled cows 
(2,480 quarters).  Prior to analysis, a number of cows were dropped for the following 
reasons: death (n = 9), sold (n = 8), abortion (n = 1), not pregnant (n = 2), dry period 
greater than 90 days or shorter than 30 days (n = 37), and other antibiotic treatment (n = 
37).  An additional 9 quarters were non-lactating, and 70 quarters were removed due to 
contamination of the sample collected at drying off.  Thus, 525 cows (2,025 quarters) 
were used in the analysis, 264 (1,019 quarters) belonging to the BDCT group and 261 
(1,006 quarters) belonging to the SDCT group. 
In total, there were forty-five reported cases of clinical mastitis, with 24 cases 
occurring in the BDCT group and 21 cases occurring in the SDCT group.  The overall 
quarter level incidence of clinical mastitis in the first 120 days of lactation was 2.2% 
(45/2,025) and at the cow level the incidence was 7.4% (39/525).  The most commonly 
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isolated pathogens were E. coli (9/45), CNS (8/45), and Staph. aureus (7/45).  A 
diagnosis of no microbial growth was made in 22.2% (10/45) of the samples.  In the final 
multivariable logistic model, neither treatment group (P = 0.58) nor infection status at 
drying off based on standard culture (P = 0.22) were statistically significant.  No 
association between the other tested variables and the risk of clinical mastitis was found.  
Evaluation of residual plots did not indicate a problem with the fit of the final model. 
 
3.5 DISCUSSION 
 
This is the first study evaluating the utility of a Petrifilm-based on-farm culture 
system in a selective dry cow therapy program.  Considering that blanket dry cow therapy 
remains the mainstay of dry period mastitis control in North America, the acceptance of 
SDCT by dairy producers necessitates a cautious approach, particularly in the 
introductory phase.  As a result, a tiered approach to the selection protocol was used, 
creating a starting point of low BTSCC herds and low SCC cows and this must be taken 
into account when interpreting the results of the study.  Following the procedures 
outlined in the current study, 46.0% of the cows dried-off during the enrolment period 
met the inclusion criteria and, after accounting for post-enrolment exclusions, 45.6% of 
cows assigned to SDCT cultured negative on-farm and did not receive dry cow 
antibiotics.  Therefore, when the Petrifilm on-farm culture system was applied at the cow 
level, a total reduction in DCT of 21% was realized.   
 
83 
 
3.5.1 Risk of Intramammary Infection at Calving 
According to the present study, the selective antibiotic treatment of low SCC 
cows at the end of lactation based on Petrifilm on-farm culture results was just as 
effective in the treatment and prevention of IMI during the dry period as BDCT in herds 
with a low BTSCC (< 250,000 cells/mL).  The success of a selective dry cow therapy 
program depends greatly on the ability of the selection protocol to accurately identify 
cows with an IMI at the time of drying off so that DCT can be applied judiciously, while 
minimizing the risk of failing to treat an infected cow.  The Petrifilm on-farm culture 
system enabled the detection of cows with an IMI at the end of lactation and as a result, 
SDCT based on Petrifilm culture results achieved the same level of success as BDCT 
with regards to infection status at calving. 
Exploration of an interaction between treatment group and IMI status at drying off 
according to standard bacteriological culture demonstrated that misclassification of cows 
by the Petrifilm on-farm culture system did not have a negative effect on the outcome at 
calving.  With respect to misdiagnosis, of greatest concern would be a false negative 
Petrifilm result at the cow level resulting in an infected quarter not receiving the 
therapeutic benefits of DCT.  In the current study, only three infected quarters belonging 
to cows with a false negative Petrifilm result remained infected with the same pathogen at 
calving, including one quarter chronically infected with Staph. aureus.  Despite 
misdiagnosis at drying off, 87% (20/23) of infected and untreated quarters experienced an 
apparent self-cure over the dry period.  Most importantly, the occurrence of a quarter 
level false negative diagnosis was infrequent (13.5%; 23/171 quarters), and therefore did 
not result in an increase in the risk of IMI post-calving when compared to BDCT. 
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In contrast to a false negative diagnosis, the consequence of a false positive 
diagnosis would be the unnecessary antimicrobial treatment of quarters without an IMI at 
drying off and is less of a concern from a clinical standpoint.  A limitation of the on-farm 
culture system is the inability of the Petrifilm to distinguish non-significant growth and 
contamination from intramammary infection.  The AC Petrifilm does not allow for 
species identification making it impossible to determine if colonies represent a single or 
multiple species, or if growth is that of a recognized mastitis pathogen.  Strict aseptic 
technique must be applied when collecting samples for use with the on-farm culture 
system in order to minimize the false positive rate and the unnecessary antimicrobial 
treatment of mammary quarters.  The Petrifilm on-farm culture system was applied at the 
cow level because, for the majority of selective dry cow therapy programs, this is the 
level at which treatment decisions are made.  As a result, many uninfected quarters were 
treated because they belonged to a cow that had at least one infected quarter.  Application 
of the on-farm culture system at the quarter level would result in a greater reduction in 
unnecessary antibiotic use, but would require individual quarter culture, which in turn 
would demand more materials and labor.  The literature has shown interdependence of 
quarters for the acquisition of new IMI during the dry period, leading to the 
recommendation that DCT be applied to all quarters of a cow, as opposed to only the 
affected quarter(s) (Browning et al., 1990; Berry et al., 2003; Robert et al., 2006a).  
However, quarter interdependence toward new IMI may be reduced when effective 
prevention strategies are in place or when the risk of cross-quarter contamination is low 
(Barkema et al., 1997; Berry et al., 2003; Robert et al., 2006a). 
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3.5.2 Prevalence of Intramammary Infection at Drying Off 
The prevalence of intramammary infection at drying off was low, reflecting the 
nature of the herds and the cows meeting the inclusion criteria, i.e. low BTSCC at the 
herd level, and low monthly SCC prior to drying off at the cow level.  According to 
results obtained from the Canadian National Cohort of Dairy Farms (NCDF) from milk 
samples collected between 4 and 2 weeks before drying off, and again between 2 weeks 
and drying off (n = 1,681 cows originating from 90 herds), the prevalence of IMI at the 
quarter level was 66.3%, and the majority of these infections were caused by minor 
pathogens (60.2%) [D. Haines (Université de Montréal, St-Hyacinthe, QC, Canada), 
personal communication (Jan. 15, 2013)].  The farms recruited in the NCDF were chosen 
to represent a uniform distribution of BTSCC, from ≤ 150,000 cells/mL to > 300,000 
cells/mL, and therefore included herds with higher BTSCC than found in the current 
study.  In the NCDF, Staph. aureus was the most commonly isolated major pathogen, and 
the third most commonly isolated pathogen overall, found in 4.2% of quarters prior to 
drying off [D. Haines (Université de Montréal, St-Hyacinthe, QC, Canada), personal 
communication (Jan. 15, 2013)].  In the present study, Staph. aureus was the fourth most 
commonly isolated pathogen at drying off, but the prevalence at the quarter level was 
only 0.4% (9 quarters positive with Staph. aureus out of 2,287 quarters cultured).  
Staphylococcus aureus remains an important mastitis pathogen in the Canadian dairy 
industry (Reyher et al., 2011).  Lactational cures rates for Staph. aureus are generally < 
50% at the quarter-level (Roy and Keefe, 2012).  As a result, it is common to treat cows 
infected with Staph. aureus at drying off, where cure rates of up to 77% have been 
reported (Halasa et al., 2009).  For the present study, inclusion criteria at the herd level 
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included low BTSCC because the likelihood of high prevalence of Staph. aureus and 
other major contagious pathogens would be low.  In herds where major contagious 
pathogens dominate and are prevalent, the practice of BDCT remains an important 
control measure. 
In the present study, CNS were the most frequently isolated pathogens in both 
study groups at all sampling points.  Coagulase negative staphylococci are considered to 
be an emerging mastitis pathogen as they are the most common cause of IMI in many 
countries, however the importance of CNS as a group of mastitis pathogens remains 
unclear (Pyörälä and Taponen, 2009; Schukken et al., 2009; Reyher et al., 2012).  Some 
studies have shown that CNS infection can be protective against major pathogen infection 
during lactation and over the dry period (Rainard and Poutrel, 1988; Østerås and Sandvik, 
1996; Green et al., 2005), while other studies have declared an increase in susceptibility 
to major pathogens when a CNS infection is established (Hogan et al., 1988; Berry and 
Hillerton, 2002a; Berry and Hillerton, 2002b).  Until further research establishes the true 
nature of CNS infection, the most prudent recommendation would be to treat all cases 
CNS IMI present at the end of lactation.  However, according to the results of this study, 
leaving a quarter infected with CNS untreated at drying off may not necessarily result in 
a negative outcome at calving, as an apparent self-cure rate of 92.3% (12/13) for CNS 
was achieved in untreated quarters that were misdiagnosed at drying off by the Petrifilm 
on-farm culture system. 
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3.5.3 Cure Risk Over the Dry Period  
Cure risks over the dry period were high in both study groups, and were similar to 
those reported in other studies in quarters receiving DCT + ITS (Godden et al., 2003; 
Newton et al., 2008; Bradley et al., 2011).  In the final multivariable model, IMI status at 
drying off according to standard bacteriological culture was not associated with the risk 
of IMI post-calving.  Dry cow antibiotic therapy was therefore effective in eliminating 
IMI in both study groups, and more specifically for the SDCT group, DCT was applied in 
a manner which successfully eliminated IMI to the same degree as BDCT.  A high cure 
risk was maintained in infected quarters that did not receive DCT as a result of a false 
negative Petrifilm result.  High apparent self-cure rates in cows with low SCC at drying 
off have been reported in other studies (Harmon et al., 1986; Huxley et al., 2002; Bradley 
et al., 2010).  In the current study, the low SCC nature of the cows might indicate that 
some of the pathogens isolated at drying off may have represented teat canal infections 
that were more easily eliminated. 
 
3.5.4 New Intramammary Infection Risk Over the Dry Period 
The risk of new IMI over the dry period was low, and was similar between BDCT 
and SDCT groups.  A notable aspect of this study was the application of an ITS in all 
quarters of all cows, as opposed to reserving ITS for quarters of cows selected not to 
receive DCT.  The use of an ITS in all quarters of all cows as a tool for the prevention of 
IMI during the dry period is well-supported by the literature (Sanford et al., 2006a; 
Newton et al., 2008; Bradley et al., 2010).  The use of an ITS alone to prevent IMI in 
quarters uninfected at the end of lactation is also established by prior studies that have 
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shown that ITS is just as effective as DCT in the prevention of IMI in quarters that are 
bacteriologically negative at drying off (Woolford et al., 1998; Sanford et al., 2006a).  
However, when ITS are used alone, strict asepsis and partial insertion technique is 
recommended.  Internal teat sealants contain no antibiotic, therefore it is essential to 
minimize the risk of accidental introduction of bacteria during infusion.  In the present 
study, all non-lactating cow treatments were administered by the producers.  The 
producers were able to maintain asepsis during infusion of ITS, and as a result, the risk of 
new IMI was not higher in quarters that received ITS as a sole treatment at drying off.  
Interestingly, the risk of new IMI caused by fungi and yeast, typically associated with 
poor aseptic technique (National Mastitis Council, 1999) was numerically higher in the 
quarters receiving BDCT, however the numbers were too small to draw definitive 
conclusions. 
In comparison to the results of the current study, other studies examining selective 
dry cow therapy have reported a higher risk of new IMI in selectively treated cows than 
in cows receiving BDCT (Rindsig et al., 1978; Berry and Hillerton, 2002b).  In the earlier 
studies, cows not receiving DCT were left unprotected during the dry period.  It has been 
shown that up to 23.4% of teats have not formed a protective keratin plug within the 
streak canal by 6 weeks dry (Dingwell et al., 2004).  Mammary quarters lacking a 
functional keratin plug remain susceptible to infection, and as a result, the odds of new 
IMI in an open quarter is 1.7 times higher compared to a closed quarter (Dingwell et al., 
2004).  In the current study, the use of an ITS in all cows, and specifically in cows not 
infused with DCT, resulted in the protection of all quarters against new IMI over the dry 
period. 
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3.5.5 Misclassification Bias 
In the current study, post-calving IMI status was modeled using an outcome based 
on parallel interpretation of milk samples collected between 3 and 4 DIM and between 5 
and 18 DIM.  Parallel interpretation of milk culture results has the benefit of increasing 
sensitivity to detect IMI over series interpretation or single sample culturing (Dohoo et 
al., 2011a).  Additionally, parallel interpretation minimized the loss of study units due to 
missing or contaminated samples.  However, because IMI status was determined using 
samples collected post-calving, it is possible that infections detected in those samples 
represented infections that were acquired in the post-calving period.  Consequently, the 
risk of IMI post-calving included not only the risk of IMI over dry period, but also the 
risk up to 18 days into the next lactation.  In fact, the prevalence of IMI was higher when 
calculated using both post-calving samples than when only the first sample was 
considered.  When considering only the first post-calving sample, which was collected 
between 3 to 4 days in lactation and would be more representative of IMI status at 
calving, the risk of IMI between study groups was not different.  Lastly, because the same 
sampling protocol was used in both study groups, any misclassification bias resulting 
from the timing of the post-calving samples would be nondifferential, that is the risk of 
misclassification error would be the same in both groups.  Nondifferential 
misclassification errors bias the estimate of the odds ratio towards the null, therefore it is 
possible that a type II error (i.e. the false conclusion that study group did not affect the 
risk of IMI post-calving) occurred as a result of the sampling protocol used (Dohoo et al., 
2009). 
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3.5.6 Clinical Mastitis in the First 120 Days in Milk 
Infections acquired during the dry period can be a cause of clinical mastitis in 
early lactation (Green et al., 2002;2007).  Therefore, prevention of IMI during the dry 
period can have the additional benefit of reducing clinical mastitis in early lactation and 
the associated negative effects on milk production and reproduction.  In this study, the 
risk of clinical mastitis in the first 120 days of lactation was the same between treatment 
groups.  Furthermore, quarters negative on Petrifilm, that did not receive DCT but were 
infused with only a ITS at drying off, were not at increased risk for an episode of clinical 
mastitis in early lactation when compared to quarters infused with DCT + ITS.  The use 
of an ITS alone, and in combination with DCT, has been shown to be protective against 
clinical mastitis in early lactation by others (Godden et al., 2003; Sanford et al., 2006a; 
Newton et al., 2008).  Overall, the risk of clinical mastitis was low, however compliance 
of study participants with this portion of the study may have been incomplete, therefore 
these results should be interpreted with caution due to the reduced sample size.  Despite 
incomplete compliance regarding clinical mastitis reporting and sampling, there is no 
reason to believe that under-reporting was greater in one study group.  
 
3.5.7 Association of Outcome with Other Predictors 
While the main focus of this study was to compare Petrifilm-based SDCT to 
BDCT, the collection of additional data provided an opportunity to evaluate the impact of 
other factors on the risk of IMI at calving.  According to the data, hind quarters were 
more likely to have an IMI post-calving than quarters located in the front.  Prior studies 
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examining quarter interdependence for IMI and clinical mastitis have reported a higher 
prevalence in hind quarters when compared to front quarters (Adkinson et al., 1993; 
Barkema et al., 1997).  Conversely, the majority of studies evaluating the use of ITS have 
failed to report a quarter effect (Berry and Hillerton, 2002a; Huxley et al., 2002; Godden 
et al., 2003).   
Another association revealed in the final multivariable model was the effect of 
season on IMI risk at calving.  According to the data, quarters belonging to cows that 
calved in the summer and fall were more likely to have an IMI post-calving than quarters 
belonging to cows that calved in the winter.  Others have hypothesized that higher 
temperatures and increased humidity in the summer and early fall result in a greater 
pathogen load in the environment (Smith et al., 1985; Todhunter et al., 1995), as well as 
increased cow susceptibility due to immunosupression from heat stress (Smith et al., 
1985; Carroll and Forsberg, 2007).  Similarly, different housing and nutrition in the 
warmer months may explain some of the seasonality effect (Godden et al., 2003). 
 
3.5.8 Limitations of the Study 
According to the initial study design, exclusion rates based on SCC data from the 
NCDF were expected to be approximately 30% of cows.  It was also estimated that an 
additional 10% of cows would be excluded based on other criteria.  Ultimately, 37% of 
cows were ineligible due to high SCC, and an additional 17% were excluded for other 
reasons.  As a result of higher than anticipated exclusion rates, in addition to post-
enrolment losses, the final sample size used in the analysis was smaller than what was 
declared required to maintain a power of 0.80.  The concern with small sample sizes is a 
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lack of power to detect differences where differences exist, especially when the 
difference is small.  While at no time were there trends in treatment group factor effects 
approaching significance, it should be noted that maintaining a power of 0.80 using the 
effective sample size attained in this study, the smallest detectable difference between 
BDCT and SDCT group would be 6.5%. 
 
3.6 CONCLUSIONS 
 
Following the selection protocol outlined in the current study, which included 
criteria based on historical SCC with the addition of Petrifilm on-farm culture, a total 
reduction in DCT of 21% was realized.  The use of a Petrifilm-based on-farm culture 
system to make targeted DCT treatment decisions on cows with a low SCC at the end of 
lactation did not affect the risk of IMI at calving nor the risk of clinical mastitis in the 
first 120 DIM, as compared to BDCT. While application of the Petrifilm on-farm culture 
system at the cow level (i.e. composite milk samples and cow level treatment) lead to a 
modest decrease in the use of DCT in the study herds, use of the culture system at the 
quarter level (i.e. quarter samples and quarter level treatment) has the potential to effect 
an even greater reduction in the use of intramammary antimicrobials at the end of 
lactation and is the focus of a forthcoming research project.  Analysis of the economics of 
Petrifilm-based SDCT is currently being conducted.  
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Table 3.1. Descriptive statistics for cows enrolled in a randomized clinical trial to evaluate the use of a Petrifilm-based on-
farm culture system in a selective dry cow therapy program 
 BDCT
1
 (n = 305)  SDCT
2
 (n = 298) 
 Number Mean SD Range  Number Mean SD Range 
Milk yield at last test (Kg)  22.3 5.7 5.5-41.6   22.2 5.6 6.1-42.4 
Dry period length  59 11 30-90   59 11 32-89 
Parity at calving          
2 145     144    
3 77     64    
4 or above 83     90    
Season at calving          
Winter 77     69    
Spring 56     54    
Summer 79     78    
Fall 93     97    
1
BDCT: Cows receiving blanket dry cow therapy plus internal teat sealant at drying off 
2
SDCT: Cows selectively treated based on Petrifilm on-farm culture results with dry cow antibiotic and internal teat sealant, or 
internal teat sealant alone, at drying off 
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Table 3.2. Prevalence of intramammary infection (IMI) and bacterial species isolated on the day prior to drying off in quarters 
receiving blanket dry cow therapy plus internal teat sealant (BDCT) and quarters selectively treated based on Petrifilm on-farm 
culture results with dry cow antibiotic (DCT) and internal teat sealant (ITS), or ITS alone (SDCT).  Definition of IMI: All 
pathogens except coagulase negative staphylococci (CNS)  ≥ 100 cfu per 1.0 mL of milk; CNS ≥ 200 cfu per 1.0 mL of milk 
(Dohoo et al., 2011b) 
 
BDCT SDCT 
 
 
n = 1157 
Overall 
n = 1130 
ITS only 
n = 530 
DCT + ITS 
n = 600 
Total quarter IMI (%) 143 (12.4)† 171 (15.1)† 23 (4.4) 148 (24.7) 
Bacterial species cultured (%) 
    
 
Staphylococcus aureus  5 (0.4) 4 (0.4) 1 (0.2) 3(0.5) 
      
 
Streptococcus uberis 1 (0.1) 1 (0.1) 0 (0) 1 (0.2) 
 
Streptococcus dysgalactiae 0 (0) 1 (0.1) 1 (0.2) 0 (0) 
 
Nondifferentiated streptococci
1 
8 (0.7) 11 (1.0) 5 (0.9) 6 (1.0) 
 
Total environmental streptococci 9 (0.8) 13 (1.2) 6 (1.1) 7 (1.2) 
      
 
Escherichia coli  2 (0.2) 2 (0.2) 0 (0) 2 (0.3) 
 
Nondifferentiated  
Gram-negative bacteria 
2 (0.2) 1 (0.1) 0 (0) 1 (0.2) 
 
Total Gram-negative bacteria 4 (0.4) 3 (0.3) 0 (0) 3 (0.5) 
      
 
Fungi & Yeast  1 (0.1) 1 (0.1) 0 (0)
 
1 (0.2)
 
 
Coagulase negative staphylococci 117 (10.1)*
 
148 (13.1)*
 
13 (2.5) 135 (22.5) 
 
Corynebacterium spp. 16 (1.4) 9 (0.8) 3 (0.6) 6 (1.0) 
† P value < 0.10; * P value < 0.05; P values from univariable analysis 
1
 Including Enterococcus spp.; does not include Streptococcus agalactiae  
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Table 3.3. Prevalence of intramammary infection (IMI) and bacterial species isolated within 18 days after calving in quarters 
receiving blanket dry cow therapy plus internal teat sealant (BDCT) and quarters selectively treated based on Petrifilm on-farm 
culture results with dry cow antibiotic (DCT) and internal teat sealant (ITS), or ITS alone (SDCT).  Definition of IMI: All 
pathogens except coagulase negative staphylococci (CNS)  ≥ 100 cfu per 1.0 mL of milk; CNS ≥ 200 cfu per 1.0 mL of milk 
(Dohoo et al., 2011b) 
 
BDCT SDCT 
 
 
n = 1157 
Overall 
n = 1130 
ITS only 
n = 530 
DCT + ITS 
n = 600 
Total quarter IMI (%) 177 (15.3) 179 (15.8) 75 (14.2) 104 (17.3) 
Bacterial species cultured (%) 
  
  
Staphylococcus aureus  16 (1.4) 18 (1.6) 12 (2.3) 6 (1.0) 
   
  
Streptococcus uberis 1 (0.1) 1 (0.1) 0 (0) 1 (0.2) 
Streptococcus dysgalactiae 3 (0.3) 2 (0.2) 1 (0.2) 1 (0.2) 
Nondifferentiated streptococci
1 
24 (2.1) 24 (2.1) 11 (2.1) 13 (2.2) 
Total environmental streptococci 28 (2.4) 27 (2.4) 12 (2.3) 15 (2.5) 
   
  
Escherichia coli  2 (0.2) 4 (0.4) 1 (0.2) 3 (0.5) 
Nondifferentiated  
Gram-negative bacteria 
5 (0.4) 2 (0.2) 0 (0) 2 (0.3) 
Total Gram-negative bacteria 7 (0.6) 6 (0.5) 1 (0.2) 5 (0.8) 
   
  
Fungi & Yeast  10 (0.9)*
 
2 (0.2)*
 
1 (0.2) 1 (0.2) 
Coagulase negative staphylococci 117 (10.1) 127 (11.2) 52 (9.8) 75 (12.5) 
Corynebacterium spp. 11 (1.0) 10 (0.9) 2 (0.4) 8 (1.3) 
* P value < 0.05; P values from univariable analysis 
1
 Including Enterococcus spp.; does not include Streptococcus agalactiae   
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Table 3.4. Species-specific and overall apparent new intramammary infection risk over the dry period for quarters receiving 
blanket dry cow therapy plus internal teat sealant (BDCT) and quarters selectively treated based on Petrifilm on-farm culture 
results with dry cow antibiotic and internal teat sealant, or internal teat sealant alone (SDCT) 
 
BDCT SDCT 
Pathogen 
 
n = 1157 
Overall 
n = 1130 
ITS only 
n = 530 
DCT + ITS 
n = 600 
Staphylococcus aureus  16 (1.4) 17 (1.5) 11 (2.1) 6 (1.0) 
  
 
 
 
Streptococcus uberis 1 (0.1) 1 (0.1) 0 (0) 1 (0.2) 
Streptococcus dysgalactiae 3 (0.3) 1 (0.1) 0 (0) 1 (0.2) 
Nondifferentiated streptococci
1
 24 (2.1) 24 (2.2) 11 (2.1) 13 (2.2) 
Total environmental streptococci 28 (2.4) 26 (2.3) 11 (2.1) 15 (2.5) 
  
 
 
 
Escherichia coli  2 (0.2) 4 (0.4) 1 (0.2) 3 (0.5) 
Nondifferentiated Gram-negative bacteria 5 (0.4) 2 (0.2) 0 (0) 2 (0.3) 
Total Gram-negative pathogens 7 (0.6) 6 (0.5) 1 (0.2) 5 (0.8) 
  
 
 
 
Fungi & Yeast 10 (0.9)* 2 (0.2)* 1 (0.2) 1 (0.2) 
Coagulase negative staphylococci 100 (9.6) 114 (11.6) 51 (9.9) 63 (13.5) 
Corynebacterium spp. 11 (1.0) 10 (0.9) 2 (0.4) 8 (1.3) 
  
 
 
 
Total pathogen count 172 175 77 98 
Quarter-level
2 
160 (13.8) 164 (14.5) 72 (13.6) 92 (15.3) 
* P value < 0.05; P values from univariable analysis 
1 
Including Enterococcus spp.; does not include Streptococcus agalactiae 
2
A quarter may have been infected with up to two different pathogens  
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Table 3.5. Unconditional associations between independent variables and the risk of 
intramammary infection at calving for quarters receiving blanket dry cow therapy plus 
internal teat sealant (BDCT) and quarters selectively treated based on Petrifilm on-farm 
culture results with dry cow antibiotic and internal teat sealant, or internal teat sealant 
alone (SDCT) 
Variable N (qtrs) Proportion with IMI (%) P value
 
Treatment group   0.318 
BDCT 1,157 15.3  
Petrifilm neg. 530 14.2  
Petrifilm pos. 600 17.3  
IMI at drying off   0.018 
Yes 314 20.1  
No 1,973 14.9  
Region   0.304 
PEI 1,409 16.2  
Quebec 878 14.6  
Herd size OR = 1.00
1 
 0.217 
Housing type   0.157 
Free-stall 1,866 16.1  
Tie-stall 421 13.3  
Season at calving   0.003 
Winter 571 11.7  
Spring 427 13.3  
Summer 598 18.6  
Fall 691 17.5  
Parity at calving   0.048 
2 1,107 14.8  
3 528 18.9  
4+ 652 14.1  
24 hour milk yield OR = 1.02
1 
 0.065 
Length of dry period OR = 1.01
1 
 0.286 
Quarter position   0.030 
Front 1,149 13.9  
Hind 1,138 17.2  
1
Odds ratio from simple logistic regression 
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Table 3.6. Final multilevel model for the risk of intramammary infection post-calving in quarters receiving blanket dry cow therapy 
plus internal teat sealant (BDCT) and quarters selectively treated based on Petrifilm on-farm culture results with dry cow antibiotic 
and internal teat sealant, or internal teat sealant alone (SDCT) 
Variable Coefficient SE Odds ratio 95% CI P value Overall P value 
Constant -2.758 0.280 NA NA NA  
       
Treatment group        
BDCT Reference NA NA NA NA 0.945 
Petrifilm negative -0.031 0.217 0.97 0.63, 1.48 0.888  
Petrifilm positive 0.051 0.201 1.05 0.71, 1.56 0.801  
       
IMI status at drying off       
Uninfected Reference NA NA NA NA  
Infected 0.204 0.194 1.23 0.84, 1.79 0.292  
       
Quarter position       
Front Reference NA NA NA NA  
Hind 0.305 0.129 1.36 1.05, 1.75 0.018  
       
Season at calving       
Winter Reference NA NA NA NA 0.021 
Spring 0.173 0.272 1.19 0.70, 2.03 0.525  
Summer 0.668 0.244 1.95 1.21, 3.15 0.006  
Fall 0.557 0.237 1.75 1.10, 2.78 0.019  
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Figure 3.1. Enrolment of cows in the randomized clinical trial to evaluate the use of a 
Petrifilm-based on-farm culture system in a selective dry cow therapy program (BDCT: 
cows receiving blanket dry cow therapy plus internal teat sealant at drying off; SDCT: 
cows selectively treated based on Petrifilm on-farm culture results with dry cow 
antibiotic and internal teat sealant, or internal teat sealant alone, at drying off).  
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CHAPTER 4 
 
 
 
EVALUATION OF SELECTIVE DRY COW TREATMENT FOLLOWING ON-
FARM CULTURE:  MILK YIELD AND SOMATIC CELL COUNT IN THE 
SUBSEQUENT LACTATION   
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4.1 ABSTRACT 
 
Compared to total dry cow therapy, the selective antimicrobial treatment of cows 
based upon on-farm culture-results has the potential to reduce the amount of antibiotics 
used in dairy production.  The objective of the study was to determine the effect of a 
Petrifilm on-farm culture-based selective dry cow therapy program on milk yield and 
somatic cell count in the following lactation.  A total of 729 low somatic cell count (< 
200,000 cells/mL) cows from 16 commercial dairy herds with a low bulk tank somatic 
cell count (< 250,000 cells/mL) were randomly assigned to receive either blanket dry cow 
therapy or Petrifilm-based selective dry cow therapy.  Cows belonging to the blanket dry 
cow therapy group were infused with a commercial dry cow antimicrobial product (DCT) 
and an internal teat sealant (ITS) at drying off.  Using composite milk samples collected 
on the day prior to drying off, cows in the selective dry cow therapy group were treated at 
drying off based on the results obtained by the Petrifilm on-farm culture system with 
DCT + ITS (Petrifilm culture positive), or ITS alone (Petrifilm culture negative).  Milk 
test day records for the following lactation were obtained from Dairy Herd Improvement 
for all cows enrolled in the trial. 
 Repeated measures linear mixed models were used to assess the effect of study 
group (blanket or selective dry cow therapy) on test day milk production and somatic cell 
count over the first 180 days of the lactation of the subsequent lactation.  According to 
the final multivariable models, when low somatic cell count cows were selectively treated 
with DCT at drying off based on results obtained using the Petrifilm on-farm culture 
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system, there was no effect on milk production or somatic cell count in the subsequent 
lactation when compared to cows receiving blanket dry cow therapy.  The results of this 
study indicate that selective dry cow therapy based on results obtained by the Petrifilm 
on-farm culture system enabled a reduction in the use of DCT without negatively 
impacting milk production and milk quality. 
 
Key words: selective dry cow therapy, Petrifilm, somatic cell count, milk yield 
 
4.2 INTRODUCTION 
 
4.2.1 The economic importance of mastitis on dairy farms 
Mastitis is a production limiting and economically important disease of dairy 
cows (Seegers et al., 2003; Hand et al., 2012).  Beyond the direct costs associated with 
the treatment of mastitis, there are financial ramifications due to decreased milk 
production and the potential to incur penalties as a result of poor milk quality.  According 
to an analysis of Dairy Herd Improvement (DHI) test day production records from 2,835 
Ontario dairy herds, in comparison to a referent SCC value of ≤ 100,000 cells/mL, 
estimates for 24 hour milk production losses at a cow-level somatic cell count (SCC) of 
200,000 cells/mL ranged from 0.35 kg to 1.09 kg depending on parity and production 
levels; at an SCC of 2,000,000 cells/mL, production losses ranged from 1.49 to 4.7 kg 
(Hand et al., 2012).  The somatic cell count at the level of the bulk tank is an important 
indicator of the quality of milk produced at the farm.  Consequently, bulk tank somatic 
  
110 
 
cell counts (BTSCC) that exceed regulatory limits can result in financial penalties and 
the suspension of the right to market milk. Thus, management of both clinical and 
subclinical mastitis on a dairy farm is very important for the profitability of the farming 
enterprise. 
 
4.2.2 Mastitis control over the dry period 
  With regard to mastitis control, the dry period is considered a critical component 
of the milk production cycle on the basis of two main factors: 1) for existing 
intramammary infections (IMI), high cure rates can be achieved, and 2) the rate of new 
intramammary infection (NIMI) is greater in the periparturient period than at any point 
during lactation (Smith et al., 1985; Dingwell et al., 2003; Halasa et al., 2009).  In North 
America, blanket dry cow therapy (BDCT) is the most common approach to mastitis 
control during the dry period (USDA, 2008; Dufour et al., 2012).  In accordance with 
BDCT, all quarters of all cows are infused with a long-acting intramammary 
antimicrobial (DCT) at the end of lactation.  As concerns regarding the emergence of 
antimicrobial resistant pathogens are on the rise, dairy producers are facing increasing 
pressure to reduce antibiotic usage on their farms.  For dairy herds with a low prevalence 
of contagious mastitis and a consistently low BTSCC, an alternative approach to mastitis 
control over the dry period would be to target antimicrobial treatment at cows with an 
IMI at drying off, a protocol known as selective dry cow therapy (SDCT).  With the 
advent of internal teat sealants (ITS), producers have at their disposal a non-antimicrobial 
product that has proven to be just as efficacious as DCT in the prevention of IMI during 
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the non-lactating period (Woolford et al., 1998; Sanford et al., 2006).  The addition of an 
ITS to a SDCT program ensures that all quarters have some form of protection against 
dry period NIMI. 
 
4.2.3 Petrifilm-based selective dry cow therapy plus internal teat sealant 
 In North America, estimates for compliance with a BDCT protocol range from 
72% of herds in the United States to 88% of herds in Canada (USDA, 2008; Dufour et al., 
2012).  In order for dairy producers to consider SDCT, the outcomes of the subsequent 
lactation regarding udder health, milk production, and milk quality must be equivalent to 
those achieved by BDCT.  The majority of studies evaluating SDCT and ITS have 
focused on the risk of IMI and clinical mastitis in the subsequent lactation, whereas 
published reports examining the effects on milk yield and SCC are sparse.  A consistent 
theme in SDCT research is that the success of such a program depends on the ability to 
determine a cow‘s IMI status at the end of lactation so that the appropriate treatment can 
be applied (Huxley et al., 2002; Robert et al., 2008; Torres et al., 2008).  A Petrifilm-
based on-farm culture system has recently been validated for use in a SDCT program.  
When used in low BTSCC herds (<250,000 cells/mL) to diagnose IMI in cows with a 
low SCC (<200,000 cells/mL) prior to drying off, the culture system performed well with 
a sensitivity of 85% and specificity of 73% (Cameron et al., 2013).  Furthermore, 
Petrifilm-based SDCT did not affect the risk of IMI at calving, nor the risk of a first case 
of clinical mastitis in the first 120 days of lactation, when compared to BDCT (Cameron 
et al., 2014).  The aim of the research outlined in this paper was to evaluate the milk 
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quality and production outcomes in the subsequent lactation following Petrifilm-based 
SDCT.  The main objectives were to compare milk production and SCC in the first 180 
days of lactation between cows receiving BDCT with the addition of an ITS and cows 
selectively treated based on the results of the Petrifilm on-farm culture system with DCT 
and an ITS, or with an ITS alone. 
 
4.3 MATERIALS AND METHODS 
 
4.3.1 Trial design 
 Cows in a convenience sample of dairy herds from Quebec (n = 6) and Prince 
Edward Island (n = 10) that entered the dry period between July 2009 and September 
2010 were considered for inclusion in the trial.  Herd inclusion criteria included an 
average BTSCC below 250,000 cells/mL over the last 12 months and participation in a 
DHI program with regular milk testing.  Herd size ranged from 44 to 251 cows with a 
median of 75 cows, and the total number of cows entering the dry period during the study 
period was 1,584.  Enrolled cows had monthly SCC <200,000 cells/mL on the last three 
tests prior to drying off, no clinical mastitis in the same time period, an expected dry 
period of 30 to 90 days, no antibiotic treatment in the last 14 days, at least 3 functional 
quarters, and all quarters scoring <2 on the California mastitis test on the day prior to 
drying off. 
 Single quarter milk samples were collected on the day prior to drying off, at 3 to 4 
days post-calving, and again at 5 to 18 days post-calving.  The first post-calving sample 
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was collected by the producer or farm personnel; all other samples were collected by the 
study personnel.  Milk samples were frozen at -20°C before shipment to the Maritime 
Quality Milk research laboratory at the University of Prince Edward Island.  Following 
pre-drying off sample collection, cows were randomly assigned to either the blanket dry 
cow therapy (BDCT+ITS) study group or the Petrifilm-based selective dry cow therapy 
(SDCT+ITS) study group according to a randomization table unique to each herd, with a 
block size of six thus randomizing six cows at a time, three to BDCT and three to SDCT.  
On the day of drying off, cows in the BDCT+ITS group were infused with a long-acting 
intramammary formulation of 500 mg ceftiofur hydrochloride (Spectramast DC, Zoetis 
Canada, Kirkland, Quebec, Canada) followed by an ITS composed of 65% bismuth 
subnitrate (Orbeseal, Zoetis Canada, Kirkland, Quebec, Canada) in all four quarters.  For 
cows assigned to the SDCT+ITS group, a composite milk sample was cultured on-farm 
using the Petrifilm on-farm culture system.  The Petrifilm on-farm culture was set-up by 
the study personnel on the day prior to drying off as follows: a composite milk sample 
was created by combining 5 mL from each quarter sample into a new sample vial.  A 3 
mL aliquot of composite milk was added to 27 mL of sterile water to make a 1:10 
dilution.  One millilitre of diluted milk was plated on a total aerobic count Petrifilm (3M 
Canada, London, Ontario) and incubated on-farm at 35°C for 24 hours in a TurboFan 
Hova-Bator (GQF Manufacturing, Savannah, Georgia, USA).  Consistent with a dilution 
factor of 1:10, a single colony forming unit (cfu) present on the Petrifilm was equivalent 
to 10 cfu per mL of milk.  On the scheduled day of drying off (Day 0), the Petrifilm was 
read by the producer and, in accordance with study protocol, cows were classified as 
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positive if 5 or more colonies were present (equivalent to ≥50 cfu/mL of milk).  Cows 
negative on Petrifilm were treated solely with an ITS at drying off; cows positive on 
Petrifilm were treated with 500 mg ceftiofur hydrochloride followed by an ITS.  All 
treatments were applied by the producer or farm personnel immediately following the last 
milking, and treatments were recorded to verify compliance with the study protocol.    
 
4.3.2 Bacteriology 
 Within one month from collection, milk samples were thawed and cultured in a 
laboratory using standardized methods outlined in the Laboratory Handbook on Bovine 
Mastitis (National Mastitis Council, 1999).  Trained laboratory technicians (n = 2) were 
blinded to the results obtained by the Petrifilm on-farm culture system.  Briefly, 
disposable plastic loops were used to streak 0.01 mL of milk on bi-plates containing half 
Columbia agar + 5% sheep blood and half MacConkey agar.  Plates were incubated at 35 
ºC and examined for bacterial growth after 24 and 48 hours.  Colonies were tentatively 
identified as staphylococci, streptococci, coliforms, or other pathogens based on colony 
growth characteristics, morphology, pattern of hemolysis, catalase reaction, and Gram 
staining.  Staphylococcal isolates were tested for coagulase production with the tube 
coagulase test.  API tests (API 20 E and API 20 Strep; bioMérieux (Marcy L‘Etoile, 
France) and the latex agglutination test for streptococcal Lancefield groups were used for 
the final identification of bacterial organisms as required.  For each positive sample, the 
number of cfu per 0.01 mL of milk was enumerated up to a maximum of 10 colonies.  A 
quarter was considered infected if ≥ 100 cfu/mL of milk of any pathogenic organism of 
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interest, except coagulase negative staphylococci (CNS), were cultured.  For CNS, a 
definition of ≥ 200 cfu/mL was used.  These definitions are in accordance with the recent 
publication of characterization of IMI based on single sample bacteriological testing 
(Dohoo et al., 2011).  Samples with three or more differing isolates were classified as 
contaminated.  However, when Staphylococcus aureus (Staph. aureus) was identified in 
a contaminated sample, it was enumerated and the associated quarter was classified as 
infected (Reyher et al., 2011).  Organisms classified as ―other Gram positive‖, which 
were mainly Bacillus spp., were assumed to be associated with environmental 
contamination and considered non-significant growth.  No samples collected during the 
trial displayed growth of Streptococcus agalactiae.   
 The quarter level culture results were interpreted in parallel to determine the cow 
level infection status.   If one or more quarter samples were contaminated, a cow was 
considered infected if at least one of the remaining quarters was infected.  If one or more 
quarter samples were contaminated and no IMI was diagnosed in the remaining samples, 
the cow‘s overall infection status was considered unknown, and the observation was 
removed from the analyses.  Throughout this manuscript, infection status or IMI refers to 
the classification of a cow based on parallel interpretation of quarter level standard 
bacteriological culture results, whereas Petrifilm on-farm culture results are referred to 
simply as Petrifilm positive or Petrifilm negative.  
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4.3.3 Data collection 
 Data on milk yields and SCC were recorded by DHI technicians on a minimum of 
ten separate occasions spaced over the course of twelve months.  Data files were 
provided by DHI and the following information was extracted for each participating cow: 
test day 24 hour milk yield (in kg) and SCC during the first 180 days of lactation 
(consisting of 5 to 6 milk tests per cow), days in milk at the time of the milk test, parity, 
and the previous lactation 305 day milk production (in kg).  Additional data collected at 
the time of collection of post-calving milk samples included the occurrence of post-
partum disease (such as metritis, displaced abomasum, or mastitis) and antimicrobial 
treatment prior to sample collection.     
  
4.3.4 Statistical analysis 
 Statistical analysis was performed using Stata/IC 11.0 (StataCorp, College 
Station, TX).  Two outcomes of interest were analyzed: test day 24 hour milk production 
and test day SCC during the first 180 days of lactation, and all analyses were at the level 
of the cow test-day.  Somatic cell counts (in ‗000/mL) were modelled using the natural 
logarithm of SCC (lnSCC).  The data consisted of repeated measurements (up to 6 milk 
tests) within a study subject, therefore milk yield and lnSCC were modelled using a 
repeated measures linear mixed model.  Different correlation structures were assessed 
(first order autoregressive, first order moving average, unstructured, Toeplitz, and 
exponential), and the most appropriate structure was determined by likelihood ratio tests 
and Akaike‘s Information Criteria (AIC).  For both outcomes, an unstructured correlation 
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structure provided the best fit for the repeated measures data and was used in the final 
models.  A random effect for herd was included in all models to account for the 
clustering of cows at the herd level.  As the main predictor, study group (BDCT+ITS or 
SDCT+ITS) was forced into the models.  Other variables considered for inclusion were 
previous lactation 305 day milk production, infection status at drying off according to 
gold standard bacteriological culture, length of the dry period, parity at calving (2, 3, or 
4+), calving season, occurrence of post-partum disease (other than mastitis), days in milk 
on the day of the milk test, herd size, housing type (free-stall [n = 11] vs tie-stall [n = 5]), 
and region.  Dry period was scaled by subtracting 30 days from each observed value, 
which was the minimum possible value as dictated by the selection criteria.  Previous 
lactation 305 day milk production was centered at the median value of 9,916 kg and 
scaled to reflect a change of 1,000 kg.  The variable for calving season was created using 
three month intervals, such that winter was designated as December to February, spring 
as March to May, summer as June to August, and fall as September to November.  
Within the milk yield model, the effect of days in milk (DIM) was estimated with the 
addition of Wilmink‘s function (DIM-0.05), as illustrated by Schaeffer et al. (2000).  To 
assess nonlinear trends for DIM in the lnSCC model, fractional polynomials were used 
and the best fitting model was determined by the deviance difference.  Unconditional 
associations between the various independent variables and the dependent variable of 
interest were assessed using simple linear regression, and variables with a P value of 0.25 
or less were offered as potential predictors in the multivariable models.  With respect to 
model building, a backwards stepwise procedure was used to select the best model, and 
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significance was declared at a P value <0.05.  Once the variables to be included in the 
final model were determined, all first-order interactions with study group were examined 
and retained if significant.  Additionally, an interaction between DIM and parity was also 
explored within each model.  Dropped variables were re-introduced into the model and 
were retained if they changed the other model coefficients substantially.  A random 
coefficient term for study group was evaluated at the herd level, but did not result in an 
improvement of the analysis of either milk yield or lnSCC based on a likelihood ratio 
test.  The herd-level contextual effect of Petrifilm on-farm culture results was assessed by 
the inclusion of an additional variable, representing the proportion of Petrifilm positive 
cows for a particular herd, but was non-significant in both the milk yield and lnSCC 
models.  The assumptions of the final models were assessed through examination of the 
residuals at the various levels. 
 
4.4 RESULTS  
 
4.4.1 Descriptive statistics 
 In total, 729 cows were enrolled of which 369 were assigned to BDCT+ITS and 
360 were assigned to SDCT+ITS.    The proportion of cows per herd eligible for 
inclusion ranged from 28.3% (15/53) to 69.4% (145/209), and the overall inclusion 
probability was 46% (729/1584).  Post-enrolment exclusions and attrition resulted in the 
loss of 129 cows for the following reasons: death (n = 15), sold (n = 11), or culled (n = 
18) prior to the first milk test, abortion (n = 2), not pregnant (n = 2), dry period greater 
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than 90 days or shorter than 30 days (n = 51), and contamination of all pre-drying off 
milk samples (n = 30).  There was no significant difference between study groups with 
respect to post-enrolment exclusion or attrition.  Thus, 307 BDCT+ITS group cows and 
293 SDCT+ITS group cows were available for analysis.  The cow level prevalence of 
IMI at drying off in the SDCT+ITS group according to Petrifilm on-farm culture was 
53.2% (156/293).  Therefore, at a Petrifilm treatment threshold of ≥50 cfu/mL, 46.8% 
(137/293) of the cows were classified as uninfected and did not receive a long-acting 
intramammary antibiotic at drying off.  Descriptive statistics for the cows included in the 
final analysis can be found in Table 4.1.  Despite random allocation into treatment 
groups, the prevalence of IMI at drying off as determined by standard bacteriological 
culture was higher in cows assigned to SDCT+ITS than that observed in cows assigned to 
BDCT+ITS (P = 0.005).  The prevalence of IMI post-calving was not different between 
the study groups (P = 0.72). 
 
4.4.2 Test day milk production        
 The results of the final repeated measures linear mixed model for milk production 
are presented in Table 4.2.  When controlling for the other independent variables 
included in the model, test day milk production was not different between cows receiving 
BDCT+ITS and cows selectively treated based on Petrifilm results (Least square means: 
BDCT+ITS = 39.3kg (95% CI: 37.9, 40.8) vs SDCT+ITS = 39.0 kg (95% CI: 37.6, 40.5); 
P = 0.43).  For every 1,000 kg increase in the previous lactation 305 day milk yield 
average daily milk production increased by 2.04 kg (P < 0.01).  According to simple 
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linear regression, higher milk production was observed for cows in their third or greater 
lactation than for cows in their second lactation.  However, in the multivariable model, 
which adjusted for previous lactation production, cows in their third lactation (P < 0.01) 
and fourth or greater lactation (P < 0.01) produced less than cows in their second 
lactation.  For example, a cow achieving a production of 10,000 kg in her first lactation 
produced more milk in her second lactation than a cow who achieved that level in her 4
th
 
lactation produced in her 5
th
 lactation.  Calving season was also a significant predictor of 
milk production (P < 0.01), with cows calving in the summer having lower production 
than cows calving during any other season.  Milk production increased with increasing 
duration of the dry period beyond 30 days (to a maximum of 90 days as dictated by the 
inclusion criteria; P < 0.01), and the occurrence of post-partum disease other than 
mastitis reduced milk yield by an average of 2.64 kg per day.  Stage of lactation, 
modelled by the variables DIM and DIM
-0.05
, followed what is considered a standard 
lactation curve with an initial rise to a peak around 50 days, followed by a gradual 
decline over time (Macciotta et al., 2005).  Illustrated in Figure 4.1 is a graph of test day 
24 hour milk yield by DIM.   
 
4.4.3 Test day somatic cell count   
   The results of the final repeated measures linear mixed model for lnSCC are 
presented in Table 4.3.  After adjusting for other independent variables included in the 
final model, there was no significant difference in test day lnSCC between cows 
receiving BDCT+ITS and cows selectively treated at drying off based on Petrifilm results 
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(P = 0.82).  Parity was significantly associated with lnSCC, with cows in their third 
lactation (P = 0.03) and fourth or greater lactation (P < 0.01) having a higher average 
lnSCC than cows in their second lactation. Cows with an IMI at drying off according to 
standard bacteriological culture had a higher test day lnSCC during the first 180 days of 
the next lactation than cows uninfected at drying off (P = 0.02).  Fractional polynomials 
suggested that DIM was best modelled using the power terms 0.5 and -0.5.  Illustrated in 
Figure 4.2 is a graph of test day SCC by DIM.  A similar pattern was apparent between 
groups with a rapid decrease in SCC from calving to approximately 50 DIM, followed by 
a gradual increase over time.     
 
4.5 DISCUSSION 
 
4.5.1 Test day milk production 
It is estimated that intramammary infections present at calving, either as a result 
of failure to eliminate existing infections or acquisition of new infections, can reduce 
lactational milk yields by 5% (Hogeveen, 2003; Berry et al., 2004).  Thus, minimizing 
the prevalence of IMI post-partum is important for achieving optimum milk production.  
The successful outcome of a SDCT program depends on the accurate diagnosis of 
infection status at drying off so that DCT is applied appropriately and judiciously for the 
purpose of eliminating existing IMI.  Furthermore, as prior studies have demonstrated 
that untreated quarters are at higher risk for the development of NIMI over the dry period, 
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it is also important that a method to protect quarters against NIMI be in place, especially 
for cows not infused with DCT (Rindsig et al., 1978; Berry and Hillerton, 2002).   
According to the present study, when low SCC cows were selectively treated with DCT 
at drying off based on results obtained using the Petrifilm on-farm culture system, there 
was no effect on milk production in the subsequent lactation when compared to cows 
receiving BDCT.  The Petrifilm on-farm culture system provided sensitive results thus 
enabling the accurate diagnosis of cows with an IMI at the end of lactation (Cameron et 
al., 2013).   Moreover, internal teat sealants were used in all cows thus ensuring some 
measure of prophylaxis against IMI for all quarters.  While internal teat sealants have 
been evaluated for use in SDCT in terms of infection status at calving and clinical 
mastitis in the subsequent lactation, no other studies to date have published data 
pertaining to the effect of SDCT + ITS on milk production.  In a decision tree analysis 
evaluating dry cow protocols by Berry et al. (2004), comparison were made between 
cows receiving DCT and negative controls, as well as cows receiving ITS and negative 
controls, and it was determined that DCT had a positive effect on milk yield but there 
was no effect of ITS.  The data originated from two separate clinical trials involving cows 
that were either uninfected or infected with CNS or Corynebacterium spp. at drying off, 
and assignment to treatment groups was based on randomization.  In previous works 
evaluating the effect of DCT on milk production, when random assignment to treatment 
groups was used, DCT displayed a significant positive effect on production when 
compared to a negative control (Østerås and Sandvik, 1996; Berry et al., 1997; Berry et 
al., 2004).  However, when selection procedures were put in place, DCT lost its 
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production-related effect.  According to Rajala-Schultz et al. (2011), there was no effect 
of DCT on milk production when BDCT was compared to no treatment in cows with a 
low SCC and no clinical mastitis prior to drying off.  This is in agreement with the 
current study, further demonstrating the importance of the selection protocol for SDCT. 
With regards to the effect of parity on milk production, the data indicated that 
cows entering their second lactation produced more milk than cows beginning their third 
or greater lactation.  However, because the final model also controlled for previous 
lactation milk production, this finding actually reflected the greater capacity of second 
parity cows to increase their milk production over the previous lactation than higher 
parity cows.  This, coupled with the significant positive association between previous 
lactation production and current production, is in agreement with Rajala-Schultz et al. 
(2011).  Season of calving as a predictor of milk production has also been explored 
elsewhere, and the results of this trial are in accord with previous research (Wilmink, 
1987; Rajala-Schultz et al., 2011).  Finally, the occurrence of post-partum disease has 
been shown to be a risk factor for decreased milk production (Wilson et al., 2004), 
therefore it was not surprising that cows experiencing one of the recorded disease events 
sometime between calving and 18 DIM had lower milk production than that observed in 
cows that remained healthy.  While mastitis events were recorded, mastitis was not 
included in the list of post-partum diseases.  Mastitis in the post-partum period was 
considered an intervening variable between study group and milk yield, and inclusion of 
mastitis would have resulted in a biased measure of the effect of study group on milk 
production (Dohoo et al., 2009).   
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4.5.2 Test day somatic cell count 
 In the current study, the selective antimicrobial treatment of cows at the end of 
lactation based on Petrifilm culture results did not affect the SCC in the following 
lactation when compared to cows that received total antimicrobial therapy at drying off.  
In earlier studies comparing BDCT to a negative control group, cows receiving DCT had 
a lower SCC in the subsequent lactation than cows left untreated over the dry period 
(McNab and Meek, 1991; Østerås and Sandvik, 1996; McDougall, 2010; Rajala-Schultz 
et al., 2011).  This illustrates the importance of providing some form of protection, such 
as ITS, for quarters of cows that do not receive DCT.  Comparisons of the effect of ITS 
alone vs. DCT on SCC are infrequent in the literature.  In a split-udder trial involving 
cows without an IMI at drying off, when the SCC at 1 to 8 DIM was compared between 
quarter receiving ITS and quarters infused with DCT, the proportion of quarters with an 
SCC >200,000 was 37% in the ITS group and 36% in the DCT group (Sanford et al., 
2006).  In an observational study by Green et al. (2008) examining dry period risk factors 
associated with high SCC in early lactation, it was concluded that DCT and ITS had the 
same effect on SCC in early lactation when used in cows with a low SCC prior to drying 
off.     
 Regarding the other significant associations revealed in the final regression 
model, the findings are in agreement with previous research.  Parity as a significant 
predictor of SCC has been reported elsewhere and is commonly attributed to increased 
risk of NIMI and clinical mastitis (Laevens et al., 1997; Walsh et al., 2007; Pantoja et al., 
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2009).  Cows with an intramammary infection at drying off according to gold standard 
laboratory culture had a higher SCC in the subsequent lactation than cows uninfected at 
drying off.  Predisposition to intramammary infection as a result of poor udder hygiene 
and teat morphology has been described in the literature (Schreiner and Ruegg, 2003; 
O'Reilly et al., 2006), and previous IMI has been shown to be a risk factor for the 
development of NIMI (Zadoks et al., 2001; Green et al., 2002).   
 
4.6  CONCLUSION 
 
 In conclusion, while much research has examined the outcome of SDCT on 
intramammary infection at calving and clinical mastitis in early lactation, investigations 
into milk production and milk quality outcomes are lacking.  The use of a Petrifilm-based 
on-farm culture system to make targeted DCT treatment decisions on cows with a low 
SCC at the end of lactation did not affect milk production and somatic cell counts in the 
subsequent lactation, as compared to BDCT.  Overall, Petrifilm-based SDCT with the 
addition of an ITS enabled a reduction in the use of antimicrobials on low BTSCC dairy 
farms without affecting the health, welfare, and future milk production of the cow. 
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Table 4.1. Descriptive statistics for cows enrolled in a randomized clinical trial to 
evaluate the use of a Petrifilm-based on-farm culture system in a selective dry cow 
therapy program.    
 
 
BDCT+ITS
1 
(n = 307) 
SDCT+ITS
2 
(n = 293) 
Somatic cell count x 10
-3
/mL
3 
36 (12, 228) 39 (14, 268) 
24 hour milk production (kg)
4
 41.4 (8.2) 40.8 (8.2) 
Previous 305 day milk production (kg)
5 
9,995 (1,865) 9,903 (1,766) 
Length of the dry period (days)
5 
59 (11) 60 (12) 
Parity at calving   
2 149 142 
3 78 64 
4+ 80 87 
Calving season
 
  
Spring (Mar – May) 58 57 
Summer (Jun – Aug) 79 76 
Fall (Sep – Nov)  94 93 
Winter (Dec – Feb) 76 67 
Prevalence of post-partum disease
6 
5.9 5.2 
% of cows with IMI
7 
at drying off 33.2* 44.4* 
% of cows with IMI
7
 after calving 38.7 40.1 
*
P = 0.005 
1
 BDCT+ITS: blanket dry cow therapy (DCT) plus internal teat sealant (ITS)
 
2
 SDCT+ITS: selective dry cow therapy based on Petrifilm on-farm culture results with 
ITS alone (Petrifilm negative), or DCT and ITS (Petrifilm positive) 
3
Median (10
th
 and 90
th
 percentile) somatic cell count in the first 180 days of the 
subsequent lactation 
4
Mean (standard deviation) 24 hour milk production in the first 180 days of the 
subsequent lactation 
5
Mean (standard deviation)  
6
Excluding clinical mastitis.  Occurring within the first 18 days of lactation 
7 
IMI: intramammary infection.  Definition of IMI: All pathogens except coagulase 
negative staphylococci (CNS)  ≥ 100 cfu per 1.0 mL of milk; CNS ≥ 200 cfu per 1.0 mL 
of milk (Dohoo et al., 2011) 
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Table 4.2. Final multilevel model evaluating the effect of Petrifilm-based selective dry 
cow therapy on twenty-four hour milk production (kg) in the first 180 days of the 
subsequent lactation. 
Variable Coefficient SE P value Overall P value 
Study group
1     
BDCT+ITS reference    
SDCT+ITS -0.29 0.37  0.43 
     
Length of the dry period
2 
0.05 0.02  <0.01 
     
Calving season
 
    
Summer (Jun – Aug) reference   < 0.01 
Fall (Sep – Nov) 1.12 0.50 0.02  
Winter (Dec – Feb) 2.61 0.53 <0.01  
Spring (Mar – May) 2.05 0.57 <0.01  
     
Days in milk (DIM)
 
-0.09 0.003  < 0.01 
DIM
(-0.05)3 
-21.49 0.89  < 0.01 
     
Parity     
2
nd
 lactation reference   <0.01 
3
rd
 lactation -1.93 0.53 <0.01  
≥ 4th lactation -3.58 0.55 <0.01  
     
Previous 305 milk
4 
2.04 0.13  < 0.01 
     
Post-partum disease
5 
-2.64 0.82  < 0.01 
     
Intercept 49.66 0.99   
     
Variance estimate     
Herd-level variance 4.87 2.18   
1
BDCT+ITS: blanket dry cow therapy (BDCT) plus internal teat sealant (ITS); SDCT+ITS: 
selective dry cow therapy (SDCT) based on Petrifilm on-farm culture results with ITS alone 
(Petrifilm negative), or DCT and ITS (Petrifilm positive) 
2
Scaled at 30 days 
3Wilmink‘s function  = eDIM (-0.05) 
4
Centered at 9,916 kg and scaled to reflect a 1,000 kg change 
5
Other than mastitis; occurring within the first 18 days of the subsequent lactation 
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Table 4.3. Final multilevel model evaluating the effect of Petrifilm-based selective dry 
cow therapy on natural log somatic cell count (lnSCC) in the first 180 days of the 
subsequent lactation. 
Variable Coefficient 
Standard 
Error 
P value 
Overall P 
value 
Study group
1     
BDCT+ITS reference    
SDCT+ITS 0.02 0.08  0.82 
     
Parity     
2
nd
 lactation reference   < 0.01 
3
rd
 lactation 0.21 0.09 0.03  
≥ 4th lactation 0.32 0.09 < 0.01  
     
Days in milk
(-0.5) 
6.94 0.60  < 0.01  
Days in milk
(0.5) 
0.14 0.01  < 0.01  
     
IMI status at drying off
2 
0.19 0.08  0.02 
     
Intercept 1.55 0.22   
     
Variance estimate     
Herd-level variance 0.04 0.03   
1
BDCT+ITS: blanket dry cow therapy (BDCT) plus internal teat sealant (ITS); 
SDCT+ITS: selective dry cow therapy (SDCT) based on Petrifilm on-farm culture results 
with ITS alone (Petrifilm negative), or DCT and ITS (Petrifilm positive) 
2
IMI: intramammary infection.  Definition of IMI: All pathogens except coagulase 
negative staphylococci (CNS)  ≥ 100 cfu per 1.0 mL of milk; CNS ≥ 200 cfu per 1.0 mL 
of milk (Dohoo et al., 2011)
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Figure 4.1.  Graph of test day milk production (least-squares means) by days in milk for 
cows receiving blanket dry cow antimicrobial therapy plus internal teat sealant 
(BDCT+ITS), and cows selectively treated at drying off based on Petrifilm on-farm 
culture results (SDCT+ITS).                                                                                                                                                                                      
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Figure 4.2. Graph of somatic cell count (least-squares means) by days in milk for cows 
receiving blanket dry cow antimicrobial therapy plus internal teat sealant (BDCT+ITS), 
and cows selectively treated at drying off based on Petrifilm on-farm culture results 
(SDCT+ITS).  
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CHAPTER 5 
 
 
 
INTERDEPENDENCE OF MAMMARY QUARTERS TOWARDS NEW 
INTRAMAMMARY INFECTION WITH COAGULASE NEGATIVE 
STAPHYLOCOCCI DURING THE DRY PERIOD AND THE EFFECT OF 
INTERNAL TEAT SEALANTS 
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5.1 ABSTRACT 
 
 For herds with a low prevalence of contagious mastitis pathogens, selective dry 
cow therapy (SDCT) is an approach to mastitis control over the dry period with the 
potential to reduce antimicrobial usage on dairy farms. While selective treatment 
decisions are usually made at the cow level, knowledge of quarter level infection status 
would enable selective treatment of individual mammary quarters.  Selective dry quarter 
therapy (SDQT) would result in even greater reductions in antimicrobial use when 
compared to SDCT, but an important barrier to SDQT is that prior research has 
demonstrated that quarters are not independent in their risk for new intramammary 
infection (NIMI) in the dry period.  It is suggested that interdependence of quarters 
towards NIMI in non-lactating cows may occur as a result of cross-contamination 
between teats.  Considering that the method of action of internal teat sealants (ITS) is to 
create a barrier to bacterial invasion of the mammary gland, it is possible that ITS may 
reduce the within-cow transmission of pathogens and thus diminish or eliminate 
interdependence.  The main objective of the study was to determine the effect of ITS on 
the interdependence of mammary quarters towards the acquisition of coagulase negative 
staphylococci (CNS) NIMI over the dry period, and the data used in the analysis 
originated from a SDCT trial and a cohort study with longitudinal milk sampling.  A 
generalized estimating equation logistic model was used to evaluate an interaction 
between infusion with ITS and the presence of CNS at drying off on the acquisition of 
CNS NIMI during the dry period.  Other factors considered included: parity at drying off, 
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quarter location, infusion with dry cow therapy, infection with any other pathogen at 
drying off (as a measure of susceptibility), and prevalence of CNS in the herd.  Of the 
main effects investigated in the analysis, only herd prevalence of CNS was significantly 
associated with dry period CNS NIMI such that increasing herd prevalence increased the 
risk of CNS NIMI.  There was no evidence to support that infusion with ITS resulted in a 
reduction in the risk for the within cow transfer of CNS from an infected quarter to an 
uninfected quarter. Surprisingly, in quarters that were infused with ITS, the presence of 
CNS in another quarter at drying off significantly increased the risk of CNS NIMI over 
the dry period.  This may have occurred as a result of inadvertent introduction of teat end 
CNS into the mammary gland during infusion of ITS.  Regarding quarters of cows 
without a CNS intramammary infection at drying off, the odds of CNS NIMI was lower 
for quarters treated with ITS, suggesting that dry period CNS NIMI can be partly 
attributed to CNS species located within the environment.  Steps to lower levels of CNS 
within the herd (e.g. through better management of dry cow housing, changes in bedding 
type, etc.) will play an important role in reducing incidence of CNS NIMI over the dry 
period.  While independence was not demonstrated, there is still a need for quarter level 
clinical trials to truly assess if SDQT in combination with ITS is a viable approach to dry 
period mastitis control that will promote udder health and concurrently lower DCT use. 
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5.2 INTRODUCTION 
 
5.2.1 Mastitis control during the non-lactating period 
Conceived in the late 1960s for the purpose of controlling contagious mastitis, the 
practice of blanket application of dry cow antimicrobial therapy (dry cow therapy; DCT) 
is still widely practiced today (Neave et al., 1969; Berry and Hillerton, 2002; USDA, 
2008; Dufour et al., 2012b).  Due in part to concerns regarding a possible link between 
antimicrobial use in food-producing animals and the development of resistance in 
bacteria, the requirement for blanket application of DCT (BDCT) is being called into 
question (Østerås et al., 1991; Berry and Hillerton, 2002; Torres et al., 2008).  For herds 
with a low prevalence of contagious pathogens and capable of maintaining a low bulk 
tank somatic cell count (BTSCC), an alternative to BDCT would be to reserve DCT for 
cows suspected or known to have an intramammary infection (IMI) at drying off 
(Rindsig et al., 1978).  This practice is known as selective dry cow therapy (SDCT) and it 
is considered a more judicious approach to the control of IMI over the non-lactating 
period (Browning et al., 1994; Torres et al., 2008). 
 
5.2.2 Level of treatment (cow vs. quarter) for selective application of DCT 
While selective treatment decisions are usually made at the cow level, with 
knowledge of quarter level infection status it would be possible to make selective DCT 
decisions for individual mammary quarters.  Selective dry quarter therapy (SDQT) would 
result in even greater reductions in antimicrobial use when compared to SDCT (Østerås 
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and Sandvik, 1996; Berry et al., 2003; Robert et al., 2006a).   With the advent of on-farm 
culture systems, producers have at their disposal a rapid test for the detection of IMI that 
could enable them to determine quarter infection status and subsequently treat only 
infected quarters (Cameron et al., 2013).  However, an important barrier to SDQT is that 
prior research has demonstrated that quarters are not independent in their risk for the 
acquisition of new intramammary infection (NIMI) in the dry period.  According to a 
study of NIMI over the dry period in cows under SDCT, it was reported that uninfected 
cows and cows infected in two or more quarters occurred more frequently than expected 
based on a random distribution, thus supporting interdependence of quarters during the 
dry period.  Consequent to these results, the authors‘ concluded that selective treatment 
decisions should be made at the cow level (Robert et al., 2006a).   
 
5.2.3 Internal teat sealants 
Also available for the purpose of managing IMI during the dry period are 
intramammary infusions known as internal teat sealants (ITS).  Internal teat sealants do 
not contain antimicrobials but protect against NIMI by creating a physical barrier in the 
teat thus preventing bacterial invasion and colonization (Godden et al., 2003).  It has been 
suggested that interdependence of quarters towards NIMI in non-lactating cows partly 
occurs as a result of cross-contamination between teats (e.g. while in a prone position; 
Robert et al., 2006a).  Considering that the method of action of ITS is to create a barrier 
to bacterial invasion of the mammary gland, it is possible that ITS may reduce the within-
cow transmission of pathogens and thus diminish or eliminate interdependence.  Since 
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the emergence of ITS, only one study has investigated the effect of ITS on the within-
cow dynamics of dry period NIMI.  In that study, it was reported that ITS may have 
resulted in quarter independence, but the authors‘ failed to achieve conclusive results 
because of low statistical power (Berry et al., 2003).  Moreover, the outcome of that 
investigation was prevalence of IMI at calving, and therefore the analyses considered 
both the acquisition of NIMI and the cure of existing IMI over the dry period. 
 
5.2.4 Coagulase negative staphylococci in non-lactating cows  
Regarding the importance of coagulase negative staphylococci (CNS) during the 
dry period, it has been reported that CNS are the most common cause of dry period NIMI 
and that prevalence of CNS is highest around calving (Dingwell et al., 2002; Taponen et 
al., 2006; Robert et al., 2006a; Bradley et al., 2010; Arruda et al., 2013).  According to 
deterministic modeling of the transmission dynamics of CNS IMI, transmission during 
lactation alone is not able to maintain the presence of CNS within a herd (Reksen et al., 
2012).  Rather, persistence of CNS in a herd requires the acquisition of CNS NIMI at 
drying off, during the dry period, and around calving, thus illustrating the importance of 
preventative measures against CNS NIMI around the non-lactating period (Reksen et al., 
2012). While intramammary infection with CNS typically results in moderate increases in 
somatic cell count (SCC) and rarely develops into clinical mastitis, research has shown 
that the role of CNS is of greater importance in herds with a low BTSCC (Schukken et 
al., 2009; Pyörälä and Taponen, 2009; Sampimon et al., 2010).  Schukken et al. (2009) 
observed that in herds with an average BTSCC < 200,000 cells/mL, CNS-infected 
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quarters contributed more somatic cells to the bulk tank than quarters infected with a 
major pathogen.  Considering that adoption of SDCT is only recommended for herds 
capable of maintaining a low BTSCC and with good control of major contagious 
pathogens, it is likely that CNS are an important causal agent of subclinical mastitis in 
herds already practising or thinking about converting to SDCT. 
 
5.2.5 Study objectives 
The main objective of the current study was to determine the effect of ITS on the 
interdependence of mammary quarters towards the acquisition of CNS NIMI over the dry 
period.  Results of this study could then be used to guide recommendations regarding the 
level of treatment (quarter versus cow) in selective DCT treatment protocols.  
 
5.3 MATERIALS AND METHODS 
 
5.3.1 Sources of data 
The data used in the analysis of the effect of ITS on the interdependence of 
mammary quarters towards NIMI during the dry period originated from two separate 
sources: a SDCT trial and a longitudinal cohort study.  Treatments in both sources were 
applied at the cow level, but infection status was determined at the quarter level.     
Selective dry cow therapy trial.  A clinical trial was conducted to evaluate the utility of 
an on-farm milk culture system when used in a SDCT program and involved sixteen 
dairy herds with a low BTSCC (<250,000 cells/mL) (Cameron et al., 2013; Cameron et 
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al., 2014).  Within each herd, cows with a low SCC (<200,000 cells/mL) on the last three 
milk tests prior to drying off and a California mastitis test score <2 in all quarters on the 
day before drying off were randomly allocated to receive BDCT, consisting of an 
infusion of DCT followed by an ITS, or SDCT.  The selection of cows for infusion with 
DCT in the latter group was based on results obtained by a Petrifilm-based on-farm 
culture system.  Using a composite milk sample collected on the day prior to drying off, 
cows with a positive Petrifilm result were infused with DCT and ITS, and cows with a 
negative Petrifilm result were infused with ITS alone.  Each herd contributed cows that 
were treated with DCT + ITS and cows that were treated with ITS alone to the final 
dataset.    
 Sample collection for submission to standard bacteriological culture consisted of 
1) a single quarter level sample collected by trained technicians on the day prior to drying 
off (dry off sample; DO), 2) a single quarter level sample collected by the dairy producer 
at 3 to 4 days postcalving (fresh cow sample 1; FC1), and 3) a single quarter level sample 
collected by a technician at 5 to 18 days in milk (fresh cow sample 2; FC2).  The results 
of standard culture, and not on-farm culture, were used in the analysis of the current 
research.        
National Cohort of Dairy Farms, Canadian Bovine Mastitis Research Network.  
Established by the Canadian Bovine Mastitis Research Network (CBMRN), the National 
Cohort of Dairy Farms (NCDF) is a national data collection platform for the purpose of 
epidemiological mastitis research (Reyher et al., 2011).  In 2006 and 2007, 91 
commercial dairy farms originating from six provinces across Canada were recruited.  
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Over the course of two years (2007 and 2008), repeated quarter milk samples were 
collected from both clinical mastitis cases and randomly selected clinically normal cows 
at various points during lactation, at drying off, and following calving.  While 
participating farms in the NCDF were selected based on BTSCC to achieve a uniform 
distribution of BTSCC from ≤ 150,000 cells/mL to > 300,000 cells/mL, for the research 
in question, only samples collected from herds with BTSCC of 250,000 cells/mL or less 
were used.  Furthermore, because individual cow data pertaining to treatments at drying 
off were not available, only herds practising BDCT (ascertained by a questionnaire on the 
subject of dry period management) were included.  Not all herds used ITS, and of the 
herds that used ITS, not all practiced blanket application of ITS.  For the analyses, 
regarding the herds that used ITS, only herds that infused ITS in all cows at drying off 
were included.  Therefore the final dataset included only herds that practiced BDCT (n = 
30), and a proportion of those herds also practiced blanket application of ITS (n = 11).        
 In the NCDF, dry period samples were collected largely by farm personnel and 
consisted of 1) single quarter level samples collected between 4 and 2 weeks before 
drying off, 2) single quarter level samples collected between 2 weeks before drying off 
and drying off, 3) single quarter level samples collected within 24 hours postcalving 
(considered the FC1 sample), and 4) single quarter level samples collected between 1 and 
2 weeks postcalving (considered the FC2 sample).  In order to be consistent with the 
SDCT trial with respect to samples collected at drying off, only those collected within 
two weeks prior to drying off were used in the analysis (considered the DO sample). 
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There were no restrictions for inclusion at the cow-level, therefore all cows with pre-
drying off and postcalving milk culture data were eligible for inclusion in the analysis.     
 
5.3.2 Milk sample collection, storage, and culture 
Techniques used for sample collection, bacteriological culture, and species 
identification in the SDCT trial were based on those used by the NCDF, which in turn 
used guidelines set forth by the National Mastitis Council (National Mastitis Council, 
1999).  All samples were collected aseptically and were maintained at -20°C until 
cultured in the laboratory.  In the NCDF, samples were processed at one of four 
laboratories using standardized methods, while samples of the SDCT trial were analyzed 
at a single laboratory common to the NCDF.  A description of the techniques used can be 
found in Cameron et al., (2014).  Samples that displayed growth of 3 or more pathogens 
were considered contaminated.  If Staphylococcus aureus was among the pathogens 
isolated in a contaminated sample, it was considered significant growth and was 
enumerated, and isolation of Bacillus spp. was classified as non-significant growth 
associated with environmental contamination. 
 
5.3.3 Definitions 
Intramammary infection.  A quarter was considered infected if ≥ 100 colony-forming 
units (cfu)/mL of milk of any pathogenic organism of interest, except for CNS, were 
cultured.  For CNS, a definition of ≥ 200 cfu/mL was used.  These definitions are in 
accordance with the recent publication of characterization of IMI based on single sample 
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bacteriological testing, and is in agreement with the National Mastitis Council (Dohoo et 
al., 2011; Lopez-Benavides et al., 2012). 
Dry period new intramammary infection.  A quarter was considered to have acquired a 
CNS NIMI over the dry period if it was uninfected at drying off but classified as infected 
with CNS postcalving.  Postcalving infection status was determined by parallel 
interpretation of FC1 and FC2.  According to parallel interpretation, a quarter was 
considered infected if either FC1 or FC2 displayed significant growth.  In cases where 
one of the postcalving samples was missing or was classified as contaminated, the quarter 
infection status was determined solely by the results of the remaining sample.   
Complete sample set.  Only cows with complete sets of samples were included in the 
analysis.  A complete set consisted of interpretable results from all four quarters for DO 
and at least FC1 or FC2.  Therefore, cows with fewer than 4 functional quarters were 
excluded. 
   
5.3.4 Statistical modeling procedure 
The outcome investigated was dry period acquired NIMI caused by CNS.  
Analyses using multilevel logistic models with random effects for herds and cows 
revealed very little variance at the herd level, thus a general estimating equation (GEE) 
with a logit link, a binomial error distribution, and an exchangeable correlation structure 
for quarters within cows was used (xtgee in Stata/IC 11.0).  General estimating equations 
have the benefit of producing population averaged estimates and make no assumption 
regarding the distribution of the random effects, but can only incorporate a single level of 
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clustering.  The main predictors in the model were a cow level predictor for the presence 
of an IMI with CNS at drying off and infusion with ITS at drying off.  The presence of 
CNS at drying off was modeled as a binary predictor with a value of 1 if CNS was 
isolated in at least one quarter, other than the quarter at risk of NIMI, based on the 
samples taken prior to the end of lactation.  To evaluate the effect of ITS on the 
interdependence of mammary quarters towards CNS NIMI, an interaction between the 
ITS treatment variable and the variable for the presence of IMI due to CNS at drying off 
was assessed.  Additional predictors considered potential confounders were parity at 
drying off (dichotomized into parity one and parity two or greater), quarter location, and 
infusion with DCT.  Susceptibility to intramammary infection was modeled by a 
dichotomous cow-level predictor for the presence of an IMI with any pathogen other than 
CNS at drying off, and a herd level variable for the prevalence of CNS was created using 
the culture results from each herd (Reyher et al., 2013).  To assess for nonlinear trends of 
herd prevalence, the fractional polynomial method was used and the best fitting model 
was determined by the deviance difference.  All biologically relevant interactions 
between the primary predictors and other variables (e.g. interaction between CNS at 
drying off and infusion with DCT) were examined and included in the final model when 
significant.  Statistical analysis was performed using Stata/IC 11.0 (StataCorp, College 
Station, TX).  Because of the relatively small numbers of NIMIs, and hence relatively 
low power of the study, statistical significance was defined as P ≤ 0.10.  
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5.4 RESULTS 
 
5.4.1 Data and descriptive statistics 
 The final dataset contained information from 9,644 quarter samples obtained from 
910 cows (3,640 unique quarters).  The SDCT trial provided data on 579 cows 
originating from 16 herds; the NCDF provided information on 331 cows originating from 
30 herds.  For the herds of the NCDF, 36.7% (11/30) used ITS in all cows at drying off.  
In total, 189 cows were missed during the FC1 sampling (756 quarter samples), and 130 
cows were missed during the FC2 sampling (520 quarter samples).  Of the quarters 
sampled at drying off, 2,847 (78.2%) did not have an IMI and were therefore considered 
at risk of acquiring a CNS NIMI over the dry period.  Table 5.1 contains a summary of 
the data included in the analysis stratified by data source.  According to standard 
bacteriological results, the apparent overall and CNS-specific intramammary infection 
pressures were greater in the herds comprising the NCDF than found in the SDCT (Table 
5.1).  Cows of the NCDF had more CNS and non-CNS IMI at drying off than cows 
enrolled in the SDCT trial, and herd prevalence of CNS was significantly higher in the 
NCDF population (Table 5.1).  Over the dry period, 449 previously uninfected quarters 
became infected with CNS for an overall quarter incidence of 15.8% (449/2,847).  
   
5.4.2 Generalized estimating equation results 
   The results of the GEE model are given in Table 5.2.  With respect to odds ratios 
(OR), values > 1 indicate that the predictor is associated with an increased risk for CNS 
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NIMI, values < 1 indicate that the predictor is associated with protection against CNS 
NIMI, and values = 1 indicate no association with CNS NIMI.  Of the main effects 
investigated in the analysis, only herd prevalence of CNS was significantly associated 
with dry period CNS NIMI.  Herd prevalence was best represented by a linear term and 
according to the GEE model, as herd prevalence increased, the odds of CNS NIMI also 
increased.   
Quarter interdependence towards CNS NIMI during the dry period was 
investigated by an interaction term between CNS infection in another quarter at drying 
off and infusion with ITS, and this term was significant with a P-value of 0.058 (Table 
5.2).  When CNS was present at drying off (i.e. isolation of CNS in at least one quarter 
other than the one of interest), the odds of acquiring a dry period CNS NIMI was not 
significantly different for quarters infused with ITS when compared to quarters not 
infused with ITS (OR = 1.04, 95% confidence interval (CI) = 0.69, 1.56).  Regarding 
quarters of cows without a CNS IMI at drying off, the odds of CNS NIMI was lower for 
quarters treated with ITS (OR = 0.59, 95% CI = 0.35, 0.99).  Furthermore, when holding 
ITS infusion status constant (i.e. all quarters infused with ITS or all quarters without 
ITS), in quarters infused with ITS, the presence of CNS in another quarter at drying off 
increased the odds of incident dry period CNS infection (OR = 1.49, 95% CI = 1.08, 
2.06), but no significant effect of CNS at drying off was observed for quarters without 
ITS treatment (OR = 0.85, 95% CI = 0.52, 1.39).   
The correlation between quarters of cows was modeled using an exchangeable 
structure with a reported within cow correlation coefficient of 0.09.  
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5.5 DISCUSSION 
 
The main objective of these analyses was to evaluate the effect of ITS on the 
interdependence of mammary quarters towards the acquisition of CNS NIMI during the 
dry period and the potential implications for selective dry cow therapy.  While it would 
have been interesting to repeat the analyses for other mastitis-causing organisms, low 
NIMI incidence rates in the data precluded the investigation of all pathogens except for 
CNS.   
 
5.5.1 Interdependence towards new intramammary infection over the dry period 
In accordance with the results of the current study, ITS did not reduce the 
interdependence of quarters towards CNS NIMI during the dry period.  There was no 
evidence to support that infusion with ITS resulted in a reduction in the risk for the within 
cow transfer of CNS from an infected quarter to an uninfected quarter. Surprisingly, in 
quarters that were infused with ITS, the presence of CNS in another quarter at drying off 
significantly increased the risk of CNS NIMI over the dry period, but this effect was not 
found in quarters without ITS treatment.  Internal teat sealants contain no antimicrobial, 
therefore strict adherence to aseptic technique during infusion is necessary to prevent 
inadvertent introduction of pathogens (Crispie et al., 2004).  It is possible that the 
presence of CNS in one quarter increased the likelihood of teat end colonization in a 
second quarter, and infusion with ITS facilitated the transfer of CNS from the teat end 
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into the mammary gland.  Alternatively, misclassification of quarters with respect to CNS 
infection status at drying off may have contributed to the observed results. The sensitivity 
of bacteriological culture using a definition of CNS infection of ≥ 200 cfu/mL is 
estimated at 56% (Dohoo et al., 2011), so potentially several negative quarters were in 
fact positive for CNS.  It stands to reason that, because cows with one CNS positive 
quarter would be more likely to have a second positive quarter, the misclassification 
occurred more frequently in quarters of cows identified with a CNS infection at drying 
off.  Infusion of a misclassified quarter (i.e. truly infected quarter classified as uninfected) 
with ITS may have caused the progression of the infection from a mild form with low 
bacterial counts to a more severe form with a greater pathogen load and thus detectable 
by bacteriological culture in samples collected postcalving.  Regarding DCT treatment in 
conjunction with ITS, 98% (400/410) of cows with a CNS IMI identified at drying off 
were infused with DCT.  Therefore, in order for either hypotheses presented above to be 
true, DCT would have to be poorly effective against CNS, either for protection against 
early dry period NIMI or cure of existing NIMI.  A discussion of DCT can be found 
below. 
In quarters belonging to cows without a CNS IMI at drying off, ITS did reduce 
the incidence of dry period CNS NIMI.  These results suggest that CNS infection over the 
non-lactating period can be partly attributed to CNS species located within the 
environment.  More than ten different CNS species have been isolated from mastitic milk 
samples, however CNS are normally not identified to species level but treated as a 
uniform group (Pyörälä and Taponen, 2009).  While commonly considered opportunistic 
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pathogens found on the skin of cows, research has established that CNS originate from 
multiple sources, including both the cow (such as infected glands and bovine skin) as 
well as the farm environment, and that reservoir type and mode of transmission are 
species-specific (Piessens et al., 2011; Piessens et al., 2012).  In the current research, 
speciation of CNS was not performed thus preventing analyses at the species-level.  
Knowledge of species distribution within CNS positive samples may have provided 
insight into the route by which cows acquired CNS NIMI over the dry period, potentially 
lending support to the hypothesis that CNS infections were environmental in origin.  
Prior studies on risk factors related to CNS IMI have reported that the environment is an 
important source of infection for both pre-calving heifers and cows (Sampimon et al., 
2009; Piepers et al., 2011).  Furthermore, in Sampimon et al. (2010), it was surmised 
environmental CNS would predominate in herds with a low BTSCC because 
maintenance of low BTSCC requires adherence to the Five Point Mastitis Control Plan, a 
mastitis control strategy which aims to reduce the prevalence of contagious pathogens 
and thus contagious species of CNS.   
 
5.5.2 Dry cow antimicrobial therapy 
According to analyses in the present study, DCT did not prevent infection with 
CNS over the dry period.  This is in agreement with the results a meta-analysis 
summarizing the effect of DCT on dry period NIMI, where it was concluded that DCT 
was not effective against CNS (Robert et al., 2006b).  Coagulase negative staphylococci 
are repeatedly identified as the primary cause of dry period NIMI despite treatment with 
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DCT causing speculation regarding the prophylactic effect of DCT against CNS (Robert 
et al., 2006a; Bradley et al., 2010; Arruda et al., 2013).  A peak in infection rate in the 
late dry period is well-supported by the literature (Oliver and Mitchell, 1983; Smith et al., 
1985; Bradley and Green, 2000).  It has also been demonstrated that, as a result of 
declining levels of active compound over time, DCT are not effective against NIMI in 
periparturient cows (Oliver et al., 1990).  Thus, for teats exposed to CNS in the late dry 
period, infusion with DCT offers little to no protection against the establishment of 
infection.  Moreover, antimicrobial resistance among CNS has been observed and may 
explain a lack of prophylactic and therapeutic effects (Makovec and Ruegg, 2003; Pitkälä 
et al., 2004; Østerås et al., 2006; Rajala-Schultz et al., 2009).  However, others consider 
CNS to respond well to antimicrobial treatment with reported DCT cure rates of 80 to 
90% (Pyörälä and Taponen, 2009).  Disagreement among researchers may be the result of 
misclassification bias.  The reported incidence rate of CNS NIMI is high, and 
concurrently the duration of infection is short (Dufour et al., 2012a).  In the absence of 
strain typing, it is possible that an IMI found at drying off was not the same CNS that was 
identified at calving, and thus it would appear that DCT was ineffective at clearing the 
prevalent CNS IMI when in fact a cure was achieved.     
 
5.5.3 Quarter location 
 In the current study, the risk of acquiring a CNS NIMI over the dry period was 
not different for different quarters within the udder.  This is in contrast with Robert et al. 
(2006a) who, in a study that evaluated the interdependence of quarters towards NIMI 
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over the dry period, observed that front quarters had more CNS NIMI than did 
hindquarters.  However, in analyses of all mastitis pathogens in aggregate, Berry et al. 
(2003) also failed to detect an effect of quarter location on the prevalence of postcalving 
IMI.  During lactation, cross-contamination between quarters due to proximity has been 
suggested as an explanation for interdependence and this hypothesis has been extended to 
the non-lactating period as well (Adkinson et al., 1993; Robert et al., 2006a; Reyher et 
al., 2013).  Adkinson et al. (1993) reported that teat ends of the hindquarters were located 
closest together and indeed, in studies based on lactational data only, CNS infections 
have been more frequently isolated in hindquarters than front quarters (Barkema et al., 
1997; Berry and Meaney, 2006).  The physical proximity hypothesis for interdependence 
over the dry period has not been upheld by prior research (Berry et al., 2003; Robert et 
al., 2006a), and it is not supported by the results of this study. 
 
5.5.4 Susceptibility parameter 
  In order to account for differences in the predilection of cows towards NIMI, a 
susceptibility parameter consisting of the presence of IMI by a pathogen other than CNS 
at drying off was included in the model.  Some of the specific factors affecting the 
susceptibility of a cow to NIMI that were not already controlled for in the analysis 
included stage of lactation, conformation, and immune system competency.  In a similar 
analysis using the complete NCDF dataset (i.e. including both lactational samples, pre-
drying-off, and postcalving samples for a total of 18,433 complete sample sets), Reyher 
et al. (2013) identified an increased risk for CNS NIMI in cows with an IMI by another 
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pathogen in one or more quarters at the previous sampling.  This effect was not observed 
in the current study and may be the result of low power.  A discussion on power in the 
present study can be found below.  It is possible that susceptibility to NIMI was greater 
for cows in the NCDF dataset than for cows in the SDCT dataset but when the two 
datasets were combined, the effect of cow susceptibility was lost.   Based on the samples 
taken, the apparent overall and CNS-specific intramammary infection pressures were 
greater in the herds comprising the NCDF.  These observed differences in infection 
pressures are likely the result of the study protocol within each data source.  For the 
NCDF, cows were chosen at random with no restrictions, thus all cows entering the dry 
period were eligible for inclusion.  For the SDCT trial, cows had to meet an SCC 
criterion of less than 200,000 cells/mL on the last three milk tests prior to drying off, and 
consequently only 46% of cows dried-off during the study period were enrolled.  Thus, 
cows comprising the NCDF (33% of the total sample size) were potentially a mix of both 
low and high SCC cows with associated low and high probabilities of infection at drying 
off.  In contrast, cows comprising the SDCT trial (67% of the total sample size) were all 
low SCC and therefore less likely to be infected at drying off.  When combined, because 
the SDCT trial made up most of the data and had low power to detect the effect of IMI at 
drying off, the susceptibility parameter was non-significant.     
 
5.5.5 Clustering of new intramammary infections 
 According to preliminary analyses using multilevel logistic regression with 
random effects of cows and herds, very little variance existed at the herd level.  With 
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inclusion of the predictor for herd prevalence of CNS, a large proportion of farm factors 
associated the occurrence of CNS NIMI were accounted for and thus the remaining 
unexplained variation within farms was minimal.  In the analysis using the complete 
NCDF dataset, Reyher et al. (2013) also identified only a small amount of herd-level 
variance when herd prevalence was included in the model.  While a within herd intra-
class correlation coefficient (ICC) was not calculated, multilevel logistic regression 
identified considerably less variance within herds than within cows, thus the ICC within 
herds would be smaller than the ICC within cows and this is in agreement with others 
(Barkema et al., 1997; Piepers et al., 2011; Reyher et al., 2013).  Clustering of NIMI 
within a cow is expected for contagious pathogens, particularly during lactation given 
that the milking routine presents many opportunities for the between quarter within cow 
transfer of microorganisms.  During the dry period however, the risk factors associated 
with milking are absent thus cross-contamination between teats would be less common.  
In the current study, the level of clustering within a cow was low (estimated ICC of 0.09) 
and thus consistent with expectations.  Prior studies have also identified cow-level 
clustering of NIMI within non-lactating cows, therefore some within-cow transmission 
must occur (Berry et al., 2003; Robert et al., 2006a).  Others have attributed this apparent 
interdependence to direct contact between teat ends when a cow lies down, or to common 
risk factors shared by the quarters of a cow such as immune competency and 
conformation (Berry et al., 2003; Robert et al., 2006a).    
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5.5.6 Herd prevalence of CNS 
The association between herd prevalence of CNS and the risk of CNS NIMI was 
expected.  Considering species of CNS that exhibit contagious properties, as the number 
of cows harbouring CNS increases, the risk of infection due to exposure to an infected 
quarter will also increase.  As previously discussed, the likelihood of cow-to-cow or 
within cow transfer of pathogens is expected to be lower during the dry period than 
during lactation.  However, non-lactating cows remain at risk of infection by pathogens 
within the environment.  For species of CNS that are environmental in nature, as levels 
within the environment increase, the risk of exposure would increase, and thus a higher 
prevalence and incidence of CNS IMI would be expected.  With respect to herd-level risk 
factors associated the incidence of CNS NIMI, bedding type has been identified as 
important in the epidemiology of CNS.  According to analyses by Dufour et al. (2012a), 
sand and wood-based products were associated with decreased risk of CNS NIMI when 
compared to straw bedding.     
The dataset used in the present study consisted of a combination of data from two 
separate sources – an SDCT trial comprising cows with a low SCC prior to drying off and 
a longitudinal cohort study without SCC restrictions.  As previously noted, these sources 
differed with respect to degree of infection, with cows comprising the NCDF having 
more prevalent and incident IMI than cows of the SDCT trial.  Inclusion of a herd level 
variable for the prevalence of CNS provided a surrogate measure of data source, thus 
enabling some control of the confounding effect of the existing inherent differences 
between the NCDF and SDCT trial.   
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5.5.7 Power and Type II error 
As a result of low numbers of CNS NIMI within the sample of quarters included 
in the analysis, it is possible that the current study lacked power thus resulting in Type II 
error.  Type II error occurs when a study fails to identify an effect when in fact the effect 
exists.  The power of a study is dependent upon both the sample size and the size of the 
effect being investigated, among other factors.  Of particular interest in the current study 
where the main association of interest consisted of an interaction term, analysis of 
interactions necessitates a larger sample size than analysis of main effects only.  Thus, the 
significance level was relaxed to P < 0.10 to reduce the risk of making a Type II error.  
Regarding the impact of CNS IMI misclassification in this study, the resulting 
bias would almost certainly be nondifferential and therefore towards the null hypothesis.   
Statistical methods to adjust for CNS IMI misclassification have been described in the 
literature and could have been used in the current study (Dufour et al., 2012).  However, 
it has also been demonstrated that the potential gains in power that result from adjusting 
for the imperfect sensitivity and specificity of bacteriological culture would be offset by 
the resulting increase in effect size and thus considerable changes in statistical 
significance were not expected, therefore no adjustments were made. 
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5.6 CONCLUSION 
 
The purpose of the analyses presented in this research was to determine if ITS 
induced independence of quarters for the acquisition of CNS NIMI during the dry period, 
and no evidence that ITS reduced interdependence was found.  As a result of low NIMI 
risk over the dry period, a very large dataset would be required in order to repeat the 
analyses for pathogens other than CNS.  Herd prevalence was an important predictor in 
the current study, therefore steps to lower levels of CNS within the herd (e.g. through 
better management of dry cow housing, changes in bedding type, etc.) will play an 
important role in reducing incidence of CNS NIMI over the dry period.  Coagulase 
negative staphylococci are group of mastitis pathogens comprising multiple species, with 
different reservoirs and modes of transmission, and various degrees of AMR.  Speciation 
and antimicrobial susceptibility testing of CNS was not done in the current study, 
therefore the authors were forced to speculate on the importance of AMR and the source 
of infection.  While independence was not demonstrated, there is still a need for quarter 
level clinical trials to truly assess if SDQT, enabled by knowledge of quarter infection 
status (e.g. obtained by an on-farm culture system) and using ITS, is a viable approach to 
dry period mastitis control that will promote udder health, concurrently lower DCT use, 
and potentially incur an economic benefit for dairy producers. 
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Table 5.1.  Summary of data included in the analysis of quarter interdependence toward new intramammary infection with coagulase 
negative staphylococci (CNS) over the dry period and the effect of internal teat sealants.  Sources of data for the analysis were a 
selective dry cow therapy trial and the National Cohort of Dairy Farms, a longitudinal cohort study for the purpose of mastitis 
research. 
 
 
Selective dry cow 
therapy trial 
National Cohort of 
Dairy Farms 
   
Number of cows 579  331  
   
Parity at drying off >1 (% of cows) 289 (49.9) 162 (48.9) 
   
Infection with CNS at drying off (% of cows)
***
 174 (30.1) 236 (71.3) 
   
Infection with other pathogen at drying off (% of cows)
***
 44 (7.6) 101 (30.5) 
   
Dry cow therapy treatment risk (% of cows)
***
 436 (75.3) 331 (100) 
   
Internal teat sealant treatment risk (% of cows)
***
 579 (100) 123 (37.2) 
   
Dry period acquired CNS infection (% of quarters)
***
 170 (8.4) 279 (34.4) 
   
Herd prevalence of CNS (% of samples)
1, *** 
 
(25
th
 percentile, median, 75
th
 percentile) 
8.4 (5.3, 8.3, 10.9) 35.2 (26.5, 34.3, 42.4) 
1
Prevalence of CNS based on samples taken within each herd 
† P ≤ 0.10, * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001; P-values from univariable analysis
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Table 5.2.  Results of a generalized estimating equation used to model the incidence of new intramammary infection (NIMI) with 
coagulase negative staphylococci (CNS) over the dry period.  Sources of data for the analysis were a selective dry cow therapy trial 
and a longitudinal cohort study. 
Variable Coefficient SE P-value Odds ratio 95% CI 
Constant -2.44 0.358 N/A N/A N/A 
Quarter position       
Left front (reference level) ─     ─  ─ ─ ─ 
Left hind -0.001 0.151 0.995 1.00 0.74, 1.34 
Right front 0.031 0.149 0.838 1.03 0.77, 1.38 
Right hind -0.066 0.154 0.669 0.94 0.69, 1.27 
Parity at drying off >1 -0.027 0.125 0.831 0.97 0.76, 1.24 
Dry cow therapy 0.055 0.204 0.787 1.06 0.71, 1.58 
Other infection(s) at drying off -0.167 0.194 0.390 0.85 0.58, 1.24 
Herd prevalence of CNS 0.061 0.007 <0.000 1.06 1.05, 1.08 
CNS IMI at drying off (CNSd/o)
1 
-0.159 0.250 0.524 0.85 0.52, 1.39 
Internal teat sealant (ITS) -0.522 0.266 0.050 0.59 0.35, 1.00 
CNSd/o x ITS 0.559 0.294 0.058 1.75 0.98, 3.11 
Contrasts 
CNSd/o ITS vs. CNSd/o ITS OR (95% confidence interval) 
Yes No vs. Yes Yes 1.04 (0.69, 1.56) 
No No vs. No Yes 0.59 (0.35, 0.99) 
No Yes vs. Yes Yes 1.49 (1.08, 2.06) 
No No vs. Yes No 0.85 (0.52, 1.39) 
 
     
1
Presence of CNS in at least quarter other than the one at risk of CNS NIMI 
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CHAPTER 6 
 
 
 
ECONOMIC ASSESSMENT OF A 3M PETRIFILM ON-FARM MILK 
CULTURE SYSTEM USED IN A SELECTIVE DRY COW THERAPY 
PROGRAM 
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6.1 ABSTRACT 
 
In many countries, blanket dry cow therapy (BDCT) is the standard protocol for 
mastitis control during the dry period.  In response to concerns regarding antimicrobial 
resistance, selective dry cow therapy (SDCT) has been suggested as an alternative with 
the potential to reduce antimicrobial use.  Recently, a Petrifilm-based on-farm culture 
system (OFCS) has been developed and validated for SDCT.  Previous research has 
estimated the economic consequences of SDCT based on somatic cell count (SCC) and 
clinical mastitis criteria, but the financial implications of SDCT based on OFCS have yet 
to be reported.  Using stochastic Monte Carlo models, the objective of this study was to 
determine the economic effect of SDCT according to results of the OFCS (OFCS-SDCT) 
and to make comparisons to BDCT, BDCT with the addition of an internal teat sealant 
(BDCT+ITS), and SDCT based on SCC and clinical mastitis criteria (SCC-SDCT).  
Additionally, the impact of the accuracy of the OFCS was examined by comparing 
observed results with those obtained from a theoretical test with perfect sensitivity (Se) 
and specificity (Sp).  The input parameters were based on data from a clinical trial 
evaluating the use of an OFCS in SDCT, information obtained from the published 
literature, and expert opinion.  Regarding reductions in antimicrobial usage, a drop in 
DCT use of 23.8% was observed under OFCS-SDCT, compared to a mean reduction of 
47.5% achieved by SCC-SDCT.  While the average cost per eligible cow was similar for 
BDCT (mean: $100.29; range: $81.50, $119.09), BDCT+ITS (mean: $110.87; range: 
$94.55, $127.19) and OFCS-SDCT (mean: $114.16; range: $95.19, $133.66), they were 
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considerably higher for SCC-SDCT, and SCC-SDCT had the greatest variation (mean: 
$147.60; range: $116.86, $178.33).  For the SCC-SDCT protocol, the model assumed the 
diagnostic accuracy of the SCC and CM criteria based on data from the clinical trial, but 
greater accuracy has been reported in the literature.  Using test characteristics of SCC and 
CM criteria based the published literature lowered the total cost (mean: $132.82; range: 
$105.67, $159.98), but SCC-SDCT still remained the most expensive and most variable 
option.  Considering a theoretical diagnostic test with perfect Se and Sp, the average total 
cost per cow was $93.55 (range: $78.10, $109.10).  The results showed that while OFCS-
SDCT resulted in a higher total cost per cow than either BDCT scenarios, it provided the 
combined benefits of lowering DCT treatment risk without increasing the risk of IMI at 
calving.  Future research direction should be the development of diagnostic methods with 
even greater accuracy, for better tests will result in larger reductions in DCT use, lower 
risk of IMI at calving, and potentially greater cost-savings for dairy producers. 
 
6.2 INTRODUCTION 
 
6.2.1 Dry period mastitis control 
The importance of the dry period with respect to mastitis control on a dairy farm 
is well-recognized.  Research into the dynamics of intramammary infection (IMI) over 
the dry period in the 1960s lead to the recommendation that all cows be infused with a 
long-acting intramammary antimicrobial at the end of lactation and it is estimated that 
88% of Canadian dairy herds and 72% of American dairy herds follow this protocol 
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(Neave et al., 1969; National Mastitis Council, 2006; USDA, 2008; Dufour et al., 2012).  
The role of dry cow antibiotic therapy (DCT) is to cure IMI that are present at the end of 
lactation and to prevent the acquisition of new intramammary infections (NIMI).  
According to meta-analysis of dry cow interventions, quarters infused with DCT have 
higher cure risk and lower NIMI risk over the dry period than untreated quarters (Halasa 
et al., 2009a; Halasa et al., 2009b).  However, as a result of decreasing levels of active 
antibiotic over time, DCT is not protective in the late dry and periparturient periods when 
rates of NIMI are elevated (Smith et al., 1985; Oliver et al., 1990; Dingwell et al., 2003).  
With the development of internal teat sealants (ITS), the prevention of dry period NIMI 
can now be accomplished without the use of antimicrobials (Woolford et al., 1998; 
Sanford et al., 2006).  Furthermore, internal teat sealants have the benefit of being 
protective against NIMI throughout the entire length of the dry period, and quarters 
infused with an ITS, either alone or in combination with DCT, have a reduced risk of 
NIMI when compared to quarters treated with only DCT (Woolford et al., 1998; Sanford 
et al., 2006; Halasa et al., 2009b).  In cows that don‘t require the therapeutic effects of 
DCT, i.e. without an IMI at drying off, prophylaxis against NIMI can be provided by ITS 
alone, therefore the requirement for blanket DCT treatment (BDCT) of all cows at the 
end of lactation is debatable. 
 
6.2.2 Selective dry cow therapy 
Choosing cows for DCT treatment based on suspected or known infection status 
at the end of lactation is known as selective dry cow therapy (SDCT).  Selective dry cow 
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therapy can result in a reduction in the use of antimicrobials in dairy production and is 
considered a more judicious approach to antimicrobial use for mastitis control during the 
dry period.  However, since BDCT is the mainstay for dry period mastitis control in 
many countries, for producers to be motivated to switch to a SDCT protocol, the udder 
health and financial outcomes of SDCT must be at least equivalent to that of BDCT.   
For selective dry cow therapy, treatment decisions are often based on somatic cell 
count (SCC) and clinical mastitis (CM) history such that cows with a monthly SCC of < 
200,000 cell/mL on all of the last three milk tests prior to drying off and no CM are 
considered low risk for IMI and are therefore not infused with DCT after the last milking 
(Torres et al., 2008; Rajala-Schultz et al., 2011).  According to the literature, 
approximately 70% of cows with an IMI at drying off will be detected, and subsequently 
treated with DCT, using this method (Torres et al., 2008).  Recently, an on-farm culture 
system (OFCS) has been developed and validated for SDCT (Cameron et al., 2013; 
Cameron et al., 2014).  The system utilizes 3M Aerobic Count Petrifilms to culture 
composite milk samples directly on the farm and provides results within 24 hours, 
enabling producers to make selective treatment decisions based on the current IMI status 
of a cow. While former selective dry cow therapy protocols have relied on historical SCC 
and CM records to make treatment decisions, the accuracy of this approach was greatly 
improved when Petrifilm-based on-farm culture was added to the protocol with a 
sensitivity (Se) of 85.2% and specificity (Sp) of 73.2% (Cameron et al., 2013).  
Furthermore, when OFCS-based SDCT was used in low bulk tank SCC herds (< 250,000 
cells/mL) on low SCC cows (< 200,000 cells/mL), the risk of IMI at calving and CM in 
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the first 120 days of the next lactation was equivalent to that observed in cows under 
BDCT (Cameron et al., 2014).   
 
6.2.3 Study objectives 
Previous research has estimated the economic consequences of SDCT based on 
SCC criteria (Berry et al., 2004; Huijps and Hogeveen, 2007; Halasa et al., 2010), but the 
financial implications of SDCT based on OFCS have yet to be reported.  The objective of 
this analysis was to determine the economic effect of selectively treating cows with DCT 
at drying off according to results of a Petrifilm-based OFCS and to make comparisons to 
both a BDCT protocol as well as an SCC and CM based selective treatment approach.   
Additionally, the impact of the accuracy of the OFCS was examined by comparing 
observed results with those obtained from a theoretical test with perfect Se and Sp. 
 
6.3 MATERIALS AND METHODS 
 
6.3.1 Clinical trial evaluation of OFCS-based SDCT 
Details of the clinical trial and on-farm culturing technique have been described in 
detail elsewhere (Cameron et al., 2014).  Briefly, inclusion criteria at the herd level 
consisted of an annual average of monthly bulk tank SCC of less than 250,000 cells/mL 
in the year prior to the study and enrolment in a dairy herd improvement (DHI) program.  
A convenience sample of 16 predominately Holstein-Friesian dairy herds were selected 
based on their proximity to the Atlantic Veterinary College, Charlottetown, PE (n = 10) 
  
172 
 
and the Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC (n 
= 6).  Cows were selected for inclusion in the trial if they had a low SCC (< 200,000 
cells/mL) on the last 3 milk tests prior to drying off, no CM in the same time period, no 
antibiotic treatment in the last 14 days, a California mastitis test score <2 in all quarters 
on the day before drying off, and an expected dry period of 30 to 90 days.  On the day 
prior to drying-off, eligible cows were randomly assigned to BDCT or OFCS-based 
SDCT.  Cows allocated to BDCT were infused in all four quarters with a long-acting 
intramammary formulation of 500 mg ceftiofur hydrochloride (Spectramast DC, Zoetis, 
Kirkland, Quebec, Canada) followed by an ITS composed of 65% bismuth subnitrate 
(Orbeseal, Zoetis, Kirkland, Quebec, Canada) at drying off.  Cows assigned to OFCS-
based SDCT had composite milk samples cultured on-farm using the Petrifilm OFCS on 
the day prior to drying off.  Cows were considered positive for IMI if ≥ 5 colonies were 
present on the Aerobic Count (AC) Petrifilm (3M Canada, London, Ontario) after 24 
hours incubation (equivalent to 50 colony forming units (cfu)/mL of milk).  At drying 
off, all quarters of cows with a positive Petrifilm result were infused with ceftiofur 
followed by an ITS, and all quarters of cows negative on Petrifilm were infused solely 
with an ITS.   
Single quarter level milk samples were collected from all participating cows on 
the day prior to drying off, at 3 to 4 days in milk (DIM) and at 5 to 18 DIM.  Samples 
were maintained at -20°C and submitted to the Maritime Quality Milk research 
laboratory at the University of Prince Edward Island for laboratory culture.  
Intramammary infection based on standard bacteriology was defined as the presence of ≥ 
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100 cfu/mL of milk of any pathogenic organism of interest, except for coagulase negative 
staphylococci (CNS).  For CNS, a definition of ≥ 200 cfu/mL was used (Dohoo et al., 
2011).  Samples with three or more differing isolates were classified as contaminated and 
isolation of Bacillus spp. was assumed to be associated with environmental 
contamination and considered non-significant growth (Reyher et al., 2013). Postcalving 
infection status was determined by parallel interpretation of the two milk samples 
obtained after calving.  According to parallel interpretation, a quarter was considered 
infected if either sample displayed significant growth.  In cases where one of the post-
calving samples was missing or was classified as contaminated, the quarter infection 
status was determined solely by the results of the remaining sample.   
      
6.3.2 Dry cow therapy strategies 
In this investigation, the economic effects of four different dry cow therapy 
protocols were evaluated: blanket dry cow therapy (BDCT), BDCT with the addition of 
an internal teat sealer (BDCT+ITS), SCC and CM guided selective dry cow therapy 
(SCC-SDCT), and Petrifilm OFCS-based selective dry cow therapy (OFCS-SDCT). 
Within each protocol, cows meeting the inclusion criteria outlined in the clinical trial 
comprised the subset of the herd for which calculations were carried out, therefore 
comparisons between interventions were based solely on cows with low SCC and no CM 
in the last 3 months prior to the end of lactation.  This approach was used to uphold the 
recommended practice of total dry cow antibiotic therapy for all quarters of cows with 
subclinical mastitis or a recent history of clinical mastitis.  Figure 6.1 illustrates 
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treatments and DCT selection procedures where applicable for each protocol.  All 
quarters of all cows in both BDCT and BDCT+ITS protocols received an infusion of 
DCT at drying off, and ITS were administered to all cows considered in the BDCT+ITS, 
SCC-SDCT, and OFCS-SDCT strategies.  In the SCC-SDCT intervention, the selection 
protocol for DCT consisted of the inclusion criteria of the clinical trial and all eligible 
cows were considered uninfected and did not receive any DCT at drying off.  For the 
OFCS-SDCT protocol, DCT treatment decisions were based on on-farm culture results 
and only cows positive on the AC Petrifilm were treated with DCT.   
 
6.3.3 Model description 
A stochastic Monte Carlo simulation model was created using @Risk 6.2.0 
(Palisade Corporation, Ithaca, New York, United States) Microsoft Excel add-in software 
to estimate the cost of the four dry period interventions.   
6.3.3.1 Input parameters. The input parameters used to simulate the dynamics of 
IMI over the dry period are listed in Table 6.1. Estimates for dry period cure risk and 
NIMI risk for DCT alone, ITS alone, and combined DCT+ITS were modeled by a 
summary estimate based on existing peer-reviewed literature.  Using PubMed (U.S. 
National Library of Medicine, Bethesda, MD), a search of the literature for clinical trials 
evaluating DCT and ITS published between the years 2000 and 2013 was conducted.  
Keywords used in the search included: teat sealant, teat seal, Orbeseal, dry cow, dry 
period, dry off,  treatment, therapy, intramammary infection, and mastitis.  Publications 
had to be peer-reviewed, report quarter-level outcome data for each of the intervention 
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groups, and report the number of quarters in each group.  An overall estimate of the effect 
(either cure risk or NIMI risk) was computed using meta-analysis methodology which 
appropriately weights the estimates of each study using the standard errors of the 
estimates (metan command; Stata/IC 11.2, College Station, TX, USA). 
The economic input parameters used to estimate the resulting costs associated 
with each intervention were based on data from the clinical trial, information obtained 
from the published literature, or expert opinion (Table 6.2).  Input values for the amount 
of labour time required for on-farm culture and application of dry cow treatments were 
based on expert opinion.  Expert opinion consisted of estimates obtained from clinical 
faculty members (n = 5) of the Atlantic Veterinary College at the University of Prince 
Edward Island, Canada.  The experts had knowledge and experience in mastitis treatment 
and control, and were familiar with regional dairy practices.  Input variables consisting of 
expert opinion were modeled using a PERT distribution in the form of most likely, 
minimum, and maximum (Van Hauwermeiren et al., 2009).        
6.3.3.2 Dynamics of intramammary infection over the dry period. The dynamics 
of IMI over the dry period was modeled via a series of consecutive steps as outlined in 
Figure 6.2.  Each iteration (10,000 per dry period scenario) of the simulation modeled an 
individual cow and began with the cow‘s IMI status at drying off as determined by the 
prevalence of IMI at the end of lactation for the cows enrolled in the source clinical trial 
(Table 6.1).  Depending on the dry period protocol in question, each cow had a 
probability of receiving DCT at drying off.  The probability of treatment with DCT was 1 
for both BDCT protocols; for SCC-SDCT, the treatment risk was 0 since all cows 
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considered in the model had low SCC and no CM prior to drying off as per the selection 
criteria.  According to OFCS-SDCT, the DCT treatment risk was dependent on the Se 
and Sp of the OFCS previously established by the clinical trial described above (Cameron 
et al., 2013).  In the model, Se and Sp were represented using a Beta distribution as 
described in Greiner and Gardner (2000).  The shape parameters of the Beta distribution 
were modelled using α = k + 1 and β = n – k + 1, where k denotes the number of correctly 
classified test results and n denotes the number of truly diseased (for Se) or truly non-
diseased (for Sp) animals (Vose et al., 1996).  The probability of infusion with DCT for 
cows with an IMI at drying off was equal to the prevalence of IMI at drying off 
multiplied by the Se of the OFCS.  Conversely, the probability of infusion with DCT for 
cows uninfected at drying off was equal to 1 – the prevalence of IMI at drying off 
multiplied by 1 - the Sp of the OFCS.   
For cows infected at drying off, the risk for a cure was dependent on the treatment 
applied (Table 6.1).  Cows that failed to cure were considered chronic and were not at 
risk for NIMI.  Cows uninfected at drying off and cows achieving a dry period cure were 
at risk for NIMI, and risk was again dependent upon the treatment(s) administered at 
drying off (Table 6.1).  Cows infected during the dry period or chronically infected due to 
failure to cure were considered infected at calving and were at risk for clinical mastitis in 
the next lactation.  The probability of clinical mastitis as a result of IMI acquired during 
lactation was assumed to be the same for all cows and was not factored into the model.  
Values for dry period cure risk and NIMI risk taken from the literature were estimates at 
the quarter level, therefore the end values for the probability of IMI at calving 
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represented quarter level risk.  In order to aggregate the quarter level values to the cow 
level, a multiplier based on the average number of quarters infected per cow with an IMI 
at calving in the clinical trial (equal to 1.3; Cameron et al., unpublished data) was 
applied.  Finally, to estimate the proportion of IMI at calving that would become clinical 
during the next lactation, a weighted average risk of CM was calculated based on the top 
three most commonly isolated pathogens at calving in the clinical trial and CM risk 
values for these pathogens obtained from the published literature (Table 6.1).  It was 
assumed that infections that did not become clinical would result in subclinical mastitis.   
6.3.3.3 Economic outcomes.  The economic outcomes were estimated by first 
simulating the total number of cows eligible for inclusion using the values for herd size, 
the proportion of cows entering the dry period, and the risk for inclusion based on the 
selection criteria (Table 6.2).  Next, the expenses associated with each of the dry cow 
therapy protocols were estimated.  The expenses considered were the cost of DCT and 
ITS, labour costs incurred during intramammary treatment and related to on-farm culture, 
the cost of the OFCS, and the cost of clinical and subclinical mastitis (Table 6.2).  It was 
assumed that herds were already enrolled in DHI, therefore no additional cost for 
monthly SCC determination was considered.  The cost of a case of clinical mastitis was 
estimated using a spreadsheet tool produced by the Canadian Bovine Mastitis Research 
Network (CBMRN; Huijps and Hogeveen, 2011) and based on a published work by 
Huijps et al (2008).  The probability of culling as a result of clinical mastitis was set at 
15% (Huijps et al., 2008) and the average culling cost was estimated at $2000 (Huijps 
and Hogeveen, 2011).  The cost of clinical mastitis was modeled as a weighted average 
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value for both non-culled and culled cases (representing 85% and 15% of cases 
respectively), and costs were calculated using both the mean Canadian milk price for 
2012 (Canadian Dairy Information Centre, 2012) as well as the mean world milk price 
for 2012 as reported by International Farm Comparison Network (International Farm 
Comparison Network, 2014).  With respect to the cost of subclinical mastitis, the cost 
was assumed to be the result of reduced milk production only (i.e. no treatment or 
veterinary fees), and once again the CBMRN tool and both milk prices were used.  The 
total cost associated with each dry cow therapy protocol was reported as cost incurred per 
eligible cow.   
To determine the indifference point at which the cost of OFCS-SDCT became 
equivalent to less costly protocols, the Se and Sp of the OFCS were changed 
independently, with all other variables remaining unchanged, until the mean total cost per 
cow for OFCS-SDCT approached that of the less expensive options. 
6.3.3.4 Alternative scenarios.  To examine model behaviour using a perfect 
diagnostic test, a model was run using a theoretical test with perfect Se and Sp.  The 
results from that model were used to determine the maximum cost such a test could incur 
that would result in an overall cost equal to that of BDCT+ITS, while simultaneously 
reducing the use of DCT. 
For the SCC-SDCT scenario, the model assumed the diagnostic accuracy of the 
SCC and CM criteria based on data from the clinical trial.  According to a study by 
Torres et al. (2008), a Se of 69.8% and Sp of 50.6% was achieved using three months of 
data, an SCC threshold of < 200,000 cells/mL, and no CM during the entire lactation to 
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identify uninfected cows (Table 6.1).  The gold standard definition of IMI used by Torres 
et al. differed slightly from the source clinical trial for pathogens other than 
Staphylococcus aureus or Streptococcus agalactiae as the requirement was set at ≥ 500 
cfu/mL.  For the purpose of comparison to the SCC-SDCT model, a second SCC and 
CM-based SDCT model was run with test characteristics obtained from Torres et al 
(2008).  Using the reported values for Se and Sp and the prevalence of IMI at drying off 
(p(D +)) from the clinical trial, the predictive value of low SCC on the last three milk 
tests and no CM in the same time frame (the predictive value of a negative test; PV-) was 
calculated using the following formula (Dohoo et al., 2009): 
    
        
                     
 
The predictive value was then used to estimate the proportion of truly negative 
and falsely negative cows observed under this scenario.  
     
6.4 RESULTS 
 
6.4.1 Standard bacteriological culture 
The pathogen data used in modelling treatment scenario outcomes was based on 
the clinical trial (described above). According to the results of standard bacteriological 
culture of quarter-level milk samples collected at drying off and within the first 18 days 
of lactation aggregated to the cow level, CNS (32.1%), environmental streptococci 
(3.7%), and Corynebacterium spp. (3.2%) were the most frequently isolated pathogens at 
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drying off; after calving, CNS (29.8%), environmental streptococci (7.8%), and 
Staphylococcus aureus (4.7%) were most commonly identified (Cameron et al., 2014).  
 
6.4.2 Summary estimates for treatment dependent cure risk and new 
intramammary infection risk  
The summary estimates for treatment dependent dry period cure risk and NIMI 
risk based on peer-reviewed literature are presented in Table 6.1.  Intramammary 
infection cure risk was comparable for DCT alone and combined DCT and ITS, whereas 
infected quarters infused with ITS alone (considered a spontaneous cure risk) had cure 
risks approximately half that of DCT treated quarters.  With respect to new 
intramammary infections, quarters treated with ITS, either alone or in conjunction with 
DCT, had lower risk than quarters infused with DCT alone.  
 
6.4.3 Results for BDCT, BDCT+ITS, SCC-SDCT, and OFCS-SDCT protocols 
The results of the stochastic models are shown in Table 6.3.  For the following, 
the average value is reported with the 5
th
 and 95
th
 percentiles in parentheses.  In all 
protocols, 38 (28, 50) cows were deemed eligible for inclusion.  Under OFCS-SDCT, 
49.8% (46.2%, 53.4%) of eligible cows were selected to receive DCT.  Considering the 
average values for inclusion risk and DCT treatment risk, a drop in DCT use of 23.8% 
was observed under OFCS-SDCT, compared to a mean reduction of 47.5% achieved by 
SCC-SDCT.   
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While SCC-SDCT resulted in the largest decrease in DCT usage, the risk of IMI 
at calving, and similarly the risk for CM in the next lactation, was highest for this 
scenario.  For the remaining scenarios, intramammary infection risk at calving was lowest 
for BDCT+ITS, followed by OFCS –SDCT and BDCT, but the differences between these 
protocols was small. 
The cost of dry cow treatments including labour was highest for BDCT+ITS, 
followed by OFCS-SDCT; SCC-SDCT had the lowest treatment related costs.  For the 
OFCS-SDCT scenario, the cost of the OFCS was $8.43 ($7.42, $9.58) per eligible cow.      
  The overall cost of the dry period intervention per eligible cow was lowest in the 
BDCT scenario and highest for SCC-SDCT.  While average total costs were similar for 
both BDCT scenarios and for OFCS-SDCT, they were considerably higher for SCC-
SDCT, and SCC-SDCT displayed the most variation.  A graphical representation of total 
costs per dry cow therapy protocol is illustrated in Figure 6.3.  The indifference point at 
which the total cost per cow for OFCS-SDCT became equivalent to BDCT+ITS was 
reached at a Se of 92% (mean total cost per eligible cow $110.86) or at a Sp of 93% 
(mean total cost per eligible cow $110.81).             
 
6.4.4 Results for alternative scenarios 
The results of the alternative models are listed in Tables 6.3 and 6.4.  Considering 
a theoretical diagnostic test with perfect Se and Sp, total costs for materials and labour  
incurred by the test could amount to a maximum of $17.32 ($16.45, $18.09) and be 
equivalent to costs associated with BDCT+ITS (Table 6.3). 
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When compared to the clinical trial-based SCC-SDCT protocol, estimations using 
Torres et al., (2008) test characteristics resulted in a lower false negative risk (32.5% vs. 
39.4%) and a reduction in the proportion of cows with an IMI at calving (33.0% vs. 
37.4%; Table 6.4).  As a result, the mean estimated cost for a SDCT scenario based on 
SCC and CM history was reduced to $132.82 (vs. $147.60 for SCC-SDCT; Table 6.4).  
   
6.5 DISCUSSION 
 
6.5.1 Total cost per eligible cow 
Using stochastic modeling, the economic outcome of an OFCS guided SDCT 
program was compared to BDCT with and without the addition of an ITS, and SCC-
based SDCT.  The most cost-effective dry period treatment intervention was BDCT 
without ITS and this is in agreement with Halasa et al. (2010).  Addition of an ITS to the 
BDCT protocol resulted in a higher net cost due to the additional labour and material 
expenses, however the overall probability of IMI at calving was lowest for this option.  
While the current study, which focused on herds with low bulk tank SCC and presumably 
low infection pressures, failed to demonstrate the economic advantage of ITS, it is 
possible that considering herds with a greater infection risk may have produced different 
results.  Prior research has demonstrated that the cost-effectiveness of ITS is most 
sensitive to the rate of NIMI during the dry period and that in herds with high rates of 
IMI during the dry period, BDCT with that addition of ITS becomes economically 
advantageous over BDCT (Halasa et al., 2010).      
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In the majority of cases, economic outcomes guide farm management decision 
making and producers could use analyses such as the one presented here to help make 
farm specific decisions.  Producers wanting to minimize the costs of dry period 
interventions will choose BDCT.  While cost differences between treatment protocols did 
exist, the choice of treatment strategy will also depend on non-economic factors.  For 
producers motivated to adopt a more targeted approach when administering antimicrobial 
products, the scenario resulting in the greatest reduction in DCT use would be the most 
appealing.  In that case, a producer could choose OFCS-SDCT with the knowledge that a 
reduction in DCT can be achieved without increased risk of IMI at calving and only a 
moderate increase in cost per cow.   
Presently in North America there are no policies preventing conventional dairy 
producers from using BDCT and therefore producers may not be highly motivated to 
switch to SDCT.  Conversely, in certain European countries the pressure to reduce 
antimicrobial use in food animal production is high, resulting in stricter regulations 
regarding their application.  For instance, in Norway where the use of antimicrobial drugs 
is highly regulated, SDCT is the recommended practice and BDCT is never used (Østerås 
and Sølverød, 2009).  In the Netherlands, the Ministry of Economic Affairs, Agriculture 
and Innovation called for a mandatory 50% reduction in antimicrobial use on all farms by 
2013 based on 2009 levels (SDA, 2012).  Historically, Dutch dairy producers have relied 
on BDCT for dry period mastitis control (Lam et al., 2013), however with the recent 
introduction of financial penalties for failing to reduce antibiotic usage, transitioning to 
an effective SDCT program is one method by which producers can meet the restrictions 
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outlined by the current Dutch strategy.  When more attention is focused on the use of 
antimicrobials in food animal production systems, alternatives that promote a more 
judicious approach to antimicrobial treatment of dairy cows will become more important.  
In 2012, the Food and Drug Administration of the United States (FDA) presented a 
guidance document titled: The Judicious Use of Medically Important Antimicrobial 
Drugs in Food-Producing Animals.  The purpose of this document was to outline a set of 
general practices that promote the judicious use of antimicrobial drugs in food animal 
agriculture (FDA, 2012).  While the outlined recommendations were nonbinding, the 
creation of this guidance document reflects the increasing importance of the issue of 
antimicrobial use in food producing animals in the United States.    
 
6.5.2  Accuracy of the selection protocol in SDCT 
The success of a SDCT program is dependent upon the accuracy of the treatment 
selection protocol used.  For SDCT to be economically beneficial, both test Se (defined 
as the proportion of cows with an IMI identified as infected by the test) and test Sp 
(defined as the proportion of cows without an IMI identified as uninfected by the test) are 
important.  As sensitivity increases, the risk of failing to treat cows with an IMI at drying 
off decreases; as Sp increases, the proportion of cows receiving unnecessary DCT 
treatment decreases.  The OFCS-SDCT economic model became a cost indifferent option 
to BDCT+ITS when the OFCS achieved a high Se of 92% or a high Sp of 93%.           
While no test for mastitis has perfect Se and Sp, even a theoretical perfect test will 
have to be priced such that the cost of implementation is equivalent to, or less than, the 
  
185 
 
cost of current DCT practices.  According to the estimates of this study and using 
BDCT+ITS as the base scenario, the combined cost of materials and labour required to 
obtain perfect information regarding a cow‘s IMI status at drying off should not exceed 
$17 per eligible cow.  Implementation of SDCT based on a perfect diagnostic test would 
result in a 28.8% reduction in DCT use.  By comparison, OFCS-SDCT resulted in a 
23.8% DCT reduction, marginally lower than a perfect test but at an average cost of 
$3.29 more than BDCT+ITS per eligible cow.  Within the current study, selective 
treatment decisions were made at the cow-level and achieved modest decreases in DCT 
use, but greater reductions in DCT use could be effected when treatment decisions are 
made at the quarter level.  Application of the OFCS at the quarter level would enable 
selective dry quarter treatment, but would result in higher material and labour costs 
associated with on-farm culture.  Quarter-level culture has the benefit of increased Se 
over cow-level composite sample culture (Reyher and Dohoo, 2011), therefore it is 
possible that reductions in false negative test results and missed treatments, leading to 
decreases in IMI at calving and lactational mastitis, might offset the increased costs of 
quarter-level culture. 
 
6.5.3  Selective dry cow therapy based on SCC and CM history    
The main objective of this research was to determine the economic viability of 
Petrifilm on-farm culture-based SDCT.  As part of that objective, a comparison was made 
with SDCT based on SCC and CM history.  Not only did SCC-SDCT bear the highest 
average total cost, but the variation in total cost was greatest for this protocol, and thus 
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would result in the most risk.  For herds enrolled in DHI, this option does not incur 
additional costs but as the results show, the economic success of such an approach 
depends greatly on the ability of this method to accurately determine the infection status 
of a cow.  Following SCC-SDCT and using data from the clinical trial, a large percentage 
of infected cows would not have received treatment.  Consequently, the risks of IMI at 
calving and mastitis during lactation were high for this scenario. One of the assumptions 
of the model was that all infections present at calving, either as a result of failing to cure 
or newly acquired infections, would result in either CM or subclinical mastitis in the 
subsequent lactation.  In reality, self-cure of IMI does occur, therefore the estimates for 
the effect of IMI at calving are overestimated.   
Using Torres et al. (2008) test characteristics, the outcome of SCC and CM-based 
SDCT was more favourable.  As a result of a different gold standard definition of IMI 
used in Torres et al., a proportion of the infections detected in the clinical trial would 
have been classified as non-significant according to Torres et al., thus explaining a lower 
apparent false negative rate. For the clinical trial described in this paper, the definition of 
IMI was chosen with the aim of identifying as many existing infections as possible, as 
described by Dohoo et al. (2011) and is in agreement with the National Mastitis Council 
(Lopez-Benavides et al., 2012).  Furthermore, the criteria used by Torres et al. differed 
slightly from those outlined in the selection criteria of the clinical trial such that the 
requirement for no clinical mastitis extended to the entire lactation as opposed to the last 
three months of lactation.  A more rigorous inclusion criterion would result in higher Se 
(and lower false negative risk), but at the expense of lower Sp (and a higher false positive 
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risk).   Finally, when considering using monthly SCC data to made SDCT decisions, an 
important factor to consider is the potential effect of the test date interval.  Because milk 
test-day intervals are typically one month or more in length, the information may not 
reflect the actual state of the cow at the end of lactation.  Conversely, Petrifilm on-farm 
culture, when performed on the day prior to drying off, provides producers with an up-to-
date assessment of a cow‘s IMI status.   
 
6.5.4 Cure risk and NIMI risk 
According to the models used in this analysis, no consideration was given to the 
variation in cure risk and NIMI risk that exists for different pathogens.  The most 
prevalent pathogen at drying off in the trial dataset was CNS.  As a group, CNS is 
considered to respond well to antimicrobial treatment with reported DCT cure rates of 80 
to 90% (Pyörälä and Taponen, 2009) and the DCT cure rates used in the modeling of the 
dynamics of IMI fall within this range.  Coagulase negative staphylococci were also the 
most commonly isolated pathogen post-calving.  This was not an unexpected finding as 
in many countries including Canada, CNS are the most common cause of IMI and are 
considered to be an emerging mastitis pathogen (Pyörälä and Taponen, 2009; Schukken 
et al., 2009; Reyher et al., 2012). 
 
6.5.5 Risk of IMI at calving 
With respect to the effect of dry period treatments on the dynamics of IMI over 
the dry period, the probability of IMI at calving was marginally higher for OFCS-SDCT 
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as compared to BDCT+ITS.  Previous work has demonstrated that the Petrifilm OFCS is 
an accurate tool for the identification of IMI at drying off, providing timely results with 
good Se and Sp.  Moreover, the selective treatment of cows at the end of lactation based 
on Petrifilm culture results did not increase the risk of IMI at calving nor the risk of CM 
in the first 120 days of the subsequent lactation.  Selective dry cow therapy based on SCC 
resulted in nearly twice the risk of IMI at calving, suggesting that, while initial antibiotic 
use was minimized, a treatment selection protocol based on monthly SCC alone would 
risk higher mastitis incidence versus the other approaches evaluated.  Surprisingly, the 
risk of IMI at calving was higher for BDCT+ITS than for SDCT based on a perfect 
diagnostic test.  According to the summary estimate of NIMI risk based on published 
literature, quarters treated with ITS alone had a lower risk of NIMI than quarters treated 
with both ITS and DCT, and thus produced the observed outcome.      
 
6.6 CONCLUSIONS 
 
Stochastic models were built to determine the costs associated with Petrifilm 
OFCS-based SDCT, and to make comparisons with BDCT, BDCT+ITS, and SCC-
SDCT.  Although blanket dry cow therapy without the addition of ITS was economically 
the best option and SCC-SDCT was the most costly, the estimated average cost per cow 
for BDCT, BDCT+ITS, and OFCS-SDCT were similar.  Regardless of the test 
characteristics used (clinical trial data or Torres et al., 2008), an SDCT protocol based on 
SCC and CM history always resulted in the highest and most variable costs.  The results 
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showed that while OFCS-SDCT resulted in a numerically higher total cost per cow than 
either BDCT scenarios, it provided the combined benefits of lowering DCT treatment 
risk without increasing the risk of IMI at calving.  When industry goals are to target 
antimicrobial use for the purpose of therapy rather than prophylaxis, there will be an 
opportunity for implementation of OFCS-based SDCT.  Future directions for SDCT 
research include: 1) the development of diagnostic methods with even greater accuracy, 
for better tests will result in larger reductions in DCT use, lower risk of IMI at calving, 
and potentially greater cost-savings for dairy producers, and 2) evaluation of the 
economic effects of selective treatment at the quarter level, for quarter level treatments 
could also reduce the necessity for DCT in dairy herds.   
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Table 6.1 The values (%) used to model the dynamics of intramammary infection (IMI) 
across the dry period for the following dry period interventions: blanket dry cow therapy 
(BDCT), BDCT plus internal teat sealant (ITS), selective dry cow therapy (SDCT) based 
on results of an on-farm culture system, and SDCT based on clinical mastitis and somatic 
cell count history.  
Input parameter Value 
3M Petrifilm on-farm culture system sensitivity
1 
85.2 
3M Petrifilm on-farm culture system specificity
1 
73.2 
Prevalence of IMI at drying off
2 
39.4 
Probability of cure with dry cow therapy (DCT) alone
3 
85.3 
Probability of cure with DCT + internal teat sealant (ITS)
4 
88.0 
Probability of cure with ITS alone
5 
46.4 
Probability of new IMI with DCT alone
6 
12.5 
Probability of new IMI with DCT+ITS
7 
11.0 
Probability of new IMI with ITS alone
8 
9.7 
Probability of clinical mastitis given IMI at calving
9 
20.0 
1
Cameron et al., 2013 
2
Data from clinical trial; Cameron et al. (unpublished data) 
3
Huxley et al., 2002; Berry and Hillerton, 2002b; Godden et al., 2003; Cook et al., 2005; Newton 
et al., 2008; Bradley et al., 2010; Bradley et al., 2011; Arruda et al., 2013 
4
Godden et al., 2003; Cook et al., 2005; Newton et al., 2008; Bradley et al., 2010; Bradley et al., 
2011; Cameron et al., 2014
 
5
Huxley et al., 2002; Berry and Hillerton, 2002a; Bradley et al., 2010; Cameron et al., 2014
 
6
Huxley et al., 2002; Berry and Hillerton, 2002b; Godden et al., 2003; Cook et al., 2005; Sanford 
et al., 2006; Berry and Hillerton, 2007; Newton et al., 2008; Bradley et al., 2010; Bradley et al., 
2011; Arruda et al., 2013
 
7
Godden et al., 2003; Cook et al., 2005; Sanford et al., 2006; Berry and Hillerton, 2007; Newton 
et al., 2008; Bradley et al., 2010; Bradley et al., 2011; Cameron et al., 2014
 
8
Huxley et al., 2002; Berry and Hillerton, 2002a; Sanford et al., 2006; Bradley et al., 2010; 
Cameron et al., 2014
 
 
9
Todhunter et al., 1995; Swinkels et al., 2005; Taponen et al., 2006; Cameron et al., 2014 
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Table 6.2 The input parameters used to estimate the total cost per eligible cow for the following dry period interventions: blanket dry 
cow therapy (BDCT), BDCT plus internal teat sealant (ITS), selective dry cow therapy (SDCT) based on results of an on-farm culture 
system (OFCS), and SDCT based on clinical mastitis and somatic cell count history.  
Input parameter Distribution Value Source 
Herd size fixed 100 Basis for analysis 
Proportion of cows dried off, % fixed 80 Data from clinical trial;  
Cameron et al. (unpublished data) 
Inclusion risk, % triangular 46.0 (28.3, 69.4)
1 
Cameron et al., 2014 
OFCS, CAD$/cow triangular 6.00 (5.00, 8.00)
1 
Maritime Quality Milk
2
; 3M Canada
3
  
DCT, CAD$/cow fixed 22.40 Commercial products
4 
ITS, CAD$/cow fixed 20.48 Commercial products
4 
Labour, CAD$/hour 
 
triangular 16.00 (10.00, 16.00)
1 
MacDonald et al., 2011; Government of Canada 
Labour Program minimum wage database
5 
Labour time, minutes    
OFCS PERT 9 (5, 15)
1 
Experts
6
 
DCT or ITS alone PERT 3 (1, 5)
1 
Experts
6
  
DCT + ITS PERT 5 (2, 7)
1 
Experts
6 
Clinical mastitis, CAD$/case 
 
discrete 
 
600, 800
7 
Canadian Bovine Mastitis Research Network
8
; 
Huijps et al., 2008 
Subclinical mastitis, 
CAD$/lactation 
discrete 170, 325
7 
Canadian Bovine Mastitis Research Network
8
; 
Huijps et al., 2008 
1
Most likely (minimum, maximum) 
2
www.milkquality.ca (accessed January 20
th
, 2014) 
3
www.3m.com/intl/ca/ (accessed January 20
th
, 2014) 
4
Values obtained from the pharmacy of the Atlantic Veterinary College at the University of Prince Edward Island, Charlottetown, PE 
5
Average minimum wage used as minimum value; http://srv116.services.gc.ca/dimt-wid/sm-mw/rpt1.aspx?lang=eng (accessed January 20
th
, 2014) 
6
See acknowledgements for details 
7
Low value based on World milk price; high value based on Canadian milk price; each value modeled with 50% probability 
8
http://www.medvet.umontreal.ca/rcrmb/en/page.php?p=13&tm=s (accessed January 20
th
, 2014) 
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Table 6.3 Results of stochastic models to determine the total cost (CAD$) per eligible cow for the following dry period interventions: blanket dry 
cow therapy (BDCT), BDCT plus internal teat sealant (BDCT+ITS), selective dry cow therapy based on results of an on-farm culture system 
(OFCS-SDCT), SDCT based on clinical mastitis and somatic cell count history (SCC-SDCT), and SDCT based on a theoretical perfect test. 
Results are presented as the average value with 5
th
 and 95
th
 percentiles in parentheses where applicable. 
Item OFCS-SDCT
 
SCC-SDCT
 
BDCT+ITS
 
BDCT
 
Perfect Test SDCT
 
Eligible cows, n 38 (28, 50) 38 (28, 50) 38 (28, 50) 38 (28, 50) 38 (28, 50) 
DCT
1
, % 49.8 (46.2, 53.4) 0 100 100 39.4 
IMI
2
calving, % 21.6 (20.8, 22.6) 37.4 19.8 22.8  18.7 
CM
3
 risk, % 4.3 (4.2, 4.5) 7.5 4.0 4.6 3.7 
OFCS cost 8.43 (7.42, 9.58) N/A N/A N/A N/A
 
Dry cow treatments 
(materials and labour) 
32.56 (31.73, 33.42) 21.18 (21.05, 21.27) 44.05 (43.82, 44.20) 23.10 (22.97, 23.19) 30.19 (30.02, 30.31) 
CM
3
 cost 30.30 (25.18, 35.74) 52.36 (44.88, 59.84) 27.68 (23.72, 31.63) 31.97 (27.41, 36.54) 26.24 (22.50, 29.99) 
SubCM
4
 cost 42.86 (28.53, 58.13) 74.05 (50.87, 97.24) 39.15 (26.89, 51.40) 45.22 (31.06, 59.38) 37.12 (25.49, 48.74) 
Total costs per  
eligible cow 
114.16 
(95.19, 133.66) 
147.60 
(116.86, 178.33) 
110.87 
(94.55, 127.19) 
100.29 
(81.50, 119.09) 
93.55 
(78.10, 109.01) 
1
DCT: dry cow therapy  
2
IMI: intramammary infection  
3
CM: clinical mastitis  
4
subCM: subclinical mastitis 
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Table 6.4 Results of stochastic models to determine the total cost (CAD$) per eligible 
cow for selective dry cow therapy (SDCT) based on clinical mastitis (CM) and somatic 
cell count history (SCC) such that cows with SCC <200,000 cells/mL on the last three 
milk tests prior to drying off and no CM would not receive dry cow therapy (DCT) at 
drying off.  The SCC-SDCT model used data collected as part of a clinical trial 
evaluating an on-farm culture system for use in a SDCT program (Cameron et al., 2013 
and 2014); the Torres-SDCT model used test characteristics for SCC and CM selection 
criteria as reported by Torres et al. (2008; sensitivity: 69.8%, specificity: 50.6%).  Results 
are presented as the average value with 5
th
 and 95
th
 percentiles in parentheses where 
applicable. 
Item SCC-SDCT
 
Torres-SDCT
 
Eligible cows, n 38 (28, 50) 38 (28, 50) 
DCT, % 0 0 
IMI
1
calving, % 37.4 33.0  
CM risk, % 7.5 6.6 
Dry cow treatments 
(materials and labour) 
21.18 (21.05, 21.27) 21.18 (21.05, 21.27) 
CM cost 52.36 (44.88, 59.84) 46.24 (39.64, 52.85) 
SubCM
2
 cost 74.05 (50.87, 97.24) 65.40 (44.92, 85.88) 
Total costs per eligible cow 147.60 (116.86, 178.33) 132.82 (105.67, 159.98) 
1
IMI: intramammary infection 
2
subCM: subclinical mastitis 
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Figure 6.1  Flowchart describing dry cow therapy protocols modeled using stochastic methods to estimate the cost of dry period 
mastitis control.  Blanket dry cow therapy (BDCT), BDCT plus internal teat sealant (BDCT+ITS), selective dry cow therapy based on 
results of an on-farm culture system (OFCS-SDCT), and SDCT based on clinical mastitis and somatic cell count history (SCC-SDCT).  
SCC: somatic cell count; DCT: dry cow antibiotic therapy; ITS: internal teat sealant. 
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Figure 6.2  Event tree for the dynamics of intramammary infection (IMI) over the dry period for cows under either blanket or 
selective dry cow therapy protocols. DCT: dry cow therapy; CM: clinical mastitis; SC: subclinical mastitis. 
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Figure 6.3  Graphical representation of the cost of various dry period mastitis control programs as estimated by stochastic models.  
Bars extend from 5
th
 to 95
th
 percentiles with average value located at the white line.  Blanket dry cow therapy (BDCT), BDCT plus 
internal teat sealant (BDCT+ITS), selective dry cow therapy based on results of an on-farm culture system (OFCS-SDCT), SDCT 
based on clinical mastitis and somatic cell count history (SCC-SDCT), and SDCT based on a theoretical test with perfect accuracy. 
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CHAPTER 7. SUMMARY AND GENERAL DISCUSSION 
 
7.1. GENERAL DISCUSSION 
7.1.1 Rationale for study 
Mastitis is the most common disease in dairy cattle worldwide, and as a result it is 
the number one indication for antimicrobial use in the dairy industry (Seegers et al., 
2003; Halasa et al., 2007; Pol and Ruegg, 2007; Saini et al., 2012).  In many countries, 
including Canada and the United States, mastitis control during the dry period includes  
treatment of all cows with dry cow antimicrobial therapy (DCT) at the end of lactation 
(Barkema et al., 1998; Berry and Hillerton, 2002; Robert et al., 2006b; USDA, 2008; 
Dufour et al., 2012).  The purpose of DCT is to cure existing intramammary infections 
(IMI) and prevent new intramammary infections (NIMI).  In response to growing 
concerns regarding the use of antimicrobials in food-producing animals, selective dry 
cow therapy (SDCT) is being promoted as an alternative to a blanket application 
approach (blanket dry cow therapy: BDCT), with the potential to reduce the amount of 
antimicrobials used in dairy production (Rindsig et al., 1978; Østerås et al., 1991).  
According to a SDCT protocol, DCT is reserved for cows with an IMI at drying off, 
therefore the success of a SDCT program requires the accurate identification of a cow‘s 
end-of-lactation infection status. 
Previous studies have investigated DCT selection strategies based on California 
mastitis test (CMT) scores, as well as monthly somatic cell counts (SCC) combined with 
clinical mastitis history. In general, reliance on these methods to dictate the infusion of 
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DCT will result in the failure to detect, and subsequently treat, approximately 30% of 
infected cows.  While less concerning from a mastitis control standpoint, these criteria 
also lack specificity and consequently the risk for DCT treatment of uninfected cows 
remains high (Sanford et al., 2006b; Torres et al., 2008; McDougall, 2010; Rajala-Schultz 
et al., 2011).  With the advent of on-farm systems for the bacteriological culture of milk, 
producers have at their disposal a diagnostic tool for the detection of IMI with a quick 
turnaround time.  The 3M Petrifilm on-farm culture system (OFCS) was developed by 
McCarron et al. (2009) for the purpose of selective treatment of clinical mastitis in 
lactating cows.  In laboratory trials to assess the ability of the OFCS to detect IMI at 
drying off, the 3M Aerobic Count Petrifilm correctly identified infected cows with 100% 
sensitivity at colony cut-off values of 5, 10 and 20.  Using the same cut-off values, the 
specificity was 70, 82 and 84%, respectively (McLaughlin et al., 2010). To fully evaluate 
the effectiveness of the OFCS for use in a SDCT program, application of the technology 
at the farm level was necessary to assess the ability of dairy producers to diagnose 
infection status at drying off, and to follow-up with outcomes of the subsequent lactation 
and the economic effects of OFCS-based SDCT.   
 
7.1.2 Study Design  
 A clinical trial was conducted using 16 predominantly Holstein dairy herds from 
Prince Edward Island (n = 10) and Quebec (n = 6) with a 12 month average bulk tank 
SCC <250,000 cells/mL prior to the commencement of the study.  Only low bulk tank 
SCC herds were enrolled because of the recommendation that SDCT be reserved for 
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herds with good control of contagious mastitis pathogens and a low prevalence of IMI at 
drying off.  The Petrifilm on-farm culture system was set-up on each of the participating 
farms and producers were provided with DCT and internal teat sealants (ITS) for the 
treatment of cows at the end of lactation.   Within each herd, cows with a monthly SCC 
<200,000 cells/mL on the last three tests prior to the end of lactation, no clinical mastitis 
in the same time-frame, and a CMT score of <2 in all quarters on the day prior to drying 
off were randomly assigned to either the study group or the positive control group.  
Eligibility criteria at the cow-level were chosen to reflect the criteria commonly used by 
current SDCT protocols (Torres et al., 2008).  Treatments in the positive control group 
(BDCT) consisted of infusion with DCT followed by ITS in all quarters.  Treatments in 
the study group (OFCS-based SDCT) were dependent upon the results of the OFCS 
when used to process composite milk samples collected on the day prior to drying off.  
Cows with a positive Petrifilm result received DCT plus ITS, while cows with a negative 
Petrifilm result received only ITS.  Blanket application of ITS was used in order to 
provide some form of prophylaxis against NIMI, which was particularly important in 
cows not receiving DCT at drying off (Sanford et al., 2006a).  Considering that the 
clinical trial involved only commercial herds, it was expected that participating dairy 
producers would be averse to leaving cows completely unprotected against NIMI for the 
duration of the dry period.   
 While treatment decisions in the current trial were made at the cow-level, a theme 
throughout the thesis was that treatment decisions at the quarter-level could lead to even 
greater reductions in DCT use on dairy farms.  Previous work has demonstrated quarter 
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interdependence towards dry period NIMI, thus recommendations are to make selective 
DCT treatment decisions at the cow-level (Berry et al., 2003; Robert et al., 2006a).  In 
order to determine the effect of ITS on the interdependence of quarters towards dry 
period NIMI, a second dataset was combined with the data from the clinical trial to 
provide information from cows not infused with ITS.  The additional dataset consisted of 
a longitudinal cohort study that was conducted from 2007 to 2008 and involved 91 
Canadian herds (Reyher et al., 2011).  For the current research, herds within the cohort 
study were chosen based on bulk tank SCC (12 month average <250,000 cells/mL) in 
order to be comparable to herds included in the clinical trial.    
 
7.2. GENERAL THESIS OVERVIEW 
 This thesis evaluated a 3M Petrifilm-based OFCS for use in a SDCT program in 
Canada.  The hypothesis was that OFCS-based SDCT would enable a reduction in the use 
of DCT without adverse effects on cow health, welfare, and milk production in the 
subsequent lactation. An initial step consisted of determination of the test characteristics 
and predictive values of the OFCS when used to detect IMI in cows at the end of 
lactation.  Comparisons were then made between cows under OFCS-based SDCT and 
cows receiving BDCT for: 1) the risk of IMI at calving, 2) the risk of a first case of 
clinical mastitis in the initial 120 days of the subsequent lactation, and 3) test day milk 
yield and SCC over the first 180 days in milk.  The economical outcomes of OFCS-based 
SDCT were estimated and comparisons were made with BDCT and with SDCT based on 
SCC and clinical mastitis criteria.  Finally, the effect of ITS on the interdependence of 
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quarters towards dry period NIMI caused by CNS was assessed so that recommendations 
with respect to level of treatment (quarter versus cow) could be made for SDCT protocols 
that also employ infusion of ITS. 
   
7.3. SUMMARY OF RESULTS 
7.3.1 Accuracy of the on-farm culture system when used to detect IMI at drying-off  
 In total, 343 cows originating from 16 herds were used to assess the performance 
of the OFCS when used to detect IMI at drying off.  According to standard 
bacteriological culture, the prevalence of IMI at drying off was 43.3%, while the 
producer-derived prevalence of IMI by Petrifilm on-farm culture results was 52.2%.  
Using a Petrifilm colony count threshold of ≥5 colonies (equivalent to 50 colony-forming 
units (cfu)/mL), the sensitivity and specificity of the OFCS were 85.2% and 73.2%, 
respectively.  Increasing the threshold to ≥10 colonies resulted in an improvement in 
specificity (86.1%), but lowered the sensitivity (71.8%).  The on-farm culture system 
demonstrated reasonably high sensitivity for detecting IMI at drying off, therefore when 
used in a SDCT program few infected cows would be missed.  While increasing the 
threshold to ≥10 colonies would result in a reduction in the unnecessary treatment of 
uninfected cows, the downside would be an increase in the misdiagnosis of infected 
cows, thus a treatment threshold of ≥5 colonies is recommended.  Compared to selective 
treatment criteria based on SCC and clinical mastitis history, or the CMT, the OFCS was 
a more accurate method to determine a cow‘s infection status at the end of lactation.  In 
fact, enrolment criteria used in the clinical trial included requirements for low SCC with 
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no clinical mastitis in the last three months of lactation and a CMT score <2 in all 
quarters prior to inclusion, yet 43.3% of cows were identified as infected at drying off 
according to standard bacteriology.  As a result, the implementation of a SDCT program 
that relies only on these criteria will result in failure to treat many infected cows.   
Using the prevalence of IMI at drying off in the current dataset, the negative 
predictive value (NPV) of the Petrifilm OFCS was 86.6%.  The negative predictive value 
increased with decreasing prevalence, and a NPV of 80 to 90% was maintained in 
populations where the proportion of cows with an IMI at drying off ranged from 55% to 
35%.  Selective dry cow therapy should only be recommended to herds with good control 
of contagious pathogens and low bulk tank SCC.  Therefore, an essential first step when 
contemplating implementation of SDCT on a farm is to determine the existing udder 
health status of the herd.   
A total of 265 Petrifilms were available for evaluation by an automated reader to 
obtain accurate colony counts.  The level of agreement between producer-derived results, 
using a threshold of ≥5 colonies, and those of the automated reader was high with a 
kappa of 0.82 and observed agreement of 91%.  Aerobic Count Petrifilms contain an 
indicator dye which stains colonies bright pink and this makes it easy to identify and 
enumerate individual bacterial colonies.  Furthermore, classification of cows into 
treatment categories using a threshold of 5 colonies was straightforward, therefore 
producers became quickly proficient at reading Petrifilms despite only minimal training 
at the onset of the trial.   
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7.3.2 Risk of IMI at calving and risk of clinical mastitis in the subsequent lactation 
The objective of dry period management regarding udder health is to minimize 
the proportion of infected quarters at the beginning of the subsequent lactation (Dingwell 
et al., 2003).  Thus, an important measure of success for OFCS-based SDCT is 
undoubtedly the prevalence of IMI at calving.  In total, 1,157 BDCT group quarters (n = 
305 cows) and 1,130 OFCS-based SDCT quarters (n = 298 cows) were available for an 
analysis of risk of IMI at calving.  The inclusion criteria of the clinical trial were met by 
46% of the cows.  Using a Petrifilm treatment threshold of ≥5 colonies (50 cfu/mL), 
45.6% (136/298) of the cows in the OFCS-based SDCT group were classified as 
uninfected and did not receive DCT at drying off.  Therefore, when the OFCS was used 
to dictate the infusion of intramammary antimicrobials, a total reduction in DCT of 21% 
was realized.   
According to univariable analysis, quarter level cure risk over the dry period was 
high and was not different between study groups (BDCT: 84.5% (95% CI: 76.0, 90.9); 
OFCS-based SDCT: 89.0% (95% CI: 81.9, 94.0); P = 0.33).  Likewise, there was no 
significant difference between quarters that received BDCT and quarters under OFCS-
based SDCT with respect to the risk of dry period NIMI (BDCT: 13.8% (95% CI: 11.8, 
15.8); OFCS-based SDCT: 14.5% (95% CI : 12.5, 16.6); P = 0.64).  A multilevel logistic 
regression model was applied to evaluate the effect of study group, and treatment within 
the study group, on the probability of postcalving IMI.  In the final model, the risk of 
postcalving IMI at the quarter-level was not different between study groups, regardless of 
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OFCS result and subsequent treatment at drying off (BDCT: 15.3%; OFCS-based SDCT: 
15.8%; P = 0.95).   
 Intramammary infections present at calving are a significant cause of clinical 
mastitis in early lactation, therefore an investigation was also undertaken to compare 
clinical mastitis risk in the first 120 days of the subsequent lactation (Bradley and Green, 
2000; Green et al., 2002).  Clinical mastitis data were available for 11 herds, 264 cows 
(1,019 quarters) belonging to the BDCT group and 261 cows (1,006 quarters) belonging 
to the OFCS-based SDCT group.  In total, there were 45 reported cases of clinical 
mastitis, with 24 cases occurring in the BDCT group and 21 cases occurring in the 
OFCS-based SDCT group. In the final multivariable logistic model, neither study group 
(P = 0.58) nor infection status at drying off based on standard culture (P = 0.22) were 
statistically significant. 
According to the present study, the selective antibiotic treatment of low SCC 
cows at the end of lactation based on OFCS results was just as effective in the treatment 
and prevention of IMI during the dry period as BDCT in herds with a low BTSCC (< 
250,000 cells/mL).  The Petrifilm on-farm culture system enabled the detection of cows 
with an IMI at the end of lactation and as a result, OFCS-based SDCT achieved the same 
level of success as BDCT with regards to infection status at calving and risk of clinical 
mastitis in early lactation. 
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7.3.3 Somatic cell count and milk yield in the subsequent lactation 
 The presence of IMI at calving, either as a result of failure to eliminate existing 
infections or acquisition of new infections, can reduce lactational milk yields by 5% 
(Hogeveen, 2003; Berry et al., 2004).  Thus, management of IMI over the dry period is 
critical for the optimization of milk production and for profitability.  The aim of the 
research outlined in Chapter 4 was to evaluate the milk quality and production outcomes 
in the subsequent lactation following OFCS-based SDCT.     
 A total of 307 BDCT group cows and 293 OFCS-based SDCT group cows were 
included in the analysis. Using repeated measures linear mixed models, two outcomes of 
interest were investigated: test day 24 hour milk production and test day natural 
logarithm SCC (lnSCC) during the first 180 days of lactation.  After controlling for the 
other independent variables included in the model (such as stage of lactation, parity, and 
previous milk production), test day milk production was not different between cows 
receiving BDCT and cows selectively treated based on OFCS results (Least square 
means: BDCT = 39.3 kg (95% CI: 37.9, 40.8) vs OFCS-based SDCT = 39.0 kg (95% CI: 
37.6, 40.5); P = 0.43).  Similarly, after adjustment for parity, stage of lactation, and 
infection status at drying off, there was no significant difference in test day lnSCC 
between cows receiving BDCT and cows selectively treated at drying off based on 
Petrifilm results (P = 0.82). With respect to SCC over the first 180 days in milk, a similar 
pattern was observed in both study groups with a rapid decrease in SCC from calving to 
approximately 50 DIM, followed by a gradual increase over time.   
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While much research has examined the outcome of SDCT on IMI at calving and 
clinical mastitis in early lactation, investigations into milk production and milk quality 
outcomes are lacking. In comparison to BDCT, OFCS-based SDCT enabled a reduction 
in the use of antimicrobials on low bulk tank SCC farms without affecting milk 
production and SCC in the subsequent lactation. 
 
7.3.4 Quarter interdependence toward dry period NIMI and effect of ITS 
 While selective dry cow antimicrobial treatment decisions are usually made at the 
cow-level, with knowledge of quarter infection status at drying off, it would be possible 
to make selective DCT decisions for individual mammary quarters.  Selective dry quarter 
therapy (SDQT) would result in even greater reductions in antimicrobial use when 
compared to SDCT (Østerås and Sandvik, 1996; Berry et al., 2003; Robert et al., 2006a), 
and the OFCS could be used to determine quarter-level infection status.  While prior 
research has demonstrated that quarters are not independent in their risk for the 
acquisition of NIMI in the dry period (Berry et al., 2003; Robert et al., 2006a), the 
hypothesis investigated in Chapter 5 was that infusion of ITS would reduce the within-
cow transmission of pathogens and thus eliminate interdependence.  The data used in the 
analysis included both data from the clinical trial, and data from a longitudinal cohort 
study known as the National Cohort of Dairy Farms (NCDF; Reyher et al., 2011).  Data 
from the NCDF was used to provide information on cows not infused with ITS at drying 
off.  The SDCT trial provided data on 579 cows originating from 16 herds; the NCDF 
provided information on 331 cows originating from 30 herds. Using a generalized 
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estimating equation logistic model, the outcome investigated was dry period acquired 
NIMI caused by coagulase negative staphylococci (CNS).  Low incidence of NIMI 
caused by other pathogens precluded the evaluation of any additional organisms.   
According to the final model, in quarters that were infused with ITS, the presence 
of CNS in another quarter at drying off significantly increased the risk of CNS NIMI over 
the dry period, but this effect was not found in quarters without ITS treatment. This 
unexpected association may have occurred as a result of introduction of teat end infection 
into the mammary gland during infusion of ITS.  Internal teat sealants do not contain 
antimicrobials, so strict asepsis must be maintained during infusion.  In quarters 
belonging to cows without a CNS IMI at drying off, ITS did reduce the incidence of dry 
period CNS NIMI, suggesting that CNS infection over the non-lactating period can be 
partly attributed to CNS species located within the environment.  Not surprisingly, 
increasing herd prevalence was also associated with increasing risk of CNS NIMI.  
Efforts to decrease the prevalence of CNS at the herd level is thus important for reducing 
the risk for dry period CNS NIMI at the quarter-level.  
In summary, there was no evidence to support that infusion with ITS resulted in a 
reduction in risk for the within cow transfer of CNS from an infected quarter to an 
uninfected quarter.  Rather, it appeared that in cows infused with ITS, the presence of 
CNS in another quarter at drying off increased the risk of CNS NIMI, but this was not 
true for cows without ITS.  This unexpected result warrants further investigations into the 
dynamics of CNS IMI over the dry period, including determination of the prophylactic 
and therapeutic effect of DCT, as well as the potential for transfer of CNS during ITS 
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infusion.  Future research would greatly benefit from speciation of CNS as prior studies 
have demonstrated that reservoir, transmission mode, and virulence of CNS are species-
specific (Supre et al., 2011; Piessens et al., 2012).  Molecular fingerprinting techniques 
would also enhance further research and would enable researchers to determine if 
prevalent CNS IMI is a source of incident CNS NIMI for the same cow.  In the current 
study, it was an initial objective to investigate different mastitis pathogens however, in 
order to repeat the analysis for other pathogens, a large dataset would be required due to 
low risk of dry period NIMI by non-CNS pathogens in herds with a low average bulk 
tank SCC.         
 
7.3.5 Economic impact 
For on-farm culture system-based SDCT to be attractive to dairy producers in 
countries where BDCT is the preferred approach, the financial ramifications of 
implementation must not be a deterrent.  Prior studies have estimated the economic 
consequences of SDCT based on SCC criteria (Berry et al., 2004; Huijps and Hogeveen, 
2007; Halasa et al., 2010), but the financial implications of OFCS-based SDCT have yet 
to be reported.  In Chapter 6, the economic outcomes of OFCS-based SDCT were 
evaluated and comparisons were made to BDCT, and to SDCT based-on SCC and 
clinical mastitis criteria.  Stochastic Monte Carlo models were used to model the 
dynamics of IMI over the dry period and estimate the cost of dry period intervention for 
cows with a low SCC and no clinical mastitis prior to drying off (i.e. cows eligible for 
SDCT as per the inclusion criteria of the clinical trial).  According to the final models, 
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BDCT was the most economical approach, but there was considerable overlap in range of 
total cost with OFCS-based SDCT, and with a BDCT approach that also included ITS.  
Included among the protocols was a SDCT approach based on SCC and clinical mastitis 
history.  The initial model was run using the performance of these criteria as determined 
by the clinical trial.  Better accuracy of SCC and clinical mastitis criteria have been 
described by others, and when the SCC-SDCT model was run an additional time using 
test characteristics from Torres et al.(2008), the economics were improved but total 
average cost was still higher than for OFCS-SDCT.  Insufficient sensitivity of SCC and 
clinical mastitis criteria meant that many infected cows were left untreated, thus the 
increased cost of SCC-based SDCT resulted from a greater proportion of IMI at calving 
than that in any of the other protocols.  Finally, a theoretical perfect test with 100% 
sensitivity and specificity was used to estimate how much such a test could cost and be 
equivalent to BDCT+ITS.  Including both materials and labour, the cost of a test 
providing perfect information could amount to $17 per cow, and implementation of a 
SDCT program using this test would result in an estimated 28.8% reduction in DCT use.  
By comparison, OFCS-SDCT resulted in a 23.8% DCT reduction, marginally lower than 
a perfect test but at an average cost of $3.29 more than BDCT+ITS per eligible cow.   
Without a clearly financially optimal option, the choice of dry period mastitis 
control program would depend on the motivation of the individual dairy producer.  
Producers looking to minimize cost would be most attracted to BDCT.  Producers 
interested in a more targeted approach to antibiotic use would be motivated to implement 
OFCS-based SDCT, and could do so with the knowledge that that a reduction in DCT can 
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be achieved without increased risk to IMI at calving and only moderate increase in cost 
per cow.  In conclusion, BDCT was economically the best option, but the cost of OFCS-
based SDCT was only marginally more. When industry goals are to target antimicrobial 
use for the purpose of therapy rather than prophylaxis, there will be an opportunity for 
implementation of OFCS-based SDCT.    
 
7.4. CONCLUDING REMARKS AND  
FUTURE RESEARCH DIRECTIONS 
This research determined that the Petrifilm-based on-farm culture system was a 
quick, simple, and accurate tool for the detection of IMI present at the end of lactation.  
Using the Petrifilm on-farm milk culture system, producers could implement SDCT on 
their farms with the knowledge that few infected cows would be missed.  Internal teat 
sealants were used in all cows to provide some form of protection against NIMI, which 
was of particular concern for quarters of cows in the OFCS-based SDCT that were 
Petrifilm negative.  As a result of the accurate identification and subsequent treatment of 
IMI present at drying off, OFCS-based SDCT achieved the same level of success with 
respect to udder health as BDCT.  Likewise, when compared to BDCT, OFCS-based 
SDCT did not affect milk production or milk quality in the subsequent lactation.  
By using the OFCS to target DCT treatment of cows at the end of lactation, a 
reduction in DCT use of approximately 21% was realized.  According to results obtained 
by the OFCS using composite samples, 47.8% of cows in the SDCT group did not have 
an IMI at drying off.  By comparison at the quarter level, 82.7% of quarters were 
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uninfected at the end of lactation as per standard bacteriology.  While application of the 
OFCS at the cow level (i.e. composite milk samples and cow level treatment) lead to a 
modest decrease in the use of DCT in the study herds, use of the culture system at the 
quarter level (i.e. quarter samples and quarter level treatment) has the potential to effect 
an even greater reduction in the use of DCT.   Moreover, quarter level culturing would 
result in an improvement in the sensitivity of the OFCS when compared to composite 
culturing (Reyher and Dohoo, 2011), thus reducing the false negative rate of the Petrifilm 
on-farm culture system.   
Quarter interdependence towards NIMI over the dry period has been 
demonstrated by others, thus the leading recommendation for selective DCT programs is 
to treat at the cow-level (Berry et al., 2003; Robert et al., 2006a).  Internal teat sealants 
provide a barrier to NIMI and could hypothetically reduce the within cow transfer of IMI, 
but studies of this potential effect are lacking in the literature.  In the present thesis, the 
application of an ITS did not reduce the risk of within-cow transfer of CNS from an 
infected quarter to an uninfected quarter.  Instead, in quarters infused with ITS, the 
presence of CNS in another quarter at drying off significantly increased the risk of CNS 
NIMI over the dry period.  This association did not occur in cows without ITS.  Internal 
teat sealants contain no antimicrobial, therefore infusion with ITS may introduce bacteria 
into the mammary gland and result in NIMI if asceptic protocols are not adhered to.  
Incorporation of an antimicrobial compound into ITS with local activity in the teat canal 
and cistern has been proposed to decrease the risk of introducing NIMI during their 
administration (Crispie et al., 2004; Crispie et al., 2005; Petrovski et al., 2011).  If such 
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products were to become commercially available, it would be of interest to investigate 
how an ITS with antimicrobial properties might impact within cow transfer of IMI in the 
dry period.  
According to economic analyses, OFCS-based SDCT was a revenue neutral 
option to BDCT+ITS.  Currently in North America, there are no regulations preventing 
the application of DCT in all quarters of all cows at drying off, thus enthusiasm for 
SDCT is likely more dependent on economic outcomes as opposed to motivation to 
reduce antimicrobial use.  Future directions for research should include the development 
and evaluation of diagnostic methods with even greater accuracy, for better tests will 
result in larger reductions in DCT use, a lower risk of IMI at calving, and potentially 
greater cost-savings for dairy producers.  Revisiting selective therapy at the quarter level, 
application of the OFCS at the quarter-level and subsequent SDQT would result in 
greater reductions in DCT use, but would result in higher labour and OFCS costs.  
Considering that quarter level culturing would improve the sensitivity of the OFCS, the 
increases in cost could potentially be offset by the greater accuracy when targeting DCT 
at drying off.  If future research were to include application of the OFCS at the quarter 
level and SDQT, an important consideration would be an assessment of economical 
outcomes. 
It is understood that the attributes of an ideal test for use in SDCT are quick and 
accurate results, cow-side application, low-cost, and easy-to-use.  As mastitis research 
focuses on the importance of CNS as an emerging mastitis pathogen, perhaps of interest 
for future development would be a on-farm diagnostic tool for the speciation of CNS.  If 
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producers had knowledge of which species of CNS would likely respond to DCT , which 
species are likely to self-cure, and which species would likely persist in spite of 
treatment, such a tool would enable them to select cows for treatment, no treatment, and 
culling based on the species of CNS isolated.  Targeting end-of-lactation treatment of 
CNS infected cows on a case-by-case manner would certainly assist in reducing the 
spread and prevalence of CNS within a herd. 
 In conclusion, selective dry cow therapy based on Petrifilm on-farm culture 
system results was successful when used in low SCC cows originating from low bulk 
tank SCC herds and resulted in a modest decrease in DCT use.  As awareness of the 
importance of judicious antibiotic use in food animal production increases, interest in 
SDCT will also increase and the availability of an accurate, cost-effective, and quick 
method to identify the end-of-lactation infection status of cows will be required.  The 
findings of this thesis are supportive of on-farm culture-based SDCT, but more research 
is warranted. 
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APPENDIX A (Chapter 2) 
Generalized estimating equation logistic model for population-averaged estimate of 
sensitivity of the Petrifilm on-farm culture system 
  
.89829308
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.78416259
. display 3.6331172 / (1+3.6331172)
3.6331172
. display exp(1.290091)
.84995472
. display 5.664655/ (1+5.664655)
5.664655
. display exp(1.734246)
end of do-file
. 
                                                                              
       _cons     1.734246   .2266138     7.65   0.000     1.290091    2.178401
                                                                              
  res_petri5        Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval]
                           Semirobust
                                                                              
                            (Std. Err. adjusted for clustering on farm_id_num)
Scale parameter:                         1      Prob > chi2        =         .
                                                Wald chi2(0)       =         .
Correlation:                  exchangeable                     max =        35
Family:                           binomial                     avg =       9.3
Link:                                logit      Obs per group: min =         1
Group variable:                farm_id_num      Number of groups   =        16
GEE population-averaged model                   Number of obs      =       149
Iteration 6: tolerance = 5.363e-07
Iteration 5: tolerance = 3.445e-06
Iteration 4: tolerance = .00002213
Iteration 3: tolerance = .00014216
Iteration 2: tolerance = .00091136
Iteration 1: tolerance = .00579122
>  corr(exchangeable) vce(robust)
.  xi: xtgee  res_petri5 if res_gs2_dc == 1 & b_random_num==1, family(binomial 1) link(logit)
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Generalized estimating equation logistic model for population-averaged estimate of 
specificity of the Petrifilm on-farm culture system 
  
.79877812
. display 3.9696384 /(1+3.9696384)
3.9696384
. display exp(1.378675)
.64095343
. display 1.785154/(1+1.785154)
1.785154
. display exp(.5795047 )
.72692756
. display 2.6620319/(1+2.6620319)
2.6620319
. display exp(.9790897)
end of do-file
. 
                                                                              
       _cons     .9790897   .2038736     4.80   0.000     .5795047    1.378675
                                                                              
res_petri5~p        Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval]
                           Semirobust
                                                                              
                            (Std. Err. adjusted for clustering on farm_id_num)
Scale parameter:                         1      Prob > chi2        =         .
                                                Wald chi2(0)       =         .
Correlation:                  exchangeable                     max =        38
Family:                           binomial                     avg =      12.1
Link:                                logit      Obs per group: min =         2
Group variable:                farm_id_num      Number of groups   =        16
GEE population-averaged model                   Number of obs      =       194
Iteration 5: tolerance = 1.022e-07
Iteration 4: tolerance = 1.804e-06
Iteration 3: tolerance = .00003186
Iteration 2: tolerance = .00056668
Iteration 1: tolerance = .01212454
>  vce(robust)
.  xtgee  res_petri5_Sp if res_gs2_dc == 0, family(binomial 1) link(logit) corr(exchangeable)
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APPENDIX B (Chapter 3) 
 
Species-specific and overall apparent new intramammary infection risk over the dry 
period for quarters receiving blanket dry cow therapy plus internal teat sealant (BDCT) 
and quarters selectively treated based on Petrifilm on-farm culture results with dry cow 
antibiotic and internal teat sealant, or internal teat sealant alone (SDCT).  New 
intramammary infections were determined using single quarter milk samples collected 
between 3 and 4 days in milk.  
 
BDCT (n = 1,017) SDCT (n = 1,023) 
Pathogen 
 
 
Staphylococcus aureus  8 (0.8) 12 (1.2) 
  
 
Streptococcus uberis 1 (0.1) 0 (0) 
Streptococcus dysgalactiae 2 (0.2) 0 (0) 
Nondifferentiated streptococci
1
 11 (1.1) 12 (1.2) 
Total environmental streptococci 14 (1.4) 12 (1.2) 
  
 
Escherichia coli  2 (0.2) 2 (0.2) 
Nondifferentiated Gram-negative bacteria 3 (0.3) 1 (0.1) 
Total Gram-negative pathogens 5 (0.5) 3 (0.3) 
  
 
Fungi & Yeast 5 (0.5) 2 (0.2) 
Coagulase negative staphylococci 58 (6.4) 62 (7.0) 
Corynebacterium spp. 4 (0.4) 4 (0.4) 
  
 
Total pathogen count 94 95 
Quarter-level
2 
92 (9.1) 95 (9.3) 
1 
Including Enterococcus spp.; does not include Streptococcus agalactiae 
2
A quarter may have been infected with up to two different pathogens 
 
